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Summary 
Since the dengue virus was first isolated in 1943, studies to understand 
the pathogenesis of dengue has long been hindered by the lack of suitable 
experimental models. In light of such crippling deficiency, molecular 
epidemiological approaches represent a viable route to understanding the role 
of the virus in dengue pathogenesis. Associations between certain dengue 
virus genotypes with severe dengue outbreaks may point to strains with 
increased pathogenicity whereas association between dengue strains with 
unusual phenotypic traits may help identify the responsible viral genetic 
determinant. 
The availability of the complete genetic blueprint of the dengue virus is 
essential in order to undertake such molecular epidemiological studies. During 
the course of this project, over two hundred complete genomes of the dengue 
virus were generated from clinical samples collected in three dengue-endemic 
Southeast Asian countries. In addition, a bioinformatics platform integrating a 
sequence database, sequence retrieval tools, sequence annotation data and 
a variety of analysis tools was developed for easy management, manipulation 
and analysis of dengue virus sequence data. 
Previous studies have mostly focused on epidemiological events in the 
Americas and Thailand. In this study, sequence data recovered from dengue 
epidemics in Indonesia, Malaysia and Singapore have uncovered some of the 
dengue virus diversity circulating in the region. The three countries appear to 
share similar pool of dengue viruses, with some viral lineages in sustained 
circulation since at least the 1970s. Sequencing of historical virus isolates 
prior to the 2004/2005 epidemics in Indonesia and Singapore revealed that 
adaptive viral evolution played little or no role in triggering those epidemics. 
Lastly, a method that utilised all available sequence data from Malaysia was 
devised to reconstruct the history of dengue virus in that country since the 
1960s. 
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Zusammenfassung 
Seit dem erstmaligen Isolieren des Dengue-Viruses in 1943, ist das 
Fehlen passender experimenteller Modelle ein Hindernis fuer die meisten 
Studien, welche die Pathogenese von Dengue untersuchen. In Anbetracht 
derart grundlegender Mängel bietet die molekulare Epidemiologie einen 
gangbaren Weg  zur Untersuchung der Rolle, welche das Virus selbst bei der 
Pathogenese von Dengue spielt. Verbindungen zwischen gewissen 
Denguevirus-Genotypen und massiven Ausbrüchen der Krankheit weisen 
unter Umständen auf Virenstämme mit erhöhter Pathogenizität hin, während 
Verbindungen zwischen verschiedenen Virenstämmen mit ungewöhnlichen 
phenotypischen Eigenschaften möglicherweise dabei helfen, den 
verantwortlichen Faktor des viralen Genoms zu identifizieren. 
Für solche molekularepidemiologischen Studien ist es essenziell, 
ueber den gesamten genetischen Fingerabdruck des Dengue-Virus zu 
verfuegen. Zu diesem Zweck wurden im Verlaufe dieses Projektes über 
zweihundert komplette Genome von Dengue-Viren aus klinischen Proben 
erzeugt, die in drei Ländern Südostasiens gesammelt wurden, in denen 
Dengue endemisch auftritt. Zusätzlich wurde zur Vereinfachung der 
Datenverwaltung eine Bioinformatikplattform entwickelt, die eine Datenbank 
für die Sequenzen, Tools zur Sequenzensuche, zusätzliche Anmerkungen zu 
den Sequenzen und eine Reihe von Analysetools miteinander integriert. 
Der Schwerpunkt bisheriger Studien lag hauptsächlich auf 
epidemiologischen Ereignissen auf dem amerikanischen Kontinent und in 
Thailand. In dieser Studie hingegen wurde der Umfang der in Indonesien, 
Malaysia und Singapur verbreiteten Denguevirus-Vielfalt aus Virensequenzen 
rekonstruiert, die bei Dengueepidemien in der Region vorgefunden wurden. In 
den drei Ländern scheint ein ähnliches Reservoir von Viren aufzutreten, 
wobei einige der Virenstämme mindestens seit den Siebziger Jahren des 20. 
Jahrhunderts stetig vertreten sind. Die Sequenzierung historischer 
Einzelproben aus der Zeit vor den Epidemien 2004/2005 in Indonesien und 
Singapur hat gezeigt, dass adaptive Virenevolution nur eine geringfuegige 
viii 
oder gar keine Rolle beim Ausbruch einer Epidemie spielt. Ausserdem wurde 
eine Methode entwickelt, mit der die Entwicklung des Dengue-Virus im Land 
ab den sechziger Jahren des 20. Jahrhundert, unter Verwendung aller 
verfügbarer malaysischen Sequenzdaten, rekonstruiert werden kann. 
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Preface 
This thesis consists of six chapters. The subject matter is the important 
tropical arboviral disease dengue. Background covering both the dengue 
disease and its etiological agent, the dengue virus, is provided in the first 
chapter entitled Literature Review. 
Apart from the first and the final sixth chapter, all other chapters are 
written in manuscript form with their own introduction, material and methods, 
results, discussion and references. A new section not found in the published 
manuscripts – Author Contributions – has been added to chapters 2–5 to 
delineate my contribution to the respective publications. 
The main theme of the work covered in this thesis involves generating, 
organising and analysing nucleotide sequence data of the dengue virus to 
better understand its molecular epidemiology. In chapters 3 and 4, dengue 
virus genome sequences obtained from virus samples collected during 
dengue epidemics in Jakarta, Indonesia in 2004 and in Singapore in 2005 
were analysed to answer pertinent questions about the role of virus genetics 
in causing outbreaks. In Chapter 5, newly-generated complete genome 
sequence information of the dengue virus were utilised to provide a historical 
account of the virus diversity in Malaysia since the 1960s, not long after 
dengue haemorrhagic fever was virologically identified in the region. Chapter 
6 summarises the results of the three studies described in chapters 2–5, 
discusses the implications arising from these results and offers suggestions 
for future work. 
1 
1. Literature Review 
1.1 Dengue the Disease 
Dengue (pronounced as den’gē) is the most common arboviral 
(arthropod-transmitted) disease and it also ranks as the most important 
mosquito-borne viral disease in the world. Some 2.5 billion people living in 
tropical and sub-tropical regions are at risk of dengue infection, which equates 
to about two-fifths of humanity (Gubler & Clark, 1995; WHO, 2009). There is 
an estimated 50-100 million infections occurring globally every year, with 
500,000 cases requiring hospitalization and causing 24,000 deaths (Halstead, 
1988; WHO, 1997). Furthermore, the number of people living in tropical and 
sub-tropical regions is set to double by the end of the century (UNEP, 2009; 
Holden 2009), thus making dengue an unqualified global threat to public 
health. 
1.1.1 Etymology 
The term “dengue” is thought to be a Spanish homonym for the Swahili 
phrase “ki denga pepo”, meaning a sudden cramp-like seizure by an evil spirit 
or plague (Christie, 1881). The name “breakbone fever”, which is attributed to 
the excruciating joint pains dengue patients suffer from, is also frequently 
used in place of dengue. 
1.1.2 Symptoms 
Dengue is an acute febrile viral disease caused by infection with one of 
the four serotypes of the dengue virus (DENV1-4). Most dengue infections are 
asymptomatic while the rest result in a wide spectrum of disease that differs in 
severity from mild undifferentiated fever, i.e. the classical dengue fever (DF), 
to the potentially fatal complications known as dengue haemorrhagic fever 
(DHF) and dengue shock syndrome (DSS) (Figure 1.1). 
Common symptoms of a classic dengue fever patient include fever, 
fatigue, rash, headache, retro-ocular pain (pain behind the eyes), arthralgia 
(joint pain) and myalgia (muscle pain), nausea, vomiting and leukopenia 
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(abnormal deficiency of leukocytes circulating in the blood). More extreme 
cases could include severe hemorrhage, loss of consciousness and abnormal 
liver and brain function (Rigau-Pérez et al., 1998). 
 
Figure 1.1. Manifestations of dengue virus infection (credit: Figure 2.1 from 
WHO, 1997). 
 
DHF, the severe form of dengue, is characterised by plasma leakage, 
thrombocytopenia (low platelet count) and haemorrhagic manifestations. DHF 
is due to increased vascular permeability believed to be caused by cytokines 
released when T cells attack dengue-infected cells (Halstead, 2007). The 
most severe form of dengue disease is DSS which includes all of the 
symptoms of classic dengue and DHF, with the addition of intense and 
sustained abdominal pain, persistent vomiting, restlessness or lethargy, a 
sudden change from fever to hypothermia with sweating and prostration, and 
shock caused by extremely low blood pressure (Rigau-Pérez et al., 1998). 
After a patient is infected with dengue virus through the bite of an 
infected female mosquito, there is an incubation period that can vary between 
3 and 14 days. The patient subsequently enters the painful febrile period 
when viremia is at its peak. Viremia ends 5-7 days after the onset of fever, 
coincident with defervescence. DHF/DSS usually develops around this time, 
and intensified observation of the patient is crucial. If DHF develops, the 
patient may rapidly go into a state of shock and die within 12 to 24 hours if left 
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untreated. After defervescence, laboratory diagnosis is based on IgG and IgM 
antibody detection. The disease progression for dengue is presented in 
schematic form in Figure 1.2. 
 
Figure 1.2. Course of dengue infection and the timings and choices of 
diagnostic methods. 
 
A person could suffer from dengue infection four times throughout 
his/her lifetime, once for each of the four DENV serotypes. Both primary (first) 
and secondary (subsequent) infections with any serotype of DENV can result 
in either the clinically less severe DF or the more severe DHF (Rosen, 1977). 
A primary dengue infection confers the recovered patient life-long immunity 
against the infecting serotype and a brief protection against infection by other 
DENV serotypes (Sabin, 1952). However, epidemiological data and some 
studies suggest that the immunity thus gained, after the lapse of the 
temporary cross-serotypic protection, increases the probability of an individual 
developing DHF when infected by a second heterologous DENV serotype 
(Halstead et al., 1967; Halstead et al., 1970). A hypothesis to explain this 
phenomenon, called antibody-dependent enhancement (ADE), proposes that 
pre-existing sub-neutralizing antibodies from the primary infection and the 
second infecting DENV serotype form complexes that bind to cells bearing 
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Fcγ receptor (FcγR) (monocytes and B cells) leading to increased virus uptake 
and replication (Figure 1.3) (Halstead, 1988). 
 
Figure 1.3. Model for antibody-dependent enhancement (ADE) of dengue 
virus replication (credit: Figure 3 from Whitehead et al., 2007).  
 
There is no specific antiviral therapy or vaccine in clinical use for 
dengue fever. Medical care is supportive in nature and focuses on monitoring 
and administration of fluids to prevent dehydration and shock, medications to 
lower fever and reduce pain, and management of bleeding complications. In 
the late 1960s, DHF fatality has been reported to be as high as 41.3% 
(Sumarmo, 1987) when healthcare providers understandably were still 
unfamiliar with the disease. Today, DHF fatality rates can exceed 20% without 
proper treatment, but can be brought down to 1% with proper medical care 
(WHO, 1997). 
1.1.3 Classification 
Although the term “dengue” is commonly used to refer to the entire 
spectrum of dengue disease, the WHO has devised a formal classification 
scheme in 1974 that defines dengue as either asymptomatic, DF or DHF/DSS 
(WHO, 1975).  The DHF category is further classified based on the number of 
haemorrhagic manifestations into four grades of severity (Table 1.1). Grade III 
and IV of DHF, where profound plasma leakage occurs, are referred to as 
Dengue Shock Syndrome (DSS). 
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Table 1.1. WHO case definition for DHF severity. 
Classification Symptoms 
Grade I 
Fever with other symptoms such as vomiting, headache, 
muscle and joint pain, skin rash: positive tourniquet test is the 
only evidence of hemorrhaging. 
Grade II Grade I symptoms and spontaneous bleeding. 
Grade III Failure of circulatory system, clammy skin, rapid and weak pulse, restlessness. 
Grade IV Severe shock, no measurable blood pressure or pulse. 
 
These guidelines were developed based on pediatric cases reported to 
the Children’s Hospital, Bangkok, Thailand in the 1960s. In recent years, 
clinicians have been reporting difficulties in following these guidelines to 
classify the disease as dengue has spread globally with a concurrent change 
in patient demographic profile (Bandyopadhyay et al., 2006; Deen et al., 206; 
Rigau-Perez, 2006). 
1.1.4 Brief History of Dengue and DHF 
DENV-1 was first isolated by Ren Kimura and Susumu Hotta in Japan 
in 1943 (Kimura and Hotta, 1943). An epidemic of DF involving at least 
200,000 cases had occurred between 1942 and 1944 during World War II in 
Japanese port cities such as Nagasaki, Kobe, and Osaka. The infections 
originated from persons returning from the tropics, in particular Southeast 
Asia and the Pacific islands (Hotta, 2000). 
A few months after the first isolation of DENV-1 in Japan, Albert Bruce 
Sabin and Walter Schlesinger isolated DENV-1 from Hawaiian and shortly 
thereafter, DENV-2 from Papua New Guinean samples (Sabin and 
Schlesinger, 1945). They demonstrated that these viruses were antigenically 
related, yet distinct, and they could be distinguished by the hemagglutination 
inhibition (HI) assay. 
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Although there were various speculations about the earliest description 
of dengue-like diseases in historical accounts (Halstead, 1980; Henchal and 
Putnak, 1990), the disease now known as DHF was first recognised in Manila, 
the Philippines in 1953 (Quinlos et al., 1954). Viruses similar to DENV-1 and 
DENV-2 were isolated from Manila patients in 1956 by William Hammond and 
were called DENV-3 and DENV-4. Dengue viruses of multiple serotypes were 
subsequently isolated from patients of another DHF epidemic in Bangkok, 
Thailand in 1958 (Hammond, 1960). It is now known all four serotypes of 
dengue virus can cause DHF. 
DHF/DSS outbreaks were mainly restricted to Southeast Asia until the 
early 1980s (Halstead, 1980). Since then, dengue transmission has intensified 
and DHF/DSS outbreaks are now frequent in most tropical countries. To this 
day, DHF/DSS remains a leading cause of hospitalisation and death among 
children in Southeast Asia. Outside the region, the disease burden of dengue 
is most acutely felt in Central and South America where 24 countries have 
reported laboratory-confirmed DHF between 1981 and 1997 (Monath, 1994; 
Gubler and Clark, 1995; Gubler, 1998). 
1.1.5 Vectors and Transmission Cycles 
Dengue is transmitted from person to person through the bites of 
infected female mosquitoes. The etiological agent, the DENV, is believed to 
have been maintained in sylvatic/enzootic transmission cycles involving non-
human primate hosts and vector species living in forests. The virus was 
transmitted to humans when the two come into contact and thereafter was 
maintained in continuous human-mosquito cycles in and/or around human 
population centers (Figure 1.4). 
Many species from the genus Aedes of the family Culicidae are known 
to transmit DENV, but the principal vector is Aedes aegypti which is also the 
vector of the yellow fever virus (YFV). Moreover, this species transmits a third 
arboviral disease, chikungunya, which is caused by the chikungunya virus 
(CHIKV), an alphavirus of the family Togaviridae. Chikungunya has similar 
symptoms as dengue which often made accurate diagnosis difficult. The 
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Australian naturalist Thomas Lane Bancroft first suggested Ae. aegypti as a 
carrier of dengue fever in 1906 based on epidemiological grounds, and this 
was confirmed in 1916 by John Burton Cleland (Cleland et al., 1916). Ae. 
aegypti is known to be a day-biting mosquito that prefers to breed in domestic 
and peridomestic water containers. Its adaptation to human habitats and its 
desiccation-resistant eggs have allowed it to flourish in urban centers. 
 
Figure 1.4. Transmission of dengue viruses (credit: Figure 2 from Whitehead 
et al., 2007). 
 
The secondary vector for dengue is Aedes albopictus which is 
commonly known as the Asian tiger mosquito. Its role as dengue vector in 
semi-tropical regions was first identified by Koizumi et al. in Taiwan in 1917 
(Kuno, 2007). Ae. albopictus serves as the primary vector for dengue in 
countries where Ae. aegypti is absent and as a maintenance vector in rural 
areas where both species coexist (Smith, 1956; Gratz, 2004). In the Pacific 
islands Ae. polynesiensis has been suggested as the primary dengue vector 
(Rosen et al., 1954; Freier and Rosen, 1987) whereas Ae. scutellaris was 
identified as the ‘jungle’ vector for dengue (Mackerras, 1946). Similar to Ae. 
aegypti, Ae. albopictus is also an efficient vector for CHIKV and it has been 
implicated in causing major chikungunya epidemics in recent years (Bessaud 
et al., 2006; Bonilauri et al., 2008). 
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Ae. aegypti and Ae. albopictus have both been shown to be  
anthropophilic, i.e. prefer to feed on humans (Ponlawat and Harrington, 2005) 
and are widely distributed in both urban and semi-urban areas in the tropics 
and subtropics. Both species have also been demonstrated to possess high 
vector competence for the dengue virus (Moncayo et al., 2004). In the 
continued absence of vaccines and specific treatment, effective vector control 
(either though fogging that kills adult mosquitoes, application of larvicides that 
target the aquatic stage of mosquitoes, or source reduction that reduces their 
breeding habitat) is currently the only practical method available for reducing 
the incidence of dengue disease. 
1.1.6 Geographical Distribution 
DENV is the world’s most geographically widespread arthropod-borne 
virus and its geographical distribution is inherently tied to the range and 
habitat of its principal vector mosquitoes (Figure 1.5). Dengue infections are 
reported in more than one hundred tropical and sub-tropical countries 
worldwide, mostly in urban and semi-urban areas where the vectors are 
widely found. Dengue is hyperendemic in many of these urban centers with 
co-circulation of multiple dengue virus serotypes. In non-tropical regions, 
dengue is usually the result of infection of international travelers that have 
visited dengue-endemic areas. 
 
Figure 1.5. Approximate global distribution of dengue and Aedes aegypti in 
2005 (credit: Figure 1 from Halstead, 2007). 
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The larvae of the principal vector Ae. agypti under naturally changing 
temperature are capable of developing into adults in conditions lower than 
10°C, whereas those of Ae. albopictus can survive even lower temperatures 
(Tsuda and Takagi, 2001). Consequently the two species can be found 
between latitudes 35°N and 35°S, approximately corresponding to a winter 
isotherm of 10°C (WHO, 1997). As shown in Figure 1.6, the southern parts of 
the United States and Europe, and major parts of Australia and Africa are 
among areas at risk of future dengue transmissions. A dengue outbreak 
reported in Buenos Aires, Argentina (34°36'S) in early 2009 is very close to 
this isotherm and is the furthest south dengue has spread. 
 
Figure 1.6. Areas at risk of dengue transmission, 2006 (credit: WHO). 
 
1.1.7 Factors Influencing Transmission 
Since the etiology of dengue and dengue haemorrhagic fever were 
virologically described in the mid-1950s, the incidence of dengue worldwide 
has increased tremendously (Figure 1.7). There is a plethora of inter-related 
factors that contributed to the prevalence of dengue around the globe. For 
vector-borne diseases such as dengue, these factors can be categorised into 
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three obvious components – virus, vector and host – and a less-clear fourth – 
the surrounding ecology for the three components. All four play important 
roles in the continued spread and transmission of dengue. 
Uncontrolled urbanization, expanding urban population, poverty, 
ineffective public health infrastructure, faster modes of transportation, 
globalization of trade and increased international travel have all been 
implicated as factors leading to the spread of dengue around the world 
(Gubler and Clark, 1995). Rapid urbanization is probably the single most 
important contributing factor – the resulting population centers tend to lack 
public piped water and residents have to resort to using containers to store 
water which often ended up as breeding sites for the Ae. aegypti vector. The 
lack of adequate sewage systems often leads to the same result. 
 
Figure 1.7. Average annual number of dengue (DF) and dengue 
haemorrhagic fever (DHF) cases reported to WHO and average number of 
countries reporting dengue (credit: WHO). The figure is accessible at 
http://www.who.int/disease/dengue/impact/en/index.html. 
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Inherent differences in the virulence of the introduced DENV strains 
have also been suggested as being a contributing factor in causing outbreaks 
and in the emergence of the severe form of dengue disease (Rosen, 1977). 
An often-cited example is the replacement of the indigenous American 
genotype of DENV-2 in the Western Hemisphere with one originating from 
Southeast Asia (Rico-Hesse et al., 1997). Viruses of the Southeast Asian 
genotype have been shown in the laboratory to be better adapted to 
transmission by the vector Ae. aegypti by causing higher viremia in both 
human dendritic cells and mosquito cells (Armstrong and Rico-Hesse, 2001; 
Cologna et al., 2005; Anderson and Rico-Hesse, 2006). 
Relaxation of vector control efforts, expansion of the vector range, and 
the build-up of vector resistance to insecticides (Gubler and Clark, 1995; 
Kawada et al., 2009) are some of the recognised factors affecting the 
contribution of the mosquito vector. The impact of environmental factors on 
the transmission and spread of mosquito-borne diseases - as exemplified by 
effects of temperature, rainfall and humidity on vector transmission cycles - 
are also well known (Watts et al., 1987). Beside the effect of generalised 
climatic factors (global warming, for example) the local ecology probably plays 
an equal, if not more important, role in a disease as complex as dengue 
(Kuno, 1995; Reiter, 2008; Johansson et al., 2009). 
1.1.8 Economic impact 
Apart from physical pain, dengue also causes economic hardship to 
recovered individuals in the form of hospitalization costs and disruption of 
earning potential. The DALYs (disability-adjusted life years) lost to dengue in 
Southeast Asia were estimated to be comparable to the burden caused by 
diseases such as HIV, malaria and tuberculosis (Gubler and Meltzer, 1999). 
At the governmental level, vast amounts of money have to be allocated for 
public awareness campaigns, medical services and vector eradication efforts. 
Another indirect cost comes in the form of loss of revenue through reduced 
tourism (WHO, 1997). 
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1.2 Dengue the Virus 
The causative agent of the dengue disease is the dengue virus (DENV), 
a group of four flaviviruses that are closely related but antigenically distinct.  
They are hypothesised to have evolved independently from ancestral sylvatic 
viruses between 100-1,500 years ago (Wang et al., 2000). The four groups 
are known as serotypes and denoted as dengue virus type 1 (DENV-1), 
dengue virus type 2 (DENV-2), dengue virus type 3 (DENV-3) and dengue 
virus type 4 (DENV-4). 
1.2.1 Taxonomy 
There are three genera in the Flaviviridae family (formerly known as 
group B arboviruses) namely Flavivirus, Pestivirus and Hepacivirus. The 
dengue virus is a member of the genus Flavivirus which consists of 55 
identified virus species (ICTVdB, 2006). The word Flavi is a derivation from 
the Latin “flavus” which means “yellow” and the type species of the genus is 
the yellow fever virus (YFV). The flaviviruses are thus named due to the 
jaundice observed in yellow fever patients. Many flaviviruses are important 
human pathogens, most notably the dengue viruses, yellow fever virus, 
Japanese encephalitis virus (JEV), West Nile virus (WNV) and tick-borne 
encephalitis virus (TBEV). The flaviviruses are predominantly transmitted by 
mosquitoes and ticks, whereas some have no known vector. 
Dengue was one of the groups classified when early researchers 
divided the flaviviruses serologically into eight antigenic complexes using 
cross-neutralization tests. However, many viruses, for example the prototype 
of the genus YFV, could not be affiliated with any complexes (Calisher et al., 
1989). When sequence data became available, phylogenetic inference from 
molecular data showed agreement with the antigenic complex classification. 
In addition, it revealed the clear clustering of the Flavivirus genus into non-
vector and vector-borne virus clusters, with the latter splitting into mosquito-
borne and tick-borne virus clusters (Kuno et al., 1998). As shown in Figure 1.8, 
the mosquito-borne virus cluster has been shown to further diverge into YFV, 
JEV, and dengue viruses, in that order (Zanotto et al., 1996). 
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The dengue virus was divided into four groups called serotypes based 
on antigenic properties. Subsequent evidence from molecular data reaffirmed 
this classification and also provided a clearer understanding of the phylogeny 
of the four serotypes: among the dengue viruses, DENV-4 diverged first from 
the common ancestor, followed by DENV-2, and finally DENV-1 and DENV-3 
(Zanotto et al., 1996). 
 
Figure 1.8. Maximum likelihood tree for the E gene from 123 flaviviruses. The 
tree is rooted by the sequence from Aedes albopictus cell fusion agent (CFA) 
virus (credit: Figure 1 from Zanotto et al., 1996). 
 
1.2.2 Virion Morphology 
The dengue virus virion, like those of other flaviviruses, is spherical and 
40-50 nm in diameter. It is comprised of a nucleocapsid about 30 nm in 
diameter that is enclosed in a lipid envelope. The nucleocapsid contains the 
viral capsid and RNA genome. The lipid-containing envelope consists of a 
lipid bilayer, an envelope protein between 51,000 and 59,000 daltons that 
mediates attachment, fusion, and penetration, and a small non-glycosylated 
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internal matrix protein of approximately 8,500 daltons. The envelope protein is 
glycosylated in most flaviviruses and is exposed on the virion surface. 
Electron microscopy studies have shown that mature dengue virions are 
characterised by a relatively smooth surface, as shown in Figure 1.9, with 180 
copies of the envelope protein forming the icosahedral scaffold (Kuhn et al., 
2002). 
 
Figure 1.9. Structure of the dengue virion and conformations of the E protein 
(credit: Figure 2 from Perera and Kuhn, 2008). ER: endoplasmic reticulum; 
TGN: trans-Golgi network; prM: precursor of membrane. 
 
1.2.3 Genomic Organization 
The genomic organization of the dengue virus, and by extension all 
flaviviruses, is relatively simple compared to other arboviral families such as 
the Togaviridae (formerly known as group A arboviruses), Bunyaviridae or 
Rhabdoviridae. The DENV genome consists of a single-stranded, positive-
sense RNA molecule roughly 10.7 kb in size. It contains a single translated 
open reading frame (ORF) that encodes a precursor polypeptide of around 
3390 amino acids which is processed catalytically into ten viral proteins (Table 
1.2). There is no evidence of alternative or overlapping reading frames that 
are translated and there is also no hyper-variable region in the DENV genome 
like those reported in the HCV genome. 
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Table 1.2. Typical lengths of the ten DENV proteins determined from multiple 
sequence alignments of deduced amino acid sequences derived from 
complete genome sequences in GenBank. 
Proteins DENV-1 DENV-2 DENV-3 DENV-4 
C 114 114 113 113 
prM/M 166 166 166 166 
E 495 495 493 495 
NS1 352 352 352 352 
NS2A 218 218 218 218 
NS2B 130 130 130 130 
NS3 619 618 619 618 
NS4A 150 150 150 150 
NS4B 249 248 248 245 
NS5 899 900 900 900 
Length of CDS 3392 3391 3390 3387 
 
The DENV ORF is flanked at its 5’ terminus by an untranslated region 
(UTR) of about 100 nucleotides and a longer UTR of about 500 nucleotides at 
its 3’ terminus. The 5’ terminus of the genome has a type I cap (m7GpppAmp) 
and there is no polyadenylation of the 3’ terminus (reviewed in Chambers et 
al., 1990). The translated polyprotein is cleaved co- and post-translationally by 
viral and host proteases into ten viral proteins: three structural proteins (C, 
capsid; prM/M, precursor of membrane; E, envelope) encoded at the 5’ end of 
the ORF, and seven non-structural proteins (NS1, NS2A, NS2B, NS3, NS4A, 
NS4B and NS5) encoded at the 3’ end (Figure 1.10). 
The three structural proteins constitute the DENV virion: the capsid 
protein surrounds the viral RNA genome to form the nucleocapsid, whereas 
the prM and E proteins are embedded in the lipid bilayer that forms the viral 
envelope. Cleavage of the prM into the membrane (M) protein by furin during 
viral release has been shown to be a prerequisite for the production of mature 
infectious virions. Of the three structural proteins, the E protein is the most 
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studied as it is the major constituent of the virus envelope. It is glycosylated at 
two sites (Asn-67 and Asn-153) and is responsible for virus attachment to 
receptors of susceptible host cells and for fusion with cell membranes. The E 
glycoprotein also contains the main epitopes recognised by neutralizing 
antibodies (reviewed in Chambers et al., 1990). Such epitopes are also found 
to a lesser extent on the M glycoprotein (Kaufman et al., 1989). 
 
Figure 1.10. Schematic diagram showing: (top) gene organisation in the 
dengue virus RNA genome, (bottom) the membrane topology and proteolytic 
cleavage sites of the transcribed polyprotein. Cellular and viral proteases, 
which are denoted by arrows, process the immature polyprotein into ten 
separate proteins (credit: adaptation of Figure 1 from Perera and Kuhn, 2008). 
 
The 3’ end of the DENV genome encodes seven non-structural (NS) 
proteins of various sizes in the order: NS1, NS2A, NS2B, NS3, NS4A, NS4B 
and NS5. Some non-structural proteins are known to be multi-functional while 
little is known about NS1, NS2A and NS4A/4B. Functions of the non-structural 
proteins are summarised in Table 1.3. 
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Table 1.3. Known and possible functions of dengue non-structural proteins 
(reviewed in Perera and Kuhn, 2008). 
NS proteins Description of known functions 
NS1 Plays a role in viral RNA replication complex; acts as soluble complement-fixing antigen. 
NS2A Forms part of the RNA replication complex. 
NS2B Co-factor for NS3 protease. 
NS3 Serine protease, RNA helicase and RTPase/NTPase. 
NS4A Possibly induces membrane alterations important for virus replication. 
NS4B Possibly blocks IFN α/β-induced signal transduction. 
NS5 Methyltransferase (MTase) and RNA-dependent RNA polymerase (RdRp). 
 
1.2.4 Genetic Diversity 
Based on available molecular data it is well known that there is great 
genetic diversity among the dengue viruses. The factors that contributed to 
this are many fold, so are the epidemiological implications arising from this 
diversity, as illustrated in Figure 1.11. 
 
Figure 1.11. The processes that have caused an increase in the genetic 
diversity of dengue virus and two possible evolutionary consequences of this 
increase (credit: Figure 1 from Holmes and Burch, 2000). 
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For most purposes the four dengue serotypes are generally treated as 
the same virus and the diseases they cause are considered as the same 
disease. However, the genetic distances between the four serotypes are 
greater than the distances between many of the recognised virus species in 
the genus, for example between the Japanese Encephalitis virus (JEV), West 
Nile virus (WNV), Murray Valley Encephalitis virus (MVEV), Usutu virus 
(USUV) and St Louis Encephalitis virus (SLEV) (Figure 1.12). Based on this 
observation, others have argued that the four dengue serotypes warrant the 
rank of species on their own right (Kuno et al., 1998; Holmes and Burch, 
2000). 
Each serotype of the dengue virus can be further classified into several 
genetic groups called genotypes (the term subtype is used interchangeably) 
based on sequence diversity. Rico-Hesse (1990) initially defined a dengue 
genotype as a group of dengue viruses having no more than 6% sequence 
divergence within a 240-nucleotide region of the DENV-1 and DENV-2 E/NS1 
junction. Since then, both the length and region of virus genome selected for 
sequencing varied greatly depending on research groups, ranging from the 
complete sequence of single genes to the complete genome of the DENV. 
Assignment of genotypes now relies on phylogenetic analysis rather than 
arbitrary cut-off values in sequence diversity. 
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Figure 1.12. Unrooted minimum evolution tree for the complete E gene 
nucleotide sequences from 554 flaviviruses (unpublished data). Genetic 
distances between the four dengue serotypes are greater than the distances 
between the many species within the tick-borne encephalitis and Japanese 
encephalitis antigenic complexes. 
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Rico-Hesse (2003) and Vasilakis and Weaver (2008) have published 
excellent and detailed descriptions of the genotype classification for all four 
dengue serotypes. The following paragraphs describe only the essential 
points of the subject matter. 
DENV-1 can be divided into five genotypes based on the complete E 
gene sequence as described by Goncalvez et al. (2002). Earlier work by Rico-
Hesse (1990) also classified DENV-1 into five groups based on the 240-
nucleotide E/NS1 junction sequences, but with some minor differences from 
the newer scheme which is listed in Table 1.4. 
Table 1.4 DENV-1 genotypes according to Goncalvez et al. (2002). 
Genotypes Original known distribution 
I Japan, Hawaii in the 1940s (the prototype strains), China, Taiwan and Southeast Asia. 
II Thailand in the 1950s and 1960s. 
III Sylvatic source in Malaysia. 
IV Nauru, Australia, Indonesia and the Philippines. 
V Africa, Southeast Asia and the Americas. 
 
 The DENV-1 genotypes all have a wide area of distribution apart from 
genotype III (sylvatic) and genotype II which consists of Thai strains from the 
1950s and 1960s. Viruses of genotype I and IV have recently been implicated 
as causing epidemics in the Pacific between 2000 and 2004 (A-Nuegoonpipat 
et al., 2004) and genotype V viruses are frequently isolated during epidemics 
in the Americas (Avilés et al., 2003). However, it is still inconclusive whether 
any of these three DENV-1 genotypes can be consistently associated with 
causing more severe dengue (Rico-Hesse, 2003). 
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DENV-2 is the most studied serotype among the dengue viruses. 
Twiddy et al. (2002) proposed the existence of six genotypes of DENV-2 
(Table 1.5) based on the complete E gene sequence following earlier work by 
Rico-Hesse (1990) and Lewis et al. (1993). Sylvatic DENV-2 strains that are 
closely related have been isolated from several countries in West Africa and 
Malaysia, two locations that are far apart, leading Wang et al. (2000) to 
hypothesise that the DENV sylvatic ancestor arose in the Asian-Oceanic 
region before diverging into today’s four DENV serotypes. 
The first DHF epidemic in the Americas occurred after an introduction 
of the Asian II genotype to Cuba in 1981 (Guzman et al., 1995). Likewise, the 
America/Asian genotype (genotype III) has been reported to have replaced 
the pre-existing American genotype (genotype V) in the Western Hemisphere 
(Rico-Hesse et al., 1997) and is considered to be the DENV-2 genotype with 
the highest epidemiological impact (Rico-Hesse, 2003). 
Table 1.5 DENV-2 genotypes according to Twiddy et al. (2002). 
Genotypes Original known distribution 
American 
Formerly known as subtype V. Found in Latin America, 
old strains from India (1957), the Caribbean, and the 
Pacific islands between 1950 and 1970s. 
American/Asian Formerly known as subtype III. Found in China, Vietnam, Thailand and in Latin America since the 1980s. 
Asian I Thailand, Myanmar and Malaysia. 
Asian II 
Formerly known as subtype I and II. Found in China, the 
Philippines, Sri Lanka, Taiwan and Vietnam. Includes the 
New Guinea C prototype strain. 
Cosmopolitan 
Formerly known as genotype IV. Wide distribution 
including Australia, the Pacific islands, Southeast Asia, 
the Indian subcontinent, Indian Ocean islands, Middle 
East, and both East and West Africa. 
Sylvatic Isolated from non-human primates in West Africa and Malaysia. 
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The current genotype classification for DENV-3 follows the 
nomenclature proposed by Lanciotti et al. (1994) which recognised four 
DENV-3 genotypes based on prM/E sequences (Table 1.6). These four 
genotypes are similar to the four groups described by Chungue et al. (1993) 
using a 195-nucleotide region at the 5’ terminus of the E gene. 
Introduced to the Americas via Nicaragua in 1994, genotype III DENV-
3 is now widely found in Central and Southern America (Balmaseda et al., 
1999; Usuku et al., 2001; Messer et al., 2003) and is considered as the most 
virulent of the four DENV-3 genotypes. It is worthy of note that genotype IV 
has never been associated with any DHF epidemics (Lanciotti et al., 1994). 
Although their existence is anticipated through the presence of DENV-3 
antibodies in non-human canopy-dwelling primates, no sylvatic lineage of 
DENV-3 has been found thus far (Rudnick, 1984). 
Table 1.6. DENV-3 genotypes according to Lanciotti et al. (1994) and the 
known distribution of the genotypes prior to 1993. 
Genotypes Original known distribution 
I 
Indonesia, Malaysia, Thailand, Burma, Vietnam, the 
Philippines and the South Pacific islands (French Polynesia, 
Fiji and New Caledonia). Includes the H87 prototype strain. 
II Thailand, Vietnam and Bangladesh. 
III Singapore, Indonesia, South Pacific islands, Sri Lanka, India, Africa and Samoa. 
IV Puerto Rico and French Polynesia (Tahiti). 
 
Lanciotti et al. (1997) initially separated DENV-4 into two genotypes, I 
and II, based on the complete E gene sequence. A further two genotypes 
were subsequently described (Table 1.7), with one found only in non-human 
primates in Malaysia and another, genotype III, found only in Bangkok, 
Thailand (Klungthong et al., 2004). Genotype II DENV-4 is the most 
widespread of the four following an introduction to the Western hemisphere in 
1981, possibly via the Pacific islands (Lanciotti et al., 1997; Foster et al., 
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2003). Although DENV-4 is the least frequently sampled serotype, it is often 
associated with haemorrhagic fever during secondary infection (Vaughn, 
2000). 
Table 1.7. DENV-4 genotypes and their known distribution. 
Genotypes Original known distribution 
I Thailand, Malaysia, the Philippines and Sri Lanka. Includes the H241 prototype strain. 
II Indonesia, Malaysia, Tahiti, the Caribbean islands (Puerto Rico and Dominica) and the Americas. 
III Thailand (Bangkok, specifically). 
Sylvatic Isolated from non-human primates in Malaysia. 
 
1.2.5 Role of virus genetics and evolution 
Except for the sylvatic genotypes, genotype classification can often 
unveil the geographical origin of the dengue virus strains. This has enabled 
tracking the route of virus transmissions across distant time and place, and 
has served as the basis of molecular epidemiological studies that can 
determine whether dengue epidemics are caused by introduction of new 
viruses or the result of re-emergence of endemic strains. 
Introduction of new viruses inevitably leads to the question whether 
particular genotypes of DENV are associated with higher virulence or severe 
disease. To date, severe disease has often been associated with several 
DENV genotypes originating in Southeast Asia (Guzman et al., 1995; Rico-
Hesse et al., 1997). The lack of a suitable animal model for the dengue 
disease, however, means such hypotheses cannot be easily verified (Rico-
Hesse, 2003). On the other hand, association of re-emergence of endemic 
strains with outbreaks leads to a different question that can only be answered 
by a combination of classic epidemiology and comparative genomics: whether 
the viruses re-emerged due to environmental, population immunity and/or 
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vectorial factors, or whether outbreaks were triggered by adaptive evolution of 
the virus that endowed it with an increase in fitness and virulence? 
Possession of the complete genetic blueprint of the dengue viruses is a 
prerequisite to answering these crucial questions. This thesis describes efforts 
to sequence and then examine the complete genome sequences of DENV 
isolates from two recent epidemics in Indonesia and Singapore. The results 
from these two studies showed that the re-emergence of endemic strains is 
likely to be the main cause of most dengue outbreaks in Southeast Asian 
countries. No evidence of mutational signatures that could serve as a trigger 
of epidemics was found in isolates collected up to six years prior to the 
epidemic. Lastly, a new way of reconstructing the history of dengue virus 
diversity from all existing sequence data was introduced. The result showed 
that Malaysia, a country occupying a central position in Southeast Asia, has 
experienced both frequent importations of DENV strains from neighbouring 
countries and maintenance of endemic viral lineages which have been in 
sustained transmission for many decades. 
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2.1 Abstract 
In order to study the distribution, molecular epidemiology, and the 
phenotype/genotype relationships of the dengue virus (DENV), 230 complete 
DENV genomes from the Southeast Asia region have been sequenced since 
2005. Along with DENV genome sequence data collected from public domain 
sources, all sequences have been meticulously annotated and stored in a 
dengue genome database. An informatics platform in the form of a Web 
application has been constructed around the database to provide easy 
sequence retrieval and as a common platform for sequence analyses. There 
was a total of 1523 DENV genomes in this database as of January 1, 2009. 
2.2 Introduction 
The dengue virus (DENV), the causative agent of dengue fever (DF) 
and the potentially fatal dengue haemorrhagic fever (DHF) and dengue shock 
syndrome (DSS), is a group of four closely-related but antigenically distinct 
viruses from the genus Flavivirus denoted as DENV-1, DENV-2, DENV-3 and 
DENV-4. The genomic material of the DENV is contained in a positive-sense, 
single-stranded RNA molecule approximately 10.7 kb in length. It contains a 
single open reading frame that encodes a polyprotein of between 3387 and 
3392 amino acids. The first complete genome sequences for all four 
serotypes of DENV have been reported since the late 1980s (Zhao et al., 
1986; Hahn et al., 1988; Osatomi and Sumiyoshi, 1990; Fu et al., 1992). 
Recent advances in sequencing technology and a coincidental drop in 
sequencing cost have resulted in a well-documented exponential growth in 
sequence data. A lot about an organism can be learned through comparative 
genomics with the availability of sequence data (Hardison, 2003). The field of 
dengue research has also benefited from this trend–there has been a huge 
increase in the number of DENV genomes published on GenBank since 2005. 
This growth in sequence data has created not only a need for models of data 
storage, but also data retrieval systems that are user-friendly, and provide the 
data in a format that is amenable to further computational analyses. 
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The DengueInfo Web portal and database (Schreiber et al., 2007), 
Flavitrack (Misra and Schein, 2007) and the NCBI’s Virus Variation Resources 
(Resch et al., 2009) represent attempts to fulfill some of these needs. 
Nevertheless, the frequency of update, choice of annotation data, accuracy of 
annotation data, data retrieval options and the format of the retrieved data 
understandably relied entirely on the resource providers. Moreover, inclusion 
of pre-released sequences generated from in-house sequencing efforts and 
the addition of new annotation fields according to personal and evolving 
needs when using these external informatics resources is impractical, further 
underlining the need for a bioinformatics application on which creative 
freedom can be fully exercised. 
In this study, a Web application was built on top of a database that 
stores manually-curated annotation and DENV genome sequence information 
generated from in-house sequencing efforts and from public-domain sources. 
The Web application was then extended to include a collection of 
independently-acting but compatible sequence analysis tools to provide a 
common bioinformatics platform for easy sequence retrieval and analysis of 
DENV genomic data. 
2.3 Material and Methods 
2.3.1 Complete genome sequencing of DENV 
The two-step strategy and experimental protocol for doing complete 
genome sequencing of dengue virus have been described in detail elsewhere 
(Ong et al., 2008; Schreiber et al., 2009). Briefly, cDNA templates were 
generated from viral RNA with priming primers using the SuperScript III 
reverse transcriptase (Invitrogen). The cDNA template was then amplified 
using Pfu Turbo DNA polymerase (Stratagene) in five separate PCR reactions 
to generate five slightly overlapping fragments (Figure 2.1). Optimum PCR 
conditions can be variable for different batches of virus samples depending on 
their source, and the parameters would have to be optimised anew. 
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Figure 2.1. Schematic representation of the strategy employed in sequencing 
the complete genomes of DENV. The example depicted is for DENV-3. 
 
The PCR products were quantified by spectrophotometry (NanoDrop 
ND-1000 Spectrophotometer) and sent for automated capillary sequencing 
using 50 serotype-specific sequencing primers. Sequencing was done with a 
3730xl DNA Analyzer (Applied Biosystems) using the BigDye Terminator 
Cycle Sequencing Ready Reaction Kit (Applied Biosystems). 
The chromatograms from capillary sequencing were assembled using 
SeqScape version 2.5 (Applied Biosystems) to produce a consensus 
sequence of the virus sample. The consensus sequences were first aligned to 
the sequences of other known genomes of the same serotype. These 
consensus sequences then went through a round of manual editing to ensure 
its accuracy and to weed out artifacts from the base-calling algorithm of the 
automated sequencer. Whenever possible, manual editing was carried out 
independently by two individuals in a “buddy system”, and the two sets of 
results are then compared and merged to produce the final version of the 
genome sequence. 
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2.3.2 Inclusion criteria of public domain DENV sequences 
Complete and near-complete DENV genomes in the public domain 
were retrieved by searching the NCBI Nucleotide database - GenBank 
(http://www.ncbi.nlm.nih.gov/) using the query string: txid11052[orgn] AND 
10000[SLEN]:13000[SLEN]. The number 11052 is the taxonomy ID for the 
Dengue Virus Group as defined by the NCBI Taxonomy Browser; the balance 
of the query string specified that sequences with length between 10,000 and 
13,000 nucleotides be retrieved. Typical DENV genomes are around 10,700 
nucleotides so the query string will retrieve near-complete genome sequences 
while leaving out almost all of the longer-than-usual sequences of engineered 
constructs and whole-virus replicon vectors. 
2.3.3 DENV genome sequence annotation 
Primary annotation of the genome sequences retrieved from GenBank 
was achieved by parsing the associated GenBank records. The only 
information that was readily available were the accession number and 
serotype, whereas other information such as strain name, severity (DF, DHF, 
DSS), country of isolation and year of isolation is not uniformly recorded and 
often required manual curation and correction. The missing information is 
filled by following the “paper trail” of cited scientific literature, searching using 
Internet search engines or through personal communication. 
A second round of annotation assigns information for fields such as the 
nature of virus (either as Wild Type, Engineered or Patent), category of virus 
based on sequencing project (EDEN, NEHCRI, Universiti Malaya, sylvatic et 
cetera), subtype classification (based on phylogenetic trees, see section 2.3.4) 
and other useful miscellaneous remarks. Coordinates for the boundaries of 
the viral genes were calculated from a massive multiple sequence alignment 
of the 4 serotypes of DENV to allow extraction of sequence fragment of 
interest. A detailed description of the fields can be found in Table 2.1. 
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Table 2.1. The description of the fields used in the annotations of the dengue 
genome sequences. 
Fields Sample Data Sources of Annotation Data 
Accession EU482478 GenBank. 
Serotype DENV-1 to DENV-4 GenBank or based on phylogenetic trees. 
Strain name NGC, MON501 etc. GenBank, literature, or assigned for in-house strains. 
Nature Wild Type, Engineered, Patent Assigned based on literature. 
Severity DF, DHF GenBank, literature, or personal communication. 
Country of isolation Singapore, India etc. GenBank, literature, or personal communication. 
Year of Isolation 1946, 2005 etc. GenBank, literature, or personal communication. 
Collection EDEN, Makassar etc. GenBank, literature, or personal communication. 
Subtype Cosmopolitan, Asian/American etc. 
Assigned based on phylogenetic 
trees. 
First seen on GenBank 8/2/1993 etc. GenBank. 
Remarks “From Hainan province” etc. 
GenBank, literature, personal 
communication, or assigned. 
 
2.3.4 DENV subtype classification 
Phylogenetic trees for each of the four DENV serotypes were 
generated from aligned complete genome sequences using the Minimum 
Evolution tree inference method implemented in MEGA version 4.0 (Tamura 
et al., 2007). The substitution model used was the Tamura-Nei model and the 
obtained tree topology was tested using 1000 bootstrap replications. The 
subtype classification scheme follows that of Goncalvez et al. (2002) for 
DENV-1, Twiddy et al. (2002) for DENV-2, Lanciotti et al. (1994) for DENV-3 
and Lanciotti et al. (1997) for DENV-4. 
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2.3.5 Technical specifications of DENV genome database 
Nucleotide sequences were retrieved from public domain sources and 
generated from sequencing efforts, and their associated annotation data were 
stored in a MySQL relational database management system. The data 
retrieval function was achieved through the implementation of a MySQL/PHP 
Web application. The Web application was hosted on Microsoft Internet 
Information Server (IIS) version 5.1. The database was implemented on 
MySQL Server version 5.0.67 whereas the scripting engine used was PHP 
version 5.2.6. 
Various analysis tools, totaling 30 at the time of writing, were 
implemented in the form of PERL scripts that are accessed via a Web 
browser. The PERL scripting engine used was ActivePerl version 5.8.8.817 
from ActiveState Software. The analysis results are also provided via the 
browser graphical user interface (GUI), thereby guaranteeing ease of use. 
The GUI design uses a standardised CSS-driven menu for easy access to the 
various sections of the Web application and the analysis tools. The application 
uses client-side JavaScripts, DHTML and AJAX snippets, where appropriate, 
to enhance its usability and aesthetic value. A screenshot of the front page of 
the application is shown in Figure 2.4. 
The application has dependencies on a number of PERL modules 
namely: GD (version 2.5), DBD-mysql (version 4.008), CGI (version 3.41), 
DBI (version 1.607), Math::Trig (version 1.18) and Tie-IxHash (version 1.21). 
The SQL file of the MySQL database generated by the mysqldump tool 
(visualised in graphical form in Figure 2.2), can be found in Appendix A. 
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Figure 2.2. Graphical representation of the database structure as visualised 
by MySQL AB’s Query Browser version 1.2.13 (left) and its entity-relationship 
diagram (right). 
 
2.4 Results and Discussion 
2.4.1 Complete genome sequencing of DENV 
As of January 1, 2009 a total of 230 complete DENV genomes have 
been generated since the middle of 2004 through the joint efforts of the 
Novartis Institute for Tropical Diseases (NITD), the Genome Institute of 
Singapore (GIS), and the NITD-Eijkman Institute-Hasanuddin University 
Clinical Research Initiative (NEHCRI). The sequenced viruses can be divided 
into 5 groups based on the time and location the viruses were sampled (Table 
2.2). The first four groups of viruses were selected for sequencing to address 
different questions and these sequences were treated as standalone data 
sets and analysed independently (Ong et al., 2008; Schreiber et al., 2009). 
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The group labeled as Miscellaneous contains laboratory strains, prototype 
strains and ad hoc sequencing of a small number of interesting viral strains. 
Table 2.2. The number of completed DENV genomes generated through 
sequencing efforts by the end of 2008, grouped by the time and location of 
virus sampling. 
Place of collection Year of collection Sequenced genomes 
Jakarta, Indonesia 1985-2003 16 
Kuala Lumpur, Malaysia 1995-2005 46 
Singapore 2005-2006 106 
Makassar, Indonesia 2006-2007 54 
Miscellaneous Not applicable 8 
 TOTAL 230 
 
The 5-fragment RT-PCR genome sequencing protocol has undergone 
various rounds of optimization since 2004, in particular the continued 
refinement of the primer sequences used for PCR amplification and capillary 
sequencing. As more sequences become available, primers can now be 
designed to cater to virus isolates from a particular subtype or from a 
particular clade within a subtype. Still, protocol optimization often has to be 
started anew for each set of “virus collections”, and this has proved to be the 
main bottleneck in the entire genome sequencing effort. New sequencing 
strategies that employ “next-generation” sequencing technology should be 
explored to speed up future DENV genome sequencing efforts. 
2.4.2 DENV genome sequence annotation 
The primary source of the annotation for the publicly-available DENV 
genome sequences was their respective accompanying GenBank record. 
Automated annotation could only be done partially because much of the 
desired metadata was not uniformly recorded. In the examples highlighted in 
Figure 2.3, a sequence submitter could use either “strain” or “isolate” to refer 
to the strain name of a virus isolate, or the information is simply absent. Many 
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GenBank records, like in the third example, are devoid of any useful 
information. 
 
 
 
Figure 2.3. Examples of GenBank records from which primary annotation for 
publicly-available DENV genomes were extracted. Red boxes highlight the 
lack of convention in field names; entries underlined in blue show the use of 
non-uniform country names; entry underlined in green shows information that 
is useful but seldom provided. The third example is devoid of any useful 
annotation data. 
 
The solution to fill the numerous gaps was to manually annotate 
information not extracted by the initial round of automated annotation. Fields 
that are useful in subsequent analyses are added in addition to those that can 
be readily found in GenBank records. Subtype information, for example, can 
be used to help design primers for specific subtypes of viruses and to follow 
the microevolution of viruses. Knowing the nature of viruses (whether Wild 
type, Engineered or Patent) would be useful when deciding which genomes to 
42 
include when doing specific kinds of sequence analysis. The “Patent” 
sequences were invariably for engineered or attenuated isolates used in 
vaccine development efforts. Detailed description of the fields used for 
genome annotation is provided in Table 2.1. 
2.4.3 DENV genome database Web application 
The Web application for the dengue genome database was named the 
Flavivirus Toolkit (FVT), as can be seen in the screenshot of the application’s 
front page (Figure 2.4). The name alludes to the initial objective of including in 
the database genome sequences of all flaviviruses. It is well known that many 
flaviviruses are important human pathogens. In addition, the flaviviruses all 
share the same genomic organization and their genomes are of more or less 
similar size. As such, they can utilise similar schemes in annotation. These 
factors made housing all flavivirus genome sequences together in a single 
repository scientifically useful and technically feasible. Currently the FVT only 
contains the genome sequences of DENV, but the infrastructure is already in 
place to integrate sequences of other flaviviruses in the future. 
 
Figure 2.4. A screenshot of the front page of the browser-based user 
interface to the dengue genome database Web application (nicknamed the 
Flavivirus Toolkit). The CSS-driven dropdown menu allows easy access to the 
available analysis tools. 
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From the user’s perspective the Web application can be functionally 
divided into three main parts: sequence retrieval, sequence analysis tools, 
and informative. The 3-step sequence retrieval function is most fundamental 
to the database and it is comprised of two tools that work one after another: 
the Sequence Selector and Sequence Extractor. The Sequence Selector tool 
allows the user to specify the selection criteria of sequences to be retrieved. 
The range of available selection criteria (which resembles the fields of 
annotation in Table 2.1) is shown in Figure 2.5, and the output of the 
Sequence Selector is shown in Figure 2.6. 
 
Figure 2.5. Step 1 of 3 to retrieve sequences stored in the dengue genome 
database. The Sequence Selector allows the user to specify the selection 
criteria of sequences to be retrieved. 
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Figure 2.6. Step 2 of 3 to retrieve sequences stored in the dengue genome 
database. The Sequence Selector produces a list of sequences that match 
the selection criteria, along with some pertinent information of the matched 
sequences. The user can remove sequences from the list before proceeding 
to the next step. 
 
The user is brought to the Sequence Extractor tool once the selection 
list is finalised by clicking the “Submit” button (Figure 2.6). DENV isolates that 
matched the selection criteria are displayed in the Sequence Extractor which 
is a tool that allows the user to control which part of the genome is to be 
retrieved. Retrieved sequences can be sorted by multiple parameters befitting 
the kind of analysis to be done subsequently. For example, DENV sequences 
from a particular subtype found in a country can be ordered by Year (of 
isolation) so that a chronological view of the mutations that have accrued over 
years of transmission can be examined. 
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Figure 2.7. Step 3 of 3 to retrieve sequences stored in the dengue genome 
database. The Sequence Extractor allows the user to decide which part of the 
selected genomes to extract, and how those sequences should be ordered in 
the output file. 
The output of the three sequence retrieval steps is a single FASTA 
format text file containing the selected (complete or partial) genome 
sequences ordered in the defined manner. This file can then be used 
externally with other software, or with the analysis tools that form the second 
functional part of the Flavivirus Toolkit. A complete description of the various 
tools here would be too lengthy, but suffice to say each of the tools are 
designed for specific tasks and they can be used serially to perform various 
kinds of analysis. A few examples of the kinds of analyses that can be 
performed with the tools are outlined in Figure 2.8. 
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Figure 2.8. Schematic diagram showing a few examples of sequence-based 
analyses that can be done by combining the various sequence analysis tools 
available in the Flavivirus Toolkit. 
 
 
47 
The third and final part of the Flavivirus Toolkit consists of a series of 
Web pages that provide various kinds of information on the state of the 
database. These are either displayed as charts and tables for statistics, maps 
and schematic diagrams, or in the form of phylogenetic trees. Web pages for 
administrative and maintenance tasks will need to be added prior to releasing 
the FVT for public use. 
2.4.4 State of the DENV genome database 
 Currently there are 1523 DENV genomes in the database consisting of 
616 DENV-2 genomes (41%), 583 DENV-1 genomes (38%), 274 DENV-3 
genomes (18%) and 48 DENV-4 genomes (3%). One thing that should be 
pointed out here is that the numbers do not reflect the frequency the 
serotypes are encountered in the wild, but are merely the results of the 
choices made by the various genome sequencing projects. There are also two 
engineered (and patented) chimeric genomes that are half DENV-1 and half 
DENV-2 (Figure 2.9). 
 
Figure 2.9. Breakdown of dengue genome sequences in the database by 
serotype as of January 1, 2009. 
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Of the 1523 genomes, 1394 genomes (91.53%) are available publicly 
on GenBank as of January 1, 2009, with 122 genomes of these (8.75%) being 
the result of the genome sequencing effort by NITD and its collaborators. 
Another 129 genomes are in the process of being completed and will be 
released soon together with a publication (Figure 2.10). 
 
Figure 2.10. Breakdown of dengue genome sequences in the database by 
main contributing institutions as of January 1, 2009. Contribution by NITD and 
collaborators are divided into two segments: Published and To-be-published. 
 
Apart from the NITD, the Broad Institute in Massachusetts, US is the 
other big contributor of DENV genomic data. The project Web site can be 
access at http://www.broad.mit.edu/annotation/viral/Dengue/ProjectInfo.html. 
Starting from March 2008 and as of January 1, 2009 the Broad Institute have 
released 523 genomes of dengue isolates from Vietnam and 421 genomes of 
isolates from the Americas. This has resulted in a massive spike in the 
number of publicly available dengue genomes in GenBank in the year 2008 
(Figure 2.11). New kinds of analysis have been made possible with the 
increased amount of sequence data and it is hoped this trend will continue for 
the foreseeable future.  
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Year Available Genomes 
1993 8 
1994 8 
1995 8 
1996 8 
1997 15 
1998 23 
1999 38 
2000 56 
2001 70 
2002 83 
2003 88 
2004 113 
2005 201 
2006 241 
2007 405 
2008 
 
 
 
 
 
 
 
1394 
 
 
 
 
 
 
  
 
Figure 2.11. Bar chart and table showing the total number of publicly 
available dengue genome sequences since 1993. NITD started releasing 
DENV genome sequences in 2005 which accounted for the first non-linear 
increase in the chart. Contributions from the Broad Institute in 2008 resulted in 
a huge spike in the number of dengue genome sequences. 
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2.5 Conclusion 
The DENV genome sequencing activities by NITD have contributed a 
large amount of valuable data to the research community since 2005. Prior to 
that, public repositories of genetic information for dengue virus were heavily 
skewed toward structural genes, in particular the E (envelope). In order to 
understand the molecular epidemiology of the DENV and to identify molecular 
markers of pathogenecity, among other things, it is crucial to obtain the 
complete genetic blueprint of the infectious agent. 
By combining the genome sequencing and annotation efforts we have 
developed a valuable bioinformatics resource of dengue genome sequences 
that far exceeds the usefulness of a general-purpose sequence repository 
such as the GenBank. The dengue genome database with its related analysis 
tools have made analysis and comparison of viral genomes manageable and 
can serve as a framework for data sharing and analysis in the future. However, 
as the quantity and complexity of sequence data continue to grow, so will the 
challenge of organizing and maintaining databases such as this. 
In the following chapters, whole-genome comparative sequence 
analyses of DENV strains isolated from three countries and at different time 
points were used to answer pertinent molecular epidemiological questions 
about the diversity, distribution, and molecular evolution of DENV serotypes 
and subtypes in Southeast Asian countries - the region where DHF was first 
identified more than five decades ago. 
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3.1 Abstract 
Indonesia experienced a severe dengue epidemic in the first quarter of 
2004 with 58,301 cases and 658 deaths reported to the WHO. All four dengue 
virus (DENV) serotypes were detected, with DENV-3 the predominant strain. 
To ascertain the molecular epidemiology of the DENV associated with the 
epidemic, complete genomes of 15 isolates were sequenced from patient 
serum collected in Jakarta during the epidemic, and two historical DENV-3 
isolates from previous epidemics in 1988 and 1998 were selectively 
sequenced for comparative studies. Phylogenetic trees for all four serotypes 
indicate the viruses are endemic strains that have been circulating in 
Indonesia for a few decades. Whole-genome phylogeny showed the 2004 
DENV-3 isolates share high similarity with those isolated in 1998 during a 
major epidemic in Sumatra. Together these subtype I DENV-3 strains form a 
Sumatran-Javan clade with demonstrated epidemic potential. No newly-
acquired amino acid mutations were found while comparing genomes from 
the two epidemics. This suggests re-emergence of little-changed endemic 
strains as causative agents of the epidemic in 2004. Notably, the molecular 
evidence rules out change in the viral genomes as the trigger of the epidemic. 
3.2 Introduction 
Dengue fever is a mosquito-born disease with high public health impact 
that is estimated to affect nearly 50 million people worldwide each year 
(Monath, 1994; Gubler and Clark, 1995; WHO, 2002). Dengue fever is 
endemic throughout most of the tropical areas of the world, coincident with the 
distribution pattern of its mosquito vectors. Dengue disease can manifest in 
the form of the mild dengue fever (DF), or the more severe and potentially 
fatal dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS) which 
has a fatality rate as high as 10–15% depending on the availability of 
healthcare (Gubler, 2002). Currently there is no vaccine or therapeutic agent 
available against dengue fever. 
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The causative agent of dengue fever, the dengue virus (DENV), is 
transmitted to humans by infected females of the mosquito vectors Aedes 
aegypti and Aedes albopictus. DENV is a single-stranded positive-sense RNA 
virus of the genus Flavivirus. The ~10.7 kb DENV genome encodes three 
structural (capsid, pre/membrane and envelope) and seven non-structural 
proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5) in a single open 
reading frame. DENV is divided into four antigenically-related serotypes 
denoted as DENV-1, DENV-2, DENV-3 and DENV-4. Each serotype is 
sufficiently different that infection with one does not provide complete cross 
protection for the other three. In a scheme first proposed by Rico-Hesse 
(1990), DENV can be further divided into intra-serotypic categories called 
interchangeably as subtypes or genotypes based on their nucleotide 
sequence data. Subtype determination via phylogenetic means are often used 
to infer the phylogeny and to monitor the spread of virus strains (Chungue et 
al., 1995; Rico-Hesse et al., 1997; Messer et al., 2003). 
South East Asia has been a focal point of dengue activity since 1950s 
when DHF was first described. Indonesia, the largest country in the region, 
has experienced periodic outbreaks of dengue since 1968 with increasing 
numbers of infections and severity (Sumarmo, 1987). Major dengue 
epidemics occurred in Indonesia in 1998, during which 72,133 cases and 
1414 deaths were reported, and again in 2004 with more than 58,301 cases 
and 658 deaths in the first 4 months of the year (WHO, May 11, 2004). In the 
2004 epidemic, running from the start of January until early May, cases were 
reported in all provinces across the Indonesian archipelago. The densely 
populated capital city of Jakarta, with a population of over 16 million people, 
was the hardest hit in terms of reported cases and deaths. 
Availability of viral genome sequence data will no doubt contribute to a 
better understanding of the molecular evolution and epidemiology of DENV, 
especially in a country with a long history of dengue infections such as 
Indonesia. To this end, we sequenced the genome of 15 DENV isolates 
collected from hospitals around Jakarta during the 2004 epidemic. In addition, 
two samples collected during previous epidemics in Jakarta in 1988 and 1998 
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were also sequenced to ascertain the ancestry of the DENV associated with 
the 2004 epidemic. Surprisingly, Indonesia does not seem to experience 
importation of DENV strains despite its proximity to busy international 
waterway that is the Malacca Strait, and to Thailand, the other country with a 
long history of dengue infections. Rather, our results point to periodic re-
emergence of endemic strains with a demonstrated epidemic potential as the 
most likely cause of the 2004 epidemic. 
3.3 Material and Methods 
3.3.1 Virus sample collection and preparation 
Sixty nine patient serum samples were collected at eight hospitals in 
the Greater Jakarta area during the epidemic. Blood samples were taken from 
patients showing symptoms of dengue fever, as part of routine surveillance, 
after administering a consent form designed by the Center for Research and 
Program Development on Disease Control in Jakarta. The presence of acute 
dengue infection was confirmed by serological tests at the CDC in Jakarta 
and the serum samples were stored at -80°C until use. The two historical 
DENV-3 samples collected in Jakarta from 1988 (den3_88) and 1998 
(den3_98) were provided by the US Naval Medical Research Unit No 2 
(NAMRU-2). 
3.3.2 Virus propagation, RNA extraction and virus typing via RT-PCR 
Virus samples were propagated in C6/36 Aedes albopictus gut cells 
and viral RNA was extracted using QIAamp Viral RNA Mini Kit (QIAGEN) 
according to manufacturer’s protocol. Serotype of the isolates was inferred via 
RT-PCR prior to sequencing. Dengue viral RNA was first reverse transcribed 
into cDNA using SuperScript III reverse transcriptase (Invitrogen) and random 
hexamers, followed by amplification using Taq DNA polymerase (Roche). 
Serotyping was performed using a slightly modified version of the multiplex 
RT-PCR protocol (Lanciotti et al., 1992) and uses primers described by Seah 
et al. (1995) that distinguishes the four dengue serotypes by PCR product 
size. 
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3.3.3 Primer design 
Four consensus sequences, one for each serotype, were derived from 
alignments of published dengue genomes in GenBank. Known recombinant 
and artificially-mutated strains were excluded. For DENV-4, partial sequences 
were included in the alignment as only two complete genomes were publicly 
available at the time. Forward and reverse primers were designed using 
Vector NTI Suite 9 (Invitrogen Bioinformatics) to give overlapping sequence 
traces. Criteria of primers design include low number of degenerate positions, 
no degeneracy in the final three bases, a Tm between 55°C and 65°C and a 
GC content of 35–60%. The binding positions for the primers on the 
consensus sequence are shown in Appendix B and the sequences of the 
sequencing and amplification primers are shown in Appendix C. 
3.3.4 Viral cDNA amplification, sequencing, assembly and annotation 
cDNA templates were generated from viral RNA using five serotype-
specific priming primers at 2 pmol each with the SuperScript III reverse 
transcriptase. Due to the linear nature of the viral genome the 5’ and 3’ 
extremes of the cDNA are primer sequence. The cDNA template was then 
amplified using Pfu Turbo DNA polymerase (Stratagene) in five separate 
reactions to generate five slightly overlapping PCR fragments. The PCR 
fragments were separated on 1% agarose gels, excised, and the DNA purified 
using the QIAquick® PCR Purification Kit (QIAGEN). The purified PCR 
fragments, ranging from 2.1 to 2.8 kb, were then sent for automated capillary 
sequencing using 50 serotype-specific sequencing primers. Sequencing was 
done with a 3730xl DNA Analyzer (Applied Biosystems) using the BigDye 
Terminator Cycle Sequencing Ready Reaction Kit (Applied Biosystems). 
Contigs were assembled using SeqScape version 2.5 (Applied Biosystems) 
and the assembled genome sequences were aligned to other relevant DENV 
sequences using ClustalW-MPI (Li, 2003), followed by manual editing of the 
alignments. 
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3.3.5 Strain nomenclature 
Details of the genomes sequenced in this study are listed in Table 3.1. 
The first two alphabets of the strain names refer to the identity of the hospitals 
from which the samples were collected. The eight hospitals were abbreviated 
as follows: BA for Budi Asih and PH for Persahabatan, two hospitals in the 
city (kota) of East Jakarta. Similarly, SW (Sumber Waras) is in West Jakarta, 
KJ (Kodja) and PI (Infectious Disease Sulianti Saroso) in North Jakarta, SC 
(St Carolus) in Central Jakarta, while both FW (Fatmawati) and TB (Tebet) 
are in South Jakarta. The genome sequences were deposited in the GenBank 
database with the accession numbers AY858035–AY858050 and AY858983. 
Both AY662691, a 2003 DF-causing strain from Singapore, and AY947539, 
the H241 prototype DENV-4, were previously sequenced in 2003 at NITD. 
Sequences and annotation of the reported genomes are also available at the 
DengueInfo database (http://www.dengueinfo.org/) (Schreiber et al., 2007). 
3.3.6 Phylogenetic analysis of the DENV genomes 
All phylogenetic trees were constructed from aligned nucleotide 
sequence data using the maximum likelihood (ML) method implemented in 
PAUP* (Swofford, 2002), with the best-fit model of nucleotide substitution 
(GTR+G) selected by Akaike Information Criterion (AIC) implemented in 
ModelTest (Posada and Crandall, 1998). Branch topology was verified by 
generating 1000 bootstraps using TBR branch swapping and the scores on 
tree nodes represent the number of bootstrap replicates (presented in 
percentage) supporting each node. The length of the tree branches is 
proportional to the number of nucleotide changes. All trees are midpoint 
rooted and strains sequenced in this study are underlined for clarity. 
Strain datasets used to construct the phylogenetic trees for the 
purpose of subtype determination were selected to provide good coverage of 
the known diversity of the four dengue serotypes. Subsequently, published 
complete genomes of DENV were collected from the DengueInfo database 
(Schreiber et al., 2007) to build genome trees for each of the serotypes. 
Information on the year of isolation, country of origin, and clinical outcome of 
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the strains (DF, DHF or DSS) was collected, when available, from GenBank 
records or through personal communication with submitters of the records. 
3.3.7 Clade-specific mutations of the DENV-3 isolates 
Clades which are phylogenetically relevant to the Indonesian strains 
and contain sufficient amount of genome sequence data were then identified 
and selected for further comparative sequence analysis. Deduced amino acid 
sequences for subtype I DENV-3 genomes were divided into two groups: 
those belonging to the Sumatran-Javan lineage (including the slightly more 
distantly-related Timor Leste strains) and those that are not. The χ2 test was 
used to identify residues that are significantly different between the two 
groups at the 0.05 significance level. The identified residues were submitted 
to SIFT (http://blocks.fhcrc.org/sift/SIFT.html), a tool that uses sequence 
homology to predict the effects of amino acid substitutions on protein function 
(Ng and Henikoff, 2001). The database used by SIFT was SWISS-PROT 51.3 
and TREMBL 34.3, with the median conservation of sequences set at 3.00. 
Conservative and non-conservative amino acid substitutions were defined 
according to the BLOSUM62 matrix (Henikoff and Henikoff, 1992) with 
changes having a positive or neutral value in the matrix considered as 
conservative whereas those with a negative value considered as non-
conservative. Similar analyses for the other DENV serotypes were not 
pursued due to a lack of closely related genome sequences for comparison 
(data not shown). 
3.3.8 Site-specific selection pressures 
Site-specific selection pressures acting on the DENV-3 coding 
sequences were determined using the HyPhy package, implemented as a 
Web application at http://www.datamonkey.org, using the single likelihood 
ancestor counting (SLAC) method (Pond and Frost, 2005a, b) and the 
General Reversible Model nucleotide substitution model. 
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Table 3.1. The GenBank Accession, strain name, serotype, year of isolation, 
sequence length and patient-related information of dengue genomes 
sequenced in this study. The disease severity for seven cases was not 
evaluated by the admitting hospitals. 
 
GenBank Accession Strain Name Serotype Year Isolated Length Severity Patient Age Patient Sex 
AY858035 BA05i DENV-2 2004 10723 DF 2 M 
AY858036 TB61i DENV-2 2004 10723 - - - 
AY858037 BA51 DENV-3 2004 10707 DF 14 M 
AY858038 den3_88 DENV-3 1988 10707 - - - 
AY858039 den3_98 DENV-3 1998 10707 - - - 
AY858040 FW01 DENV-3 2004 10706 DF + HM 33 M 
AY858041 FW06 DENV-3 2004 10707 - - - 
AY858042 KJ30i DENV-3 2004 10707 - - - 
AY858043 KJ46 DENV-3 2004 10706 DHF-I 18 F 
AY858044 KJ71 DENV-3 2004 10707 - - - 
AY858045 PH86 DENV-3 2004 10707 DF 15 M 
AY858046 PI64 DENV-3 2004 10707 DHF-I 31 M 
AY858047 TB16 DENV-3 2004 10707 DF 59 M 
AY858048 TB55i DENV-3 2004 10673 - - - 
AY858049 SW36i DENV-4 2004 10114 DHF-I 12 F 
AY858050 SW38i DENV-4 2004 10516 DHF-I 30 F 
AY858983 SC01 DENV-1 2004 7455 DF 7 M 
 
Key: DF- dengue fever; HM – haemorrhagic manifestations; DHF-I dengue 
haemorrhage fever grade I according to WHO guidelines, i.e. patients with positive 
tourniquet test, thrombocytopenia and plasma leakage. 
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3.4 Results 
3.4.1 Genome sequencing of dengue isolates 
The genomes of 15 DENV isolates were successfully sequenced out of 
the 69 serum samples collected in Jakarta, Indonesia during the 2004 
epidemic. Ten of the genomes were found to be DENV-3, along with two 
DENV-2, two DENV-4 and one DENV-1. In the remaining cases, there was 
insufficient virus in the serum samples to allow viral propagation or RNA 
extraction. Two historical Indonesian dengue samples collected in 1988 and 
1998 (den3_88 and den3_98) were similarly sequenced. The two samples 
were selected to represent the two other major dengue epidemics reported in 
Indonesia in 1988 and 1998 (Corwin et al., 2001; WHO, May 11, 2004; 
Suwandono et al., 2006). The final length obtained for each genome and 
other relevant details are listed in Table 3.1. The solitary DENV-1 genome 
was sequenced apart from the last 2.7 kb which were recalcitrant to repeated 
amplification attempts. Similarly, approximately 550 bases at the 50 end for 
SW36i could not be obtained. Due to the small number of published DENV-4 
genomes in GenBank, it was not possible to design redundant primers that 
encompass the variability typically seen within a dengue serotype. For this 
reason, the two DENV-4 isolates were subsequently sequenced using a 
primer walking approach. 
3.4.2 Phylogeny of the DENV-1, DENV-2 and DENV-4 isolates 
Phylogeny of the sequenced DENV-1, DENV-2 and DENV-4 isolates 
were inferred based on the nucleotide sequences of the complete envelope (E) 
gene. This choice is due to the availability of a greater diversity of E gene 
sequences for these serotypes compared to genome sequences. The E gene 
phylogenetic tree of DENV-1 places the solitary DENV-1 isolate in this study, 
SC01 (AY858983), in subtype IV as described by Goncalvez et al. (2002) 
(Figure 3.1). This group primarily contains isolates from Australia and the 
West Pacific islands (Indonesia and the Philippines included) – a result that 
suggests SC01 is an endemic strain in Indonesia. 
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Figure 3.1. Phylogenetic tree of DENV-1 based on the complete nucleotide 
sequences of the E gene (1485 bases). The leaves are labeled with the 
GenBank accession number, country of isolation, and year of isolation. The 
dataset used is identical to the one used by Goncalvez et al. (2002) with the 
addition of AY858983, which fall within subtype IV of DENV-1. 
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Figure 3.2. Phylogenetic tree of DENV-2 based on the complete nucleotide 
sequences of the E gene (1485 bases). The leaves are labeled with the 
GenBank accession number, country of isolation, and year of isolation. The 
dataset used is a subset of the one used by Twiddy et al. (2002), comprising 
just 52 of the original 147 strains, and with the addition of AY858035 and 
AY858036. The two 2004 Indonesian strains sequenced in this study fall 
within the ‘‘Cosmopolitan’’ subtype of DENV-2. 
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Figure 3.3. Phylogenetic tree of DENV-4 based on the complete nucleotide 
sequences of the E gene (1485 bases). The leaves are labeled with the 
GenBank accession number, country of isolation, and year of isolation. The 
dataset used is identical to the one used by Lanciotti et al. (1997) with the 
addition of AY858049, AY858050 and AY947539. The two 2004 Indonesian 
strains sequenced in this study fall within subtype II of DENV4. 
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The E gene phylogenetic tree for DENV-2 (Figure 3.2) places BA05i 
(AY858035) and TB61i (AY858036) in the Cosmopolitan subtype according to 
the classification scheme proposed by Twiddy et al. (2002). This subtype has 
previously been associated with DHF/DSS (Leitmeyer et al., 1999) and as the 
name suggests, is a diverse lineage that contains viruses from India, 
Southeast Asia, Africa, the Middle East and Australia. This means the two 
DENV-2 strains are likely to be regionally endemic strains. 
The E gene phylogenetic tree for DENV-4 (Figure 3.3) shows both 
SW36i (AY858049) and SW38i (AY858050) as belonging to subtype II, a 
genetic lineage that contains viruses from Indonesia, the South Pacific and 
the Western hemisphere (Chungue et al., 1995; Lanciotti et al., 1997). 
Another Indonesian strain isolated in 1973 is also found in the clade that 
contains the two 2004 strains, thereby confirming the two as being endemic in 
Indonesia. 
3.4.3 Diversity and phylogeny of the DENV-3 isolates 
Figure 3.4 shows the phylogenetic tree constructed from a dataset 
containing the 40 DENV-3 isolates described by Messer et al. (2003), but with 
additional sequences from a DF-causing strain isolated in 2003 in Singapore 
(AY662691) and the newly sequenced Indonesian DENV-3 isolates. This tree 
is based on a 705-base segment covering pre-M/M and a portion of the E 
gene. All DENV-3 strains from Indonesia fall into subtype I, according to the 
classification described by Lanciotti et al. (1994), a lineage that can be traced 
all the way back to strains isolated in the same region in the early 1970s. In 
contrast, the strain from nearby Singapore clusters with subtype III strains 
which are commonly associated with viruses found in Eastern Africa and 
South Asia. The 2004 Indonesian strains can be further divided into two 
distinct clades, but there is no spatial clustering by the location of the 
admitting hospitals. The amount of data available is insufficient to attempt any 
correlation between genetic variation and the reported disease severity. 
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Figure 3.4. Phylogenetic tree of DENV-3 based on a 705-base segment 
covering the pre-M/M and a part of the E gene (from position 437 to 1141 of 
the DENV-3 genome). The leaves are labeled with the GenBank accession 
number, strain name/country of isolation, and year of isolation. The dataset 
used is identical to the one used by Messer et al. (2003) with the addition of 
AY858037-AY858048 and AY662691. All Indonesian strains sequenced in 
this study fall within subtype I of DENV-3 whereas the AY662691 strain from 
Singapore fall within subtype III. 
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Figure 3.5. Phylogenetic tree based on 30 subtype I DENV-3 whole-genome 
nucleotide sequences. The tree leaves are labeled with the GenBank 
accession number, country of isolation, year of isolation and known clinical 
severity. The branch topology for the Indonesian strains sequenced in this 
study is similar to the prM-E tree in Figure 3.4. 
 
After the intra-serotypic classification of the DENV-3 strains had been 
established, all published DENV-3 complete genomic sequences were 
collected to construct a whole-genome phylogeny. The whole-genome 
phylogenetic tree for 30 subtype I genomes (Figure 3.5) shows a distinct 
cluster that groups strains isolated from 1988, 1998 and 2004 in Indonesia, as 
well as strains isolated in a subsequent outbreak in Timor Leste in 2005 
(WHO, 2005). This Sumatran-Javan clade is potentially a viral lineage that 
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possesses a superior level of evolutionary fitness and epidemic potential, as 
evident by its sustained transmission since 1970s and being implicated in 
major dengue epidemics in 1988, 1998 and 2004. In contrast, the other clade 
within subtype I does not have a similar epidemic-causing history, and has not 
been implicated in any epidemic since the early 1990s. The ability to cause 
DHF/DSS is not restricted to the Sumatran-Javan lineage and is observed in 
both lineages within subtype I (Figure 3.5), suggesting that disease severity 
and epidemic potential are likely to be governed by separate discrete factors. 
3.4.4 Clade-specific mutations of the DENV-3 isolates 
The availability of complete genome sequences made it possible to 
identify amino acid mutations that are specific to the Sumatran-Javan lineage, 
which could be the viral genetic elements that contribute to its continuing 
circulation in the region and its epidemic potential. Comparative analysis 
identified 24 amino acid residues that are significantly different between the 
Sumatran-Javan lineage and the other subtype I DENV-3 strains at the 0.05 
significance level (Figure 3.6). 
The impact of amino acid changes on protein function were 
subsequently predicted using SIFT (Ng and Henikoff, 2001) to identify 
residues that could be conferring competitive fitness advantage to the 
Sumatran-Javan lineage. Within the prM protein an A107T substitution 
located downstream of the furin cleavage site and retained in the mature virus 
was identified. Two non-conservative mutations were found in the E protein: a 
leucine typically found at position 124 of the E protein in strains within the 
Sumatran-Javan clade is replaced by a serine (L124S) outside the clade; the 
second mutation (S301L) is located within domain III of the E protein which is 
believed to be involved in antigenicity (Roehrig, 2003). There were also 
mutations within the non-structural proteins but none that are chemically non-
conservative and predicted as not tolerated by SIFT (Table 3.2). 
Using the single likelihood ancestor counting (SLAC) method (Pond 
and Frost, 2005a, b) we determined site-specific selection pressures acting on 
all the available DENV-3 coding sequences. While many sites seem to be 
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under a negative selection pressure, no evidence of positive selection was 
found. Unfortunately the Sumatran-Javan clade is too small to confidently 
detect any evidence of positive selection within this group. 
 
Figure 3.6. Amino acid residues that are significantly different between the 
Sumatran-Javan lineage and other subtype I DENV-3 strains (p < 0.05, chi-
square). Sequences AY858037-AY858048 are the strains sequenced in this 
study. Amino acids are color-coded as shown in the key beneath the main 
diagram. 
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Figure 3.7. Amino acid differences among the Indonesian DENV-3 strains 
isolated in 1988, 1998 and 2004. The sequences are sorted in chronological 
order followed by accession number, starting from the left. Only 98 positions 
out of 3390 of the DENV-3 polyprotein reported any mutations, and none 
could be suggested as the trigger for the epidemic in 2004. Amino acids are 
color-coded as shown in the key beneath the main diagram. 
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A similar comparison of the deduced amino acid sequences involving 
only the 16 Indonesian DENV-3 strains from the epidemics in 1988, 1998 and 
2004 did not detect any specific mutation that could have served as the trigger 
of the epidemic in 2004 (Figure 3.7). Only 98 sites out of 3390 (2.89%) of the 
DENV-3 polyprotein reported any mutation, and this number drops to 87 if 
den3_88 from 1988 is removed from the analysis. From the pattern of 
mutations observed these differences are likely to be the result of random 
mutations that confers little or no evolutionary advantage. 
3.5 Discussion 
The genome sequences of three serotypes of DENV were successfully 
obtained using a genome sequencing strategy that can be used on patient 
serum samples. Success with DENV-4 sequencing using this approach is 
expected in the future as more DENV-4 genomes become available for better 
RT-PCR primer design. Based on the obtained sequences, we have 
determined the molecular characteristics and phylogenetic relationships of the 
DENV strains isolated during the 2004 epidemic in Jakarta, Indonesia. 
The phylogenetic trees for each of the four serotypes show that the 
viruses isolated in the 2004 epidemic cluster within subtypes that have been 
circulating in South East Asia for at least 30 years. The strongest evidence of 
these being endemic strains comes from the phylogenetic data for DENV-3. 
All 12 Indonesian DENV-3 strains sequenced in this study fall into subtype I 
which is recognized as comprising strains from Southeast Asia and the South 
Pacific islands. The close phylogenetic relationship observed between the 
strains isolated from Sumatra in 1998 and those from Jakarta in 2004 
indicates that the 2004 epidemic might have had its origins in strains derived 
from viruses circulating in Sumatra in 1998, or possibly in a common ancestor 
of the Sumatran strains (Figure 3.5). Sumatra is one of the largest Indonesian 
islands and Jakarta on the nearby island of Java is the capital city of 
Indonesia, therefore frequent transmission by travelers is likely. 
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The identified Sumatran-Javan clade links the newly sequenced 
DENV-3 strains directly to the strains implicated in the epidemic on the island 
of Java in 1988, on the island of Sumatra 6 years earlier and those that 
subsequently caused an outbreak in Timor Leste in 2005. This clearly 
suggests these viruses possess an inherent epidemic potential. Since viruses 
from this particular lineage have been implicated in causing four epidemics in 
the past two decades, it is very likely these viruses could yet cause another 
dengue epidemic in Indonesia in the near future if they remained in circulation. 
We then examined the clade-specific mutations of the Sumatran-Javan 
DENV-3 isolates for potential viral genetic markers that could be the trigger of 
the epidemics. However, comparative study of the deduced polyprotein 
sequences established that re-emergence of little-changed endemic strains, 
and not newly-acquired amino acid mutations by the DENV-3 strains, as the 
most likely cause of the dengue epidemic in 2004 (Figure 3.7). 
According to a parallel serological study involving 272 hospitalised 
patients, all four dengue serotypes were detected during the 2004 epidemic 
with DENV-3 being the predominant circulating serotype (Suwandono et al., 
2006). Similar serological result was reported for the 1998 epidemic in south 
Sumatra, and the predominance of DENV-3 as a result of inherent sampling 
bias (on the premise that DENV-3 causes more severe illness and therefore 
causes more hospitalisation that facilitates sampling) has been proposed 
(Corwin et al., 2001). The fact that all four serotypes were found to be 
circulating in successive epidemics adds credence to the suggestion that 
advantageous amino acid mutations is not the trigger of the epidemics, 
otherwise this hypothetical fitter form would then dominate and become the 
sole serotype detected in subsequent outbreaks. 
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Table 3.2. Amino acid residues that potentially confer competitive fitness 
advantage to the Sumatran-Javan DENV-3 lineage when compared to other 
subtype I DENV-3 genomes. The two most likely candidates are shaded in 
grey. Mutations predicted by SIFT as “Tolerated” are less likely to have an 
impact on the fitness level of the virus. Threshold of intolerance used by SIFT 
is 0.05. 
 
Viral Protein Mutation Functional Domain Amino Acid Variation SIFT Prediction 
C I65V Helix α3 Conservative Not tolerated 
prM/M A107T - Conservative Tolerated 
E L124S Domain II Non-conservative Not tolerated 
E V129A Domain II Conservative Tolerated 
E S301L Domain III Non-conservative Not tolerated 
E V355I Domain III Conservative Not tolerated 
E I377V Domain III Conservative Tolerated 
NS1 V88I - Conservative Tolerated 
NS1 I93V - Conservative Tolerated 
NS1 I128T - Non-conservative Tolerated 
NS1 N145S - Conservative Tolerated 
NS2A V5A - Conservative Not tolerated 
NS2A V36A - Conservative Not tolerated 
NS2A R55H - Conservative Not tolerated 
NS2B L21F - Conservative Not tolerated 
NS3 Y60H Protease Conservative Tolerated 
NS3 S71N Protease Conservative Tolerated 
NS4A I100V Transmembrane Segment 2 Conservative Tolerated 
NS5 Y246H Methyltransferase Conservative Tolerated 
NS5 T336M Polymerase Non-conservative Tolerated 
NS5 T399I Polymerase Non-conservative Tolerated 
NS5 T631A Polymerase Conservative Tolerated 
NS5 I643V Polymerase Conservative Tolerated 
NS5 K749R Polymerase Conservative Tolerated 
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The availability of genome sequence data has made possible the 
attempt to identify putative viral genetic factors that contributed to the 
continuing circulation of the Sumatran-Javan lineage and its epidemic 
potential. Two candidate residues were found in the E protein (Table 3.2) that 
may account for this difference however no conclusive evidence of positive 
selection was found. It is clear the genome sequencing and analysis strategy 
broadens the search for novel functional mutants beyond the scope of most 
previous studies which have mainly focused on using nucleotide sequences 
from the three dengue structural proteins. 
The sequence data obtained in this study tells little about the role of 
population dynamics of the four serotypes in causing epidemics, but it clearly 
shows that the viruses that caused the 2004 epidemic in Indonesia are local 
strains that have been circulating in the region for a few decades. The 
identified Sumatran-Javan lineage of DENV-3 apparently is robust enough for 
sustained transmissions and has demonstrated strong epidemic potential 
spanning two decades. 
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4.1 Abstract 
Dengue is one of the most important emerging diseases of humans 
with no preventative vaccines or antiviral cures available at present. Although 
one-third of the world’s population live at risk of infection, little is known about 
the pattern and dynamics of dengue virus (DENV) within outbreak situations. 
By exploiting genomic data from an intensively studied major outbreak we are 
able to describe the molecular epidemiology of DENV at a uniquely fine-
scaled temporal and spatial resolution. Two DENV serotypes (DENV-1 and 
DENV-3), and multiple component genotypes, spread concurrently and with 
similar epidemiological and evolutionary profiles during the initial outbreak 
phase of a major dengue epidemic that took place in Singapore during 2005. 
Although DENV-1 and DENV-3 differed in viremia and clinical outcome, there 
was no evidence for adaptive evolution before, during, or after the outbreak, 
indicating that ecological or immunological rather than virological factors were 
the key determinants of epidemic dynamics. 
4.2 Introduction 
The phylogenetic analysis of gene sequence data is commonly used to 
determine the origins of disease outbreaks, particularly those caused by 
rapidly evolving RNA viruses (1, 2, 7, 9, 16, 26). Historically, such molecular 
epidemiological studies have usually utilized a small number of genes and 
have largely concentrated on determining the origins of disease outbreaks 
and retracing their pathways of spread. As such, these studies have rarely 
been able to shed light on the precise spatial and temporal dynamics of viral 
transmission. Recently, whole genome sequencing of viruses has been 
utilized to provide greater phylogenetic resolution on outbreak dynamics (12, 
14, 15, 20) and is likely to become the benchmark in the near future.  
One disease where genomic sequence may be especially informative 
is dengue fever (DF), an acute febrile disease caused by a mosquito-borne 
RNA virus (DENV; single-strand positive-sense, family Flaviviridae) and the 
most common vector-borne viral infection of humans; some 100 million 
dengue cases are reported on an annual basis, with epidemics especially 
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common in Southeast Asia (10, 11). The potential expansion of the viable 
geographic range for Aedes aegypti mosquitoes following global warming 
coupled with the current lack of an effective vaccine or anti-viral therapies 
make understanding the epidemic dynamics of this important emerging virus a 
key priority. 
Dengue has the ability to cause major outbreaks in urban settings, 
often with high levels of morbidity. The Singapore dengue outbreak of 2005 
was the largest of its kind in this locality, with a case rate of 335 per 100,000 
population (17). The 2005 outbreak was also notable in that it was 
characterized by the co-circulation of two of the four viral serotypes – DENV-1 
and DENV-3 – combined with a low level of DENV-2 transmission. The 
resurgence of dengue in Singapore is particularly striking given that an 
aggressive vector control program started in 1970 has resulted in a very low 
household index of mosquito breeding sites (21). Lessons learnt in Singapore, 
with its long history of commitment to dengue control, may therefore be vital to 
the overall global effort in dengue prevention. 
By undertaking a detailed analysis of whole-genome data sampled 
from a major outbreak of dengue virus (DENV) in Singapore during 2005 – the 
first of its kind – we demonstrate how a synthesis of comparative genomics 
and fine-scale spatial and temporal epidemiological data provides 
unprecedented power to reveal the origins, causes and dynamics of this 
important emerging virus in a densely population urban environment. 
4.3 Material and Methods 
4.3.1 Collection of viral samples 
Viral samples were collected as described in Low et al. (17). Briefly, 
blood samples were collected by a research nurse from consenting patients 
presenting with fever of ≥ 38°C for less than 72 hours. One ml of serum from 
samples confirmed as dengue positive by RT-PCR was inoculated onto the 
Aedes albopictus mosquito (C6/36) cell line (ATCC: CRL-1660). Cells were 
incubated at 37°C for up to 10 days or until 75% of the cell monolayer showed 
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cytopathic effects. Isolation of the virus was confirmed and serotyped by 
indirect immunofluorescence using DENV group-specific and DENV serotype-
specific monoclonal antibodies. 
4.3.2 Molecular Analysis 
Viruses were propagated by two passages in C6/36 mosquito cell 
culture. Viral titer was measured using a plaque-assay. Viral titers of at least 
1x106 were found to be required for optimal success in subsequent RT-PCR 
steps. Viral RNA was extracted from the culture supernatant using the 
QIAGEN QiaAmp kit and extraction protocol. 
The extracted RNA was copied to cDNA using an RT reaction followed 
by PCR amplification. The virus was amplified as five overlapping fragments. 
Unless specified below the same conditions were used for all five fragments. 
RT of fragments 1, 3 and 4 was performed in a single tube. RT of fragments 2 
and 5 was performed in separate tubes. Samples were kept on ice and 
pipetting was carried out using RNAase free filter tips. PCR primers used in 
the RT reaction are detailed in Supplementary Table 1 and reaction conditions 
are in Supplementary Table 2. The five RT fragments were subsequently 
amplified by PCR. The PCR primers that were used to amplify the RT 
fragments are detailed in Supplementary Table 3. PCR of the RT fragments 
was carried out in a thermal cycler using the program in Supplementary Table 
4. 
Gel electrophoresis was used for visualization of the PCR products as 
well as gel extraction and purification of products. The products were 
separated in 1% agarose TBE gels after visualization of ethidium bromide 
stained bands under UV light. DNA was extracted from bands excised from 
agarose gels using a Qiagen QiaQuick extraction kit. 
Finally, gel-purified fragments were sequenced using an Applied 
Biosystems BigDye ddNTP capillary sequencer. Viral genome sequences 
generated in this study are deposited in GenBank with accession numbers 
EU081177-EU081281. All genome sequences, their GenBank accession 
82 
numbers and their standard strain names (27) used in the analyses in this 
paper are detailed in Supplementary Table 5. 
4.3.3 Evolutionary analysis 
To reveal the origins of the Singapore viruses we conducted a 
phylogenetic analysis of the complete coding region of the genome 
sequences of all those viruses sequenced here as well as those already 
available in GenBank. This resulted in data sets of the following size: DENV-1 
= 145 taxa, 10,176 nt; DENV-2 = 116 taxa, 10,173 nt; DENV-3 = 122 taxa, 
10,173 nt. To determine the best-fit model of nucleotide substitution we 
employed MODELTEST (24). In all cases the most general GTR+I+?4 model 
was favored. Maximum likelihood (ML) trees were then inferred under this 
model using PAUP* (30), employing TBR branch-swapping in each case. 
Finally, a neighbour-joining (NJ) bootstrap analysis (1000 replications), but 
employing the ML substitution model, was used to determine the robustness 
of key nodes on each phylogeny. 
To determine the population dynamics of DENV-1 and DENV-3 during 
the 2005 dengue outbreak in Singapore we analyzed those isolates that 
clearly diversified during the course of the epidemic. For DENV-1, this meant 
our analysis was confined to 53 genome sequences from Singapore 
(genotype I), while 42 genomes (genotype III) were used in the case of 
DENV-3. There were insufficient sequences for an analysis of DENV-2. 
Demographic and evolutionary parameters for both serotypes were estimated 
using the Bayesian MCMC (Markov Chain Monte Carlo) approach 
implemented in the BEAST package (4). Because of the typically complex 
population dynamics we utilized the Bayesian skyline plot as a coalescent 
prior. This provides a piecewise graphical depiction of changes in the effective 
number of infections (Neτ), where Ne is the effective population size and τ the 
generation time. We also utilized both strict and relaxed (uncorrelated 
lognormal) molecular clocks. The GTR+Γ4 model of nucleotide substitution 
was used in all cases, with the invariant sites parameter (I) excluded as it 
tended to over-fit to the data. Uncertainty in the data for each estimated 
parameter is reflected in values of the 95% high probability density (HPD), 
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with all MCMC chains run for sufficient time (50 million steps, with 10% 
removed as burn-in) to ensure statistical convergence. 
To determine the nature of selection pressures acting on each gene of 
DENV-1 and DENV-3 sampled from Singapore, we computed the mean ratio 
of nonsynonymous (dN) to synonymous (dS) substitutions per site (dN/dS) 
using the Single Likelihood Ancestor Counting (SLAC) method available 
through the DATAMONKEY web interface (23) and assuming the GTR model 
of nucleotide substitution and an input NJ tree. This analysis also allowed us 
to compute the Tree Length (TL) in substitutions per site for each gene. In 
addition, we used the CODEML program within the PAML package (33) to 
estimate an overall dN/dS for the entire coding region of both serotypes (the 
‘one-ratio’ model). This was compared to the case in which a separate dN/dS 
value was estimated for the external and internal branches of each data set 
(the ‘two-ratio’ model). 
Finally, to determine the strength of spatial structure in both DENV-1 
and DENV-3 we first obtained the physical address of each viral isolate and 
produced clusters according to their geographical proximity by K-means 
clustering. For DENV-1, the physical address was available for 48 isolates 
which were then placed into one of six different spatial groups (with a single 
letter character state code identifying each group). In the case of DENV-3, 
address information was available for 42 isolates and these were separated 
into four spatial groups. Although there are a variety of methods by which the 
extent of spatial structure in phylogenetic data can be determined, particularly 
utilizing parsimony character state mapping (28), we employed a Bayesian 
MCMC approach (22) thereby accounting for any error in the underlying 
phylogeny. This analysis was based on the trees output from the previous 
BEAST analysis (with a new BEAST analysis conducted on the 48 sequence 
DENV-1 data set), employing 1000 replications and with 10% of trees 
removed as burn-in. From these trees we computed the mean values, 
credible intervals, and significance of the parsimony score (PS) and 
association index (AI) statistics of the strength of geographical clustering (22). 
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4.4 Results and Discussion 
Fortuitously, the 2005 outbreak coincided with the launch of a 
longitudinal “Early DENgue Infection and Outcome” (EDEN) study in the 
central Ang Mo Kio district of Singapore (17). From a sample of 133 RT-PCR 
dengue positive patients enrolled during the EDEN study, and collected 
between April and November 2005, serotyping determined 66 (48.9%) to be 
DENV-1, 62 (46.6%) to be DENV-3 and 5 to be DENV-2 (3.8%). No cases 
due to DENV-4 were observed (17), and one patient was found to be co-
infected with serotypes 1 and 3. The detection of large numbers of DENV-3 in 
the Ang Mo Kio area was unusual as DENV-1 was the predominant serotype 
in the rest of Singapore. We were able to isolate 112 (84.2%) viruses, 
corresponding to 57 DENV-1, 50 DENV-3 and 5 DENV-2 isolates. Complete 
genome sequences were obtained for 54 DENV-1, 44 DENV-3 and 4 DENV-2 
viruses. The remaining samples, although shown to be dengue positive by 
RT-PCR, did not yield sufficient viral RNA for genome sequencing.  
To determine the origins of the viral isolates responsible for the 2005 
dengue epidemic in Singapore we conducted a phylogenetic analysis of the 
complete genomes of the viruses sampled here combined with representative 
DENV isolates taken from GenBank. To assist in this comparison we also 
completed whole genome sequences of some historical DENV samples from 
Singapore. All but one of the DENV-1 genomes from this epidemic were 
classified as genotype I, which commonly circulates in Southeast Asia (Figure 
4.1). The single outlier belongs to genotype III, which is predominantly found 
in Latin America and West Africa (8), although a genotype III virus was 
previously sampled in Singapore in 1993. The closest relatives of the 53 
genotype I Singapore DENV-1 isolates are the Chinese isolates DENV-
1/CN/Fj231/2004 and DENV-1/CN/ZH1067/XXX, suggesting that frequent 
transfer of DENV may occur between Singapore and China, and DENV-
1/JP/20-Feb/XXX from Japan. Importantly, as three historical Singapore 
DENV-1 samples isolated in 2003 fell at the base of the 2005 cluster it is 
possible that this particular lineage of DENV-1 genotype I has been circulating 
continuously in Singapore since at least 2003. 
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Figure 4.1.  Phylogenetic relationships of 145 complete genomes DENV-1 
sampled globally determined using a maximum likelihood method.  Isolates 
sampled from Singapore are shown in red and individual genotypes are 
shown.  Bootstrap values (>80%) are shown next to key nodes and all 
horizontal branch lengths are drawn to scale. 
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The four DENV-2 genomes form part of the “cosmopolitan” genotype 
(Figure 4.2), that has a wide distribution in tropical and subtropical localities 
(32). Close relatives of these strains include, DENV 2/ID/BA05i/2004 and 
DENV 2/ID/TB16i/2004, which were isolated during a dengue fever epidemic 
in Jakarta in 2004 (29) as well as three strains from Brunei Darussalam, one 
from China and an older isolate from Queensland, Australia (DENV-
2/AU/TSV01/1993) (13), possibly introduced from the nearby Indonesian 
islands. As a number of these viruses were isolated between 2004 and 2006 it 
seems likely that this lineage was relatively common in this geographical area 
at the time of the outbreak. 
The majority of DENV-3 genomes fell into genotype III (Figure 4.3). 
This genotype was originally associated with the Indian subcontinent until the 
mid-1990s when it was introduced into Latin America and the Caribbean (19). 
Of more importance from the perspective of this outbreak was that an isolate 
from genotype III was first detected in Singapore in 2003 (DENV-
3/SG/S221/2003) and which fell basal to the 2005 outbreak viruses in our 
phylogenetic analysis. Such a phylogenetic pattern is compatible with the in 
situ evolution of this lineage in Singapore since at least 2003. Hence, as is 
also likely the case with DENV-1, the 2005 outbreak of DENV-3 may also be 
due to the amplification of a pre-existing viral lineage rather than the invasion 
of an ‘exotic’ DENV strain. To further test this hypothesis we obtained the 
additional genome sequence of a Singaporean DENV-3 genotype I isolate 
(DENV-3/SG/SS710/2004) sampled in 2004. As expected under the 
hypothesis of in situ evolution, this isolate occupies an intermediate position 
between the 2003 and 2005 strains. Finally, two of the 44 DENV-3 isolates 
from the 2005 outbreak in Singapore fall into genotype I which is endemic in 
the Malay archipelago. This observation provides an additional point of 
similarity between the DENV-1 and DENV-3 components of the 2005 DENV 
outbreak in Singapore: that individual epidemic serotypes can be composed 
of multiple viral genotypes. 
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Figure 4.2.  Phylogenetic relationships of 116 complete genomes DENV-2 
sampled globally determined using a maximum likelihood method.  Isolates 
sampled from Singapore are shown in red and individual genotypes are 
shown.  Bootstrap values (>80%) are shown next to key nodes and all 
horizontal branch lengths are drawn to scale. 
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Figure 4.3.  Phylogenetic relationships of 122 complete genomes DENV-3 
sampled globally determined using a maximum likelihood method.  Isolates 
sampled from Singapore are shown in red and individual genotypes are 
shown.  Bootstrap values (>80%) are shown next to key nodes and all 
horizontal branch lengths are drawn to scale. 
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The majority of DENV-3 genomes fell into genotype III (Figure 4.3). 
This genotype was originally associated with the Indian subcontinent until the 
mid-1990s when it was introduced into Latin America and the Caribbean (19). 
Of more importance from the perspective of this outbreak was that an isolate 
from genotype III was first detected in Singapore in 2003 (DENV-
3/SG/S221/2003) and which fell basal to the 2005 outbreak viruses in our 
phylogenetic analysis. Such a phylogenetic pattern is compatible with the in 
situ evolution of this lineage in Singapore since at least 2003. Hence, as is 
also likely the case with DENV-1, the 2005 outbreak of DENV-3 may also be 
due to the amplification of a pre-existing viral lineage rather than the invasion 
of an ‘exotic’ DENV strain. To further test this hypothesis we obtained the 
additional genome sequence of a Singaporean DENV-3 genotype I isolate 
(DENV-3/SG/SS710/2004) sampled in 2004. As expected under the 
hypothesis of in situ evolution, this isolate occupies an intermediate position 
between the 2003 and 2005 strains. Finally, two of the 44 DENV-3 isolates 
from the 2005 outbreak in Singapore fall into genotype I which is endemic in 
the Malay archipelago. This observation provides an additional point of 
similarity between the DENV-1 and DENV-3 components of the 2005 DENV 
outbreak in Singapore: that individual epidemic serotypes can be composed 
of multiple viral genotypes. 
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Figure 4.4a. Observed amino acid changes in DENV-1 
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Figure 4.4b. Observed amino acid changes in DENV-3 
 
Figure 4.4.  Observed amino acid changes in DENV-1 (a) and DENV-3 (b).  
Viral isolates are plotted on the x axis.  The aligned polyproteins of each virus 
were compared to count the number and distribution of amino acid changes.  
Positions that were not completely conserved are shown with the individual 
protein name and the amino acid position within the protein on the Y axis.  
The color of each square indicates the type of amino acid residue found in 
isolate x at position y. 
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To determine the evolutionary processes that enabled the emergence 
of multiple DENV genotypes in a single outbreak we examined each of the 
amino acid changes associated with these viruses. Remarkably, no amino 
acid changes were completely fixed on the branches leading to the DENV-1 
or DENV-3 isolates sampled in Singapore during 2005 (Figure 4.4a). In 
DENV-1 residue 76 of NS4A was observed to be K in all samples from 2003 
and R in many 2005 samples. However, the penetration of the mutation was 
incomplete and is quite conservative in nature and therefore unlikely to be 
significant. Similarly, no amino acid variants in DENV-1 observed during 2005 
were found in the two genomes isolated and sequenced from the 2006 non-
epidemic year, indicating that no mutations that occurred in 2005 became 
fixed. Some substitutions were observed in DENV-3 between the 2003 and 
2004 non-epidemic strains although all are conservative except for the 
change from serine to lysine at residue 895 in NS5. Position 895 is not 
conserved in the four serotypes and is usually S, P or E. In the recently solved 
structure of the DENV-3 RNA dependent RNA polymerase (34) position 895 is 
near the C terminal (position 900) and does not appear to functionally 
significant. More notably, there are no fixations between the 2004 isolate and 
the 2005 epidemic isolates. Although a number of non-conservative 
substitutions were observed within the 2005 isolates of DENV-3, that this 
serotype was not detected in 2006 indicates that none were capable of 
perpetuating the clade (Figure 4.4b). Finally, there was no evidence for 
positive selection in any gene of the Singapore viruses, with a relatively low 
ratio of nonsynonymous to synonymous substitutions per site (dN/dS) in all 
genes and no evidence for site-specific positive selection (Table 4.1; which 
also gives a variety of other gene-specific measures of genetic diversity).  
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Table 4.1.  Phylogenetic and evolutionary patterns among the proteins of 
DENV-1 and DENV-3 sampled from Singapore during 2005. 
 
 
DENV-1 
 
 
DENV-3 
 
 
 
Protein 
 
 
Length 
(nt) ISa TLb dN/dS IS TL dN/dS 
Capsid 342 5 0.026 0.359 3 0.023 0.064 
Membrane 498 9 0.034 0.332 1 0.008 0.175 
Envelope 1479-1485c 11 0.031 0.206 9 0.013 0.095 
NS1 1056 7 0.025 0.042 4 0.011 0.204 
NS2A 654 6 0.029 0.318 3 0.009 0.067 
NS2B 390 8 0.043 0.029 1 0.010 0 
NS3 1857 16 0.024 0.059 4 0.014 0.265 
NS4A 450 6 0.029 0.037 2 0.009 0 
NS4B 744-747 c 6 0.031 0.019 3 0.009 0 
NS5 2679-2700 c 19 0.022 0.157 11 0.011 0.131 
Genome 
(coding) 
10,158 
- 10,170 
96 NAd NA 41 NA NA 
 
a Number of parsimony informative sites, b Tree length in substitutions per site, c Length for 
DENV-1 and DENV-3 respectively, d Not applicable. No significant evidence for positive 
selection was observed in any gene in either DENV-1 or DENV-3. 
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To infer the epidemiological dynamics of DENV-1 and DENV-3 during 
the Singapore outbreak we used a Bayesian coalescent approach (3, 5) 
incorporating data on the exact day of viral sampling. For both serotypes we 
estimated the changing patterns of relative genetic diversity through time as 
reflected in the effective number of infections (Neτ) using a Bayesian skyline 
plot and assuming a relaxed (uncorrelated lognormal) molecular clock 
(although very similar results were observed under a strict molecular clock; 
results available from the authors on request). Similar epidemic profiles were 
observed in both viruses, comprising a rapid growth phase followed by a 
constant population size, although the mean age of the common ancestor was 
significantly greater in DENV-1 (1740 days; 95% HPD = 741 – 3222 days) 
compared to DENV-3 (298 days; 95% HPD = 225 – 387 days), indicating that 
already diverse lineages of DENV-1 were present in Singapore at the outset 
of the 2005 outbreak (Figure 4.5). Similarly, mean estimates of peak Neτ were 
smaller in DENV-3 (1632; 95% HPD = 56 – 4334) than DENV-1 (7211; 95% 
HPD = 637 – 23130), although with overlapping HPD values. Interestingly 
DENV-3 was not widely reported in Singapore during the outbreak and 
appeared to be mainly contained to the sampling area which supports this 
result. The substitution dynamics of both serotypes were also similar, with 
mean evolutionary rates of 1 x 10-3 subs/site/year (95% HPD, 0.4 x 10-3 – 1.6 
x 10-3 subs/site/year) and 1.3 x 10-3 subs/site/year (95% HPD, 8.7 x 10-4 – 1.8 
x 10-3 subs/site/year) for DENV-1 and DENV-3, respectively, and equivalent to 
those estimated previously for DENV (32). 
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Figure 4.5.  Population dynamics of DENV-1 and DENV-3 in Singapore 
during 2005 depicted using Bayesian skyline plots.  The plots show changes 
in relative genetic diversity, depicted as the effective number of infections 
(Neτ), through time.  The black line represents the mean estimate of Neτ, while 
the 95% HPD intervals are shown in blue.  Time is shown as the number of 
days from the most recent sample.  To aid interpretation, DENV-1 and DENV-
3 have been shown on the same time axis. 
96 
As an additional analysis of evolutionary dynamics we determined the 
genetic distance (under the ML substitution model) for each pair of DENV-1 
and DENV-3 sequences and compared these values to time intervals of 
sampling (based on day of fever onset) (Figure 4.6). Interestingly, it appears 
that genetic distances are often higher between isolates separated by shorter 
periods of time but then decline between pairs sampled over a longer time 
period (although this analysis does not take into account phylogenetic 
structure). This may in part be due to the presence of transient deleterious 
mutations in samples that are only separated by short time-periods (such that 
genetic distances strongly reflect the background mutation rate), which are 
later purged by purifying selection, so that longer term genetic distances are 
more indicative of the population substitution rate (12). This is supported by 
the observation that dN/dS is higher on external (0.130 and 0.157) than 
internal (0.081 and 0.030) branches of the complete coding region 
phylogenies for both DENV-1 and DENV-3, respectively, as expected if most 
nonsynonymous polymorphisms are deleterious (25). 
 
Figure 4.6.  Distribution of pairwise nucleotide, temporal and geographic 
distances among complete coding sequences of DENV-1 and DENV-3 
combined.  Histograms show the frequency of temporal and nucleotide 
distances on the X and Y axes respectively.  Each pair is represented as a 
point and the colour of the point indicates the physical distance between the 
home address of the patients from whom the viruses were isolated. 
97 
Interestingly, our analysis of DENV spatial dynamics in Singapore 
revealed significant population substructure (i.e. the existence of distinct 
spatial clusters) in both DENV-1 and DENV-3. This spatial dynamic was 
especially strong in the case of DENV-3 (p < 0.001 for both the PS and AI 
statistics) compared to DENV-1 (p = 0.008 and 0.037 for the PA and AI 
statistics, respectively). Hence, although these viruses were sampled from a 
relatively restricted region within Singapore, the movement of hosts and/or 
vectors is sufficiently limited that spatial structure is present in the data. 
Finally, the viremia from each patient’s sera was estimated from a 
cross-over threshold (Ct) calculated using quantitative RT-PCR (Q-PCR) at 1 
to 3 days and 4 to 7 days post-fever onset. Low Ct value of the RT-PCR, 
indicating high viremia levels, in the first sampling has been previously shown 
to be predictive of severe thrombocytopenia in our cohort (31). The Ct value 
for DENV-1 was significantly lower (p = 0.002) than for DENV-3 at both the 
first (17.07 vs. 19.76) and second (26.87 vs. 29.57) serum samplings, 
indicating a higher viremia level for DENV-1. DENV-1 also resulted in a 
significantly (p = 0.021) higher ratio of hospitalizations among the sampled 
population compared to DENV-3 (0.74 vs. 0.50) and may also be reflected in 
the higher values of Neτ for DENV-1 than DENV-3. 
Overall, these results suggest that ecological and/or immunological 
factors, rather than aspects of viral evolution, were central in shaping the 
dynamics of this dengue outbreak. Most notably, two different serotypes, and 
multiple co-circulating genotypes, emerged simultaneously, experienced 
similar epidemiological dynamics, and seemingly spread without the aid of 
positive selection, accumulating no amino acid fixations. Similarly, it is clear 
that viral evolution did not succeed in extending the epidemic; despite 
numerous mutations (Table 4.1), the number of dengue cases declined 
rapidly in 2006, suggesting that few, if any, of these mutations provided any 
selective advantage in the face of rising immunity. However, both DENV-1 
and DENV-3 appear to possess an inherent robustness that allows them to 
persist at a low level of infection at times when ecological and immunological 
conditions do not favour an outbreak. This is supported by the observation 
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that the DENV-1 and DENV-3 lineages that characterize this outbreak were 
found in Singapore as early as 2003 but did not result in an outbreak until 
2005. However, a wider sampling of viral isolates from neighbouring 
geographic areas is needed to fully test this analysis. Furthermore, dengue 
epidemics in Singapore follow a regular 6-7 year periodic cycle, which is 
difficult to explain by patterns of viral evolution or by vector population density 
and might be more attributable to changing levels of herd immunity (6). 
Additionally, in Colombia it has been observed that epidemic years are 
correlated with an increase in the infection rate of mosquitoes and not the 
total number of mosquitoes per household (18) indicating surveillance of 
mosquito populations may also be important in understanding epidemics. 
Together our results have important implications for the future study 
and control of DENV epidemics. In particular, the epidemic surveillance of 
viral genome sequences in this case would not have been sufficient to predict 
the 2005 outbreak. Hence, incumbent strains with apparently inherent 
epidemic potential are required but apparently not sufficient to spark an 
outbreak. Concurrent surveillance of viral isolates, mosquito vector (including 
proportion of mosquitoes infected with the dengue virus) and periodic surveys 
of seroprevalence rates of the population may therefore provide the additional 
required predictive information. The chance discovery of the DENV-3 
outbreak also highlights the value of comprehensive city-wide fever surveys in 
detecting rare events. 
4.5 Acknowledgements 
We wish to thank the staff involved in undertaking the EDEN study 
together with Lai Yee Ling from the Environmental Health Institute, and Fu 
Xiuju from the Institute for High Performance Computing and Leng Marcel 
from the National University of Singapore. We thank professors Edison Liu 
and Duane Gubler for their useful comments on the manuscript. 
99 
4.6 Author Contributions 
SH Ong assembled the sequences, performed the sequence analysis 
and reviewed the manuscript. Contributions from co-authors are as listed: 
conceived and designed the experiments: EEO, SGV, MLH, AO; contributed 
samples and reagents: JGHL; analyzed patient clinical profiles: YSL; 
propagated the virus samples: HCT, WL; sequenced the genomes: LT, PPKA; 
performed the population dynamics analysis: HS, ECH; wrote the manuscript: 
MJS, ECH; reviewed the manuscript: LCN, EEO, SGV, MLH. 
4.7 References 
1. Bennett, S. N., E. C. Holmes, M. Chirivella, D. M. Rodriguez, M. Beltran, 
V. Vorndam, D. J. Gubler, and W. O. McMillan. 2006. Molecular 
evolution of dengue 2 virus in Puerto Rico: positive selection in the viral 
envelope accompanies clade reintroduction. J Gen Virol 87:885-93. 
2. de Oliveira, T., O. G. Pybus, A. Rambaut, M. Salemi, S. Cassol, M. 
Ciccozzi, G. Rezza, G. C. Gattinara, R. D'Arrigo, M. Amicosante, L. 
Perrin, V. Colizzi, and C. F. Perno. 2006. Molecular epidemiology: HIV-1 
and HCV sequences from Libyan outbreak. Nature 444:836-7. 
3. Drummond, A. J., S. Y. Ho, M. J. Phillips, and A. Rambaut. 2006. 
Relaxed phylogenetics and dating with confidence. PLoS Biol 4:e88. 
4. Drummond, A. J., and A. Rambaut. 2007. BEAST: Bayesian evolutionary 
analysis by sampling trees. BMC Evol Biol 7:214. 
5. Drummond, A. J., A. Rambaut, B. Shapiro, and O. G. Pybus. 2005. 
Bayesian coalescent inference of past population dynamics from 
molecular sequences. Mol Biol Evol 22:1185-92. 
6. Egger, J. R., E. E. Ooi, D. W. Kelly, M. E. Woolhouse, C. R. Davies, and 
P. G. Coleman. 2008. Reconstructing historical changes in the force of 
infection of dengue fever in Singapore: implications for surveillance and 
control. Bull World Health Organ 86:187-96. 
7. Gilbert, M. T., A. Rambaut, G. Wlasiuk, T. J. Spira, A. E. Pitchenik, and 
M. Worobey. 2007. The emergence of HIV/AIDS in the Americas and 
beyond. Proc Natl Acad Sci U S A 104:18566-70. 
100 
8. Goncalvez, A. P., A. A. Escalante, F. H. Pujol, J. E. Ludert, D. Tovar, R. 
A. Salas, and F. Liprandi. 2002. Diversity and evolution of the envelope 
gene of dengue virus type 1. Virology 303:110-9. 
9. Guan, Y., B. J. Zheng, Y. Q. He, X. L. Liu, Z. X. Zhuang, C. L. Cheung, S. 
W. Luo, P. H. Li, L. J. Zhang, Y. J. Guan, K. M. Butt, K. L. Wong, K. W. 
Chan, W. Lim, K. F. Shortridge, K. Y. Yuen, J. S. Peiris, and L. L. Poon. 
2003. Isolation and characterization of viruses related to the SARS 
coronavirus from animals in southern China. Science 302:276-8. 
10. Gubler, D. J. 2002. Epidemic dengue/dengue hemorrhagic fever as a 
public health, social and economic problem in the 21st century. Trends 
Microbiol 10:100-3. 
11. Halstead, S. B. 2007. Dengue. Lancet 370:1644-52. 
12. Jarman, R. G., E. C. Holmes, P. Rodpradit, C. Klungthong, R. V. 
Gibbons, A. Nisalak, A. L. Rothman, D. H. Libraty, F. A. Ennis, M. P. 
Mammen, Jr., and T. P. Endy. 2008. Microevolution of Dengue viruses 
circulating among primary school children in Kamphaeng Phet, Thailand. 
J Virol 82:5494-500. 
13. Johansson, M., A. J. Brooks, D. A. Jans, and S. G. Vasudevan. 2001. A 
small region of the dengue virus-encoded RNA-dependent RNA 
polymerase, NS5, confers interaction with both the nuclear transport 
receptor importin-beta and the viral helicase, NS3. J Gen Virol 82:735-45. 
14. King, C. C., D. Y. Chao, L. J. Chien, G. J. Chang, T. H. Lin, Y. C. Wu, 
and J. H. Huang. 2008. Comparative analysis of full genomic sequences 
among different genotypes of dengue virus type 3. Virol J 5:63. 
15. Klungthong, C., C. Zhang, M. P. Mammen, Jr., S. Ubol, and E. C. 
Holmes. 2004. The molecular epidemiology of dengue virus serotype 4 in 
Bangkok, Thailand. Virology 329:168-79. 
16. Lanciotti, R. S., J. T. Roehrig, V. Deubel, J. Smith, M. Parker, K. Steele, 
B. Crise, K. E. Volpe, M. B. Crabtree, J. H. Scherret, R. A. Hall, J. S. 
MacKenzie, C. B. Cropp, B. Panigrahy, E. Ostlund, B. Schmitt, M. 
Malkinson, C. Banet, J. Weissman, N. Komar, H. M. Savage, W. Stone, 
T. McNamara, and D. J. Gubler. 1999. Origin of the West Nile virus 
responsible for an outbreak of encephalitis in the northeastern United 
States. Science 286:2333-7. 
101 
17. Low, J. G., E. E. Ooi, T. Tolfvenstam, Y. S. Leo, M. L. Hibberd, L. C. Ng, 
Y. L. Lai, G. S. Yap, C. S. Li, S. G. Vasudevan, and A. Ong. 2006. Early 
Dengue infection and outcome study (EDEN) - study design and 
preliminary findings. Ann Acad Med Singapore 35:783-9. 
18. Mendez, F., M. Barreto, J. F. Arias, G. Rengifo, J. Munoz, M. E. Burbano, 
and B. Parra. 2006. Human and mosquito infections by dengue viruses 
during and after epidemics in a dengue-endemic region of Colombia. Am 
J Trop Med Hyg 74:678-83. 
19. Messer, W. B., D. J. Gubler, E. Harris, K. Sivananthan, and A. M. de 
Silva. 2003. Emergence and global spread of a dengue serotype 3, 
subtype III virus. Emerg Infect Dis 9:800-9. 
20. Ong, S. H., J. T. Yip, Y. L. Chen, W. Liu, S. Harun, E. Lystiyaningsih, B. 
Heriyanto, C. G. Beckett, W. P. Mitchell, M. L. Hibberd, A. Suwandono, S. 
G. Vasudevan, and M. J. Schreiber. 2008. Periodic re-emergence of 
endemic strains with strong epidemic potential-a proposed explanation 
for the 2004 Indonesian dengue epidemic. Infect Genet Evol 8:191-204. 
21. Ooi, E. E., K. T. Goh, and D. J. Gubler. 2006. Dengue prevention and 35 
years of vector control in Singapore. Emerg Infect Dis 12:887-93. 
22. Parker, J., A. Rambaut, and O. G. Pybus. 2008. Correlating viral 
phenotypes with phylogeny: accounting for phylogenetic uncertainty. 
Infect Genet Evol 8:239-46. 
23. Pond, S. L., and S. D. Frost. 2005. Datamonkey: rapid detection of 
selective pressure on individual sites of codon alignments. Bioinformatics 
21:2531-3. 
24. Posada, D., and K. A. Crandall. 1998. MODELTEST: testing the model of 
DNA substitution. Bioinformatics 14:817-8. 
25. Pybus, O. G., A. Rambaut, R. Belshaw, R. P. Freckleton, A. J. 
Drummond, and E. C. Holmes. 2007. Phylogenetic evidence for 
deleterious mutation load in RNA viruses and its contribution to viral 
evolution. Mol Biol Evol 24:845-52. 
26. Rico-Hesse, R., L. M. Harrison, A. Nisalak, D. W. Vaughn, S. 
Kalayanarooj, S. Green, A. L. Rothman, and F. A. Ennis. 1998. 
Molecular evolution of dengue type 2 virus in Thailand. Am J Trop Med 
Hyg 58:96-101. 
102 
27. Schreiber, M. J., S. H. Ong, R. C. Holland, M. L. Hibberd, S. G. 
Vasudevan, W. P. Mitchell, and E. C. Holmes. 2007. DengueInfo: A web 
portal to dengue information resources. Infect Genet Evol 7:540-1. 
28. Slatkin, M., and W. P. Maddison. 1989. A cladistic measure of gene flow 
inferred from the phylogenies of alleles. Genetics 123:603-13. 
29. Suwandono, A., H. Kosasih, Nurhayati, R. Kusriastuti, S. Harun, C. 
Ma'roef, S. Wuryadi, B. Herianto, D. Yuwono, K. R. Porter, C. G. Beckett, 
and P. J. Blair. 2006. Four dengue virus serotypes found circulating 
during an outbreak of dengue fever and dengue haemorrhagic fever in 
Jakarta, Indonesia, during 2004. Trans R Soc Trop Med Hyg 100:855-62. 
30. Swofford, D. L. 2003. PAUP*. Phylogenetic Analysis Using Parsimony 
(*and other methods). Version 4. . Sinauer Associates. Sunderland, 
Mass. 
31. Tanner, L., M. Schreiber, J. G. Low, A. Ong, T. Tolfvenstam, Y. L. Lai, L. 
C. Ng, Y. S. Leo, L. Thi Puong, S. G. Vasudevan, C. P. Simmons, M. L. 
Hibberd, and E. E. Ooi. 2008. Decision tree algorithms predict the 
diagnosis and outcome of dengue Fever in the early phase of illness. 
PLoS Negl Trop Dis 2:e196. 
32. Twiddy, S. S., E. C. Holmes, and A. Rambaut. 2003. Inferring the rate 
and time-scale of dengue virus evolution. Mol Biol Evol 20:122-9. 
33. Yang, Z. 2007. PAML 4: phylogenetic analysis by maximum likelihood. 
Mol Biol Evol 24:1586-91. 
34. Yap, T. L., T. Xu, Y. L. Chen, H. Malet, M. P. Egloff, B. Canard, S. G. 
Vasudevan, and J. Lescar. 2007. Crystal structure of the dengue virus 
RNA-dependent RNA polymerase catalytic domain at 1.85-angstrom 
resolution. J Virol 81:4753-65.
103 
5. Inferring the History of Dengue Virus Diversity in 
Malaysia from Sequence Data 
Swee Hoe Ong1,2,3, Pauline P.K. Aw3, Jin Teen Yip1, Jasmin Schmid1, Wei 
Liu1, Siew Gyan Khoo5, Subhash G. Vasudevan1†, Pei Yong Shi1, Martin L. 
Hibberd3, Shamala Devi4, Mark J. Schreiber1 
 
1. Novartis Institute for Tropical Diseases, 10 Biopolis Road, Chromos #05-01, 
Singapore 138670. 
2. Swiss Tropical Institute, Socinstrasse 57, P.O. Box CH-4002 Basel, 
Switzerland. 
3. Genome Institute of Singapore, A*STAR, 60 Biopolis Street, Genome #02-01, 
Singapore 138672. 
4. Department of Medical Microbiology, Faculty of Medicine, University of 
Malaya, Malaysia. 
5. School of Computer Engineering, Block N4, Nanyang Technological 
University, Nanyang Avenue, Singapore 639798. 
† Current address: Emerging Infectious Diseases Program, Duke-NUS Graduate 
Medical School, 2 Jalan Bukit Merah, Singapore 169547. 
 
 
 
 
 
______________________________________________________________ 
Manuscript in preparation. 
______________________________________________________________
104 
5.1 Abstract 
To understand the molecular epidemiology of dengue viruses in 
Malaysia, the complete genomes of 46 clinical isolates sampled over an 11 
year period between 1995 and 2005 were sequenced. High sequence 
diversity was found with viruses from all four dengue serotypes and various 
subtypes detected. In addition, all publicly-available sub-genomic length 
sequences from Malaysian isolates were used to construct a snapshot of 
dengue virus diversity in the country since 1968. This study suggests that 
Malaysia, situated at the center of Southeast Asia which is often thought to be 
the source of dengue virus diversity, has experienced several episodes of 
importation in addition to maintaining several lineages of viruses that have 
been in sustained transmission for several decades. 
5.2 Introduction 
Dengue has become the most important arboviral disease in the world, 
affecting an estimated 50-100 million people each year (WHO, 2009). It is 
transmitted by the mosquito vectors Aedes aegypti and Aedes albopictus 
which are widely found in most tropical and subtropical countries. The health 
burden of dengue is particularly heavy in Southeast Asian countries where 
epidemic DHF was first recognised in the 1950s (Quinlos et al., 1954; 
Hammond et al., 1960). Since that time the countries have had a long and 
sustained history of dengue infections (Gubler & Clark, 1995). A lack of 
antiviral drugs or vaccines means there is little that can be done, apart from 
vector control measures, to stem the upward trend in the incidence rate of 
dengue. 
Dengue disease is caused by any one of the four closely-related but 
antigenically-distinct dengue viruses (DENV) denoted as DENV-1, DENV-2, 
DENV-3 and DENV-4. The genome of the dengue virus is a single-stranded, 
positive-sense RNA molecule approximately 10,700 nucleotides in length that 
encodes three structural proteins (C, capsid; prM, precursor to membrane; E, 
envelope) and seven nonstructural proteins (NS1, NS2A, NS2B, NS3, NS4A, 
NS4B, and NS5). Accumulated molecular data indicate there is great diversity 
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of dengue viruses. Each of the four serotypes can be further divided into 
distinct subtypes (also called genotypes) based on their nucleotide sequence. 
Phylogenetic analysis of the viral nucleotide sequences often allows the origin 
of virus isolates to be identified and their transmission across time and space 
to be tracked. 
Malaysia is a tropical country situated in the middle of Southeast Asia, 
bordered by Thailand to the north and by Singapore and Indonesia to the 
south. Classical dengue fever cases have been reported in Malaysia since 
1901-1902 (Skae, 1902) and laboratory-confirmed DHF was first reported in 
November 1962 in its northern state of Penang (Rudnick et al., 1965). Dengue 
was made a notifiable disease in 1973 and the number of reported cases has 
been on the increase ever since (Lam, 1994). Short sequences from 
Malaysian DENV isolates have been routinely included in phylogeny studies 
(Rico-Hesse et al., 1990; Lewis et al., 1993; Lanciotti et al., 1994, Wang et al., 
2000). However, despite Malaysia’s long association with dengue, relatively 
little is known about the diversity and molecular epidemiology of the etiological 
agent circulating in the country. 
The few previous studies of dengue molecular epidemiology in 
Malaysia have multifariously involved sequencing either the 240-nucleotide 
region spanning the E/NS1 junction (Fong et al., 1998; Chee and AbuBakar, 
2003), a 1050-nucleotide region spanning the complete C, prM and part of E 
(Kobayashi et al., 1999) or the complete E gene sequence (AbuBakar et al., 
2002). Three complete genomes of sylvatic DENV from the 1970s have been 
made available recently (Vasilakis et al., 2007) but no complete genome from 
post-1970s urban dengue outbreaks have been reported thus far. 
In order to fill the gap in knowledge and to gain a better understanding 
of DENV molecular epidemiology in Malaysia, we sequenced the complete 
genomes of virus samples collected in the Malaysian capital city of Kuala 
Lumpur over an 11-year period. Using the complete genome sequences as 
signposts we devised a routine that employs all available partial sequences of 
Malaysian isolates for phylogeny inference. The results were then assembled 
to produce a snapshot of DENV diversity in Malaysia since 1968. 
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5.3 Material and Methods 
5.3.1 Sample inclusion/collection criteria 
Blood samples were obtained from clinically diagnosed dengue 
patients admitted to the University Malaya Medical Centre (UMMC), Kuala 
Lumpur from 1995-2005. These were classified as dengue fever (DF) or 
dengue haemorrhagic fever (DHF) based on the WHO dengue classification 
scheme and case definition (WHO, 1997). The serum samples collected were 
subjected to an in-house IgM capture ELISA for IgM antibodies (Lam et al., 
1987). Samples that were IgM negative were then subjected to virus isolation 
and a second sample was requested. All serum samples were stored at -80°C 
until use. 
5.3.2 Virus isolation and serotyping 
Dengue viruses were cultured in the C6/36 Ae. albopictus cell line 
(Igarashi et al., 1982). The C6/36 cell layer was grown in a 25 cm3 angle-neck 
tissue culture flask inoculated with 100 µl of patient serum and kept at 37°C 
for 1 hour to allow for virus adsorption. Flasks were then topped up with 5 ml 
of maintenance media (RPMI containing 2% FCS) and incubated at 28°C for 
10 days after which the infected cells were harvested and fixed onto Teflon-
coated slides. The presence of virus was determined by indirect 
immunofluorescence antibody test (IFAT) using dengue-specific monoclonal 
antibodies (DENV-1: MAB D2-1F1-3; DENV-2: MAB 3H2-1-21; DENV-3: MAB 
D6-8A1-12; and DENV 4: MAB 1410-6-7, kindly provided by the Centers for 
Disease Control and Prevention, Fort Collins, CO, USA). Viral antigen in fixed 
infected cells was visualised using an UV microscope (Olympus). 
5.3.3 Complete genome sequencing 
Complete genome sequencing was performed as previously described 
(Ong et al., 2008). Briefly, viral RNA was extracted using the QIAamp Viral 
RNA Mini Kit (QIAGEN) and cDNA templates were generated from viral RNA 
by reverse transcription. Five serotype-specific primer pairs were then used to 
produce five slightly-overlapping PCR fragments from the cDNA. The PCR 
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fragments were sequenced by capillary sequencing using a 3730xl DNA 
Analyzer (Applied Biosystems). The obtained sequences were assembled 
using SeqScape version 2.5 (Applied Biosystems) and manually edited for 
quality before being aligned to other DENV complete genomes. 
5.3.4 Phylogeny inference of sequenced complete genomes 
Complete DENV genome sequences annotated with country and year 
of isolation were obtained from the DengueInfo database (Schreiber et al., 
2007). Distance-based neighbour-joining phylogenetic trees were generated 
from all available complete genome sequences for each of the four DENV 
serotypes using the Minimum Evolution (ME) tree inference method (Rzhetsky 
and Nei, 1993) as implemented in MEGA version 4.0 (Tamura et al., 2007). 
The nucleotide substitution model used was the Tamura-Nei model (Tamura 
and Nei, 1993) and the obtained tree topology was tested using 1000 
bootstrap replications. Based on the generated ME trees, highly-similar 
complete genome sequences in overly dense branches were removed and 
the pruned data set used to produce the final set of trees using both Minimum 
Evolution and Maximum Likelihood (ML) methods. Pruning was not required 
for DENV-4 due to the limited number of available genome sequences. 
The ML phylogenetic trees were constructed using the maximum 
likelihood (ML) method implemented in PAUP* (Swofford, 2002), with the 
best-fit model of nucleotide substitution selected by Akaike Information 
Criterion (AIC) as implemented in ModelTest (Posada and Crandall, 1998). 
Branch topology was verified by generating 1000 neighbour-joining bootstraps 
using the ML substitution model and the scores on tree nodes represent the 
number of bootstrap replicates (presented in percentage) supporting each 
node. The length of the tree branches is proportional to the number of 
nucleotide changes. 
The DENV subtype classification scheme follows that of Goncalvez et 
al. (2002) for DENV-1, Twiddy et al. (2002) for DENV-2, Lanciotti et al. (1994) 
for DENV-3 and Lanciotti et al. (1997) for DENV-4. 
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5.3.5 Search for sub-genomic length sequences 
DENV sub-genomic length sequences were retrieved on April 15, 2009 
from the National Center for Biotechnology Information (NCBI) GenBank 
database (http://www.ncbi.nlm.nih.gov/) using the query string txid11052[orgn] 
AND 1[SLEN]:9999[SLEN]. The number 11052 is the taxonomy ID for the 
Dengue Virus Group as defined by the NCBI Taxonomy Browser; the balance 
of the query string specified that sequences with length between 1 and 9,999 
nucleotides be retrieved. Sequences originating from virus samples collected 
in Malaysia and their isolation year were identified by parsing the respective 
GenBank records and/or from literature search. 
5.3.6 Subtype classification for sub-genomic length sequences 
A multiple sequence alignment of the Malaysian sub-genomic length 
sequences was generated to identify the most sequenced regions. A 
procedure was then devised based on the sequence coverage in the multiple 
sequence alignment to rationally apportion all sub-genomic length sequences 
for subtype classification. Sequences were divided into discrete sets starting 
with those that have the highest coverage, i.e. the complete E gene and 
followed by the 240-nucleotide E/NS1 junction. Lastly, the remaining 
analogous sequences of identical length were divided into yet more discrete 
sets. This process was repeated for each serotype. Analogous sequences 
extracted from complete genomes were then added to the resulting sets of 
sub-genomic length sequences (Table 5.2). 
To avoid discrepancies introduced through the use of different tree 
construction methods, phylogenetic trees were constructed from each of the 
sets using the Minimum Evolution method as described in section 5.3.4. The 
subtype of the sub-genomic length sequences was determined based on their 
respective clustering location in the trees, and the consistency in subtype 
classification of the completely sequenced isolates was also scrutinised. 
Finally, the subtype and year of isolation information of all DENV sequences 
from Malaysia were combined to produce a snapshot of the history of virus 
diversity in the country. 
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5.4 Results 
5.4.1 Complete genome sequencing of clinical isolates from Malaysia 
A total of 46 DENV complete genomes were obtained with all four 
dengue serotypes represented, producing a data set with 10 DENV-1, 5 
DENV-2, 23 DENV-3 and 8 DENV-4 sequences (Table 5.1). Multiple subtypes 
were observed for DENV-1 and DENV-3 whereas only single subtypes were 
observed for DENV-2 and DENV-4, although this may be due to the limited 
number of samples. The obtained sequences have been deposited in 
GenBank with the accession numbers FN429881–FN429926. 
Table 5.1. The GenBank accession number, isolate name, serotype, year of 
sample collection, subtype classification and some patient-related information 
of the 46 dengue virus genomes sequenced in this study. 
Accession Isolate Name Serotype Year Subtype Severity Patient Age Patient Sex
FN429881 D1MY95-3891 DENV-1 1995 IV DF 6 M 
FN429882 D1MY95-3928 DENV-1 1995 IV DF 40 M 
FN429883 D1MY96-7814 DENV-1 1996 IV DF 21 F 
FN429884 D1MY96-7891 DENV-1 1996 IV DF 21 F 
FN429885 D1MY96-7905 DENV-1 1996 IV DF 22 F 
FN429886 D1MY96-8064 DENV-1 1996 IV DF - F 
FN429887 D1MY96-8080 DENV-1 1996 IV DF 27 F 
FN429888 D1MY96-8081 DENV-1 1996 IV DF 19 F 
FN429889 D1MY97-10245 DENV-1 1997 IV DF 27 M 
FN429890 D1MY05-33915 DENV-1 2005 I DF 5 F 
FN429891 D2MY97-10340 DENV-2 1997 Cosmopolitan DF 27 F 
FN429892 D2MY00-22563 DENV-2 2000 Cosmopolitan DF 37 F 
FN429893 D2MY04-32618 DENV-2 2004 Cosmopolitan DF 22 F 
FN429894 D2MY04-32883 DENV-2 2004 Cosmopolitan DF 21 M 
FN429895 D2MY04-33054 DENV-2 2004 Cosmopolitan DF 24 M 
FN429896 D3MY95-2471 DENV-3 1995 II DF 10 F 
FN429897 D3MY95-3952 DENV-3 1995 II DF 22 F 
FN429898 D3MY96-4269 DENV-3 1996 II DF 24 M 
FN429899 D3MY97-12440 DENV-3 1997 I DF 1 M 
FN429900 D3MY99-21531 DENV-3 1999 I DF 5 F 
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FN429901 D3MY00-22447 DENV-3 2000 I DHF - M 
FN429902 D3MY00-22460 DENV-3 2000 I DF 7 M 
FN429903 D3MY00-22550 DENV-3 2000 I DF 32 M 
FN429904 D3MY00-22583 DENV-3 2000 I DF 30 F 
FN429905 D3MY00-22366 DENV-3 2000 II DHF 7 M 
FN429906 D3MY01-22939 DENV-3 2001 I DF 35 M 
FN429907 D3MY01-24056 DENV-3 2001 III DF - M 
FN429908 D3MY02-25811 DENV-3 2002 II DF 20 M 
FN429909 D3MY02-25850 DENV-3 2002 II DF 21 F 
FN429910 D3MY03-27834 DENV-3 2003 I DF 16 M 
FN429911 D3MY03-28526 DENV-3 2003 I DF 28 F 
FN429912 D3MY04-32645 DENV-3 2004 I DF 25 F 
FN429913 D3MY04-33077 DENV-3 2004 II DF 57 F 
FN429914 D3MY05-33464 DENV-3 2005 I DF 11 F 
FN429915 D3MY05-33506 DENV-3 2005 I DF 6 M 
FN429916 D3MY05-33610 DENV-3 2005 I DF 32 M 
FN429917 D3MY05-33927 DENV-3 2005 I DF 12 F 
FN429918 D3MY05-34640 DENV-3 2005 I DF 60 M 
FN429919 D4MY95-328 DENV-4 1995 II DF 20 F 
FN429920 D4MY01-22713 DENV-4 2001 II DF 42 M 
FN429921 D4MY01-23476 DENV-4 2001 II DF 26 M 
FN429922 D4MY02-26658 DENV-4 2002 II DF 49 F 
FN429923 D4MY03-27498 DENV-4 2003 II DF 1 M 
FN429924 D4MY03-27949 DENV-4 2003 II DF 40 M 
FN429925 D4MY04-31586 DENV-4 2004 II DF 3 M 
FN429926 D4MY04-32729 DENV-4 2004 II DF 15 F 
Abbreviations: DF: dengue fever and DHF: dengue haemorrhagic fever according to 
WHO guidelines. 
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5.4.2 Phylogeny of DENV complete genomes between 1995-2005 
Nine of the ten sequenced DENV-1 genomes, collected between 1995 
and 1997, form a distinct clade within subtype IV (Figure 5.1). This suggests 
that an unbroken chain of transmission by this viral lineage was partly 
responsible for the dengue incidences in Malaysia during that 3-year period. 
The tenth DENV-1 sample was collected in 2005 and its sequence clusters 
near a subtype I virus collected at the tail end of the 2005 epidemic in 
Singapore described by Schreiber et al. (2009). This could either be evidence 
of an importation event from Singapore into Malaysia, or the same subtype of 
DENV-1 could have been circulating in both countries in 2005. However, 
since its isolation date is not known the exact role of this Malaysian isolate in 
the Singapore epidemic cannot be ascertained. Until more DENV-1 isolates 
from Kuala Lumpur during and immediately before 2005 become available, it 
will not be possible to determine the relatedness of viruses in Kuala Lumpur 
and Singapore in 2005. Nevertheless, it can be concluded that subtype I and 
IV DENV-1 form part of the local reservoir of dengue viruses in the region due 
to the fact that the Malaysian isolates in both clades are closely related to 
isolates from nearby countries like Singapore, Indonesia, and Brunei and  the 
more distant region of southern China. 
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Figure 5.1.  Minimum evolution (ME) phylogenetic tree built from 107 full-
length DENV-1 genome sequences. The DENV-1 subtypes are indicated on 
the main branches and the 10 Malaysian clinical isolates sequenced in this 
study are shown in red. The tree is mid-point root for clarity only, all horizontal 
branch lengths are drawn to a scale of nucleotide substitutions per site, and 
bootstrap values are shown for key nodes. 
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All 5 DENV-2 genome sequences obtained belong to the Cosmopolitan 
subtype and they also cluster with recent isolates from neighbouring countries 
such as Indonesia, Singapore and Brunei (Figure 5.2). The distribution of 
these isolates within the Cosmopolitan subtype tree branch strongly suggests 
that this subtype is prevalent in those Southeast Asian countries and points to 
frequent transmissions across national borders. 
 
Figure 5.2.  Minimum evolution (ME) phylogenetic tree built from 125 full-
length DENV-2 genome sequences. The DENV-2 subtypes are indicated on 
the main branches and the 5 Malaysian clinical isolates sequenced in this 
study are shown in red. The tree is mid-point root for clarity only, all horizontal 
branch lengths are drawn to a scale of nucleotide substitutions per site, and 
bootstrap values are shown for key nodes. 
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DENV-3 forms the bulk of the genomes sequenced in this study. With 
23 isolates belonging to three different subtypes DENV-3 is also the serotype 
exhibiting the greatest genetic diversity. The distribution of the subtype I 
isolates suggest great degree of intermixing with isolates from Indonesia and 
Singapore (Figure 5.3A). The subtype II isolates showed the same pattern, 
clustering closely with isolates from neighbouring Singapore, Indonesia and 
Thailand (Figure 5.3B). 
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The solitary subtype III isolate clustered to the base of the clade that 
led to the DENV-3 isolates from the 2005 epidemic in Singapore (Figure 5.3C). 
From the branching topology it is most likely that the Malaysian isolate is not a 
direct ancestor of the Singapore outbreak. Two other isolates, from Taiwan 
and Sri Lanka respectively, are genetically closer to the Singapore isolates. If 
all isolates in this clade were from autochthonous dengue infections, then it is 
most likely subtype III DENV-3 has established a strong foothold in SEA and 
all the way to southern China and Taiwan since its high epidemic potential 
was first reported in Sri Lanka (Messer et al., 2003). 
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Figure 5.3.  Minimum evolution (ME) phylogenetic tree built from 143 full-
length DENV-3 genome sequences. The DENV-3 subtypes are indicated on 
the main branches and the 23 Malaysian clinical isolates sequenced in this 
study are shown in red. The tree is mid-point root for clarity only, all horizontal 
branch lengths are drawn to a scale of nucleotide substitutions per site, and 
bootstrap values are shown for key nodes. 
 
The eight DENV-4 genomes obtained in this study added considerable 
new information to the relatively small pool of publicly-available DENV-4 
complete genome sequences. The eight isolates all belong to subtype II 
(Figure 5.4) with the older 1995 isolate clustering with an isolate from 
Singapore of the same year at the base of a clade of viruses from the 
Americas. The other seven isolates fell into the Southeast Asian clade of 
subtype II viruses where post-2000 isolates from Malaysia, Singapore, 
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Indonesia and Thailand all clustered together. This clade likely represents a 
lineage that is currently endemic in Southeast Asia. 
 
Figure 5.4.  Minimum evolution (ME) phylogenetic tree built from 34 full-
length DENV-4 genome sequences. The DENV-4 subtypes are indicated on 
the main branches and the 8 Malaysian clinical isolates sequenced in this 
study are shown in red. The tree is mid-point root for clarity only, all horizontal 
branch lengths are drawn to a scale of nucleotide substitutions per site, and 
bootstrap values are shown for key nodes. 
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Apart from differences in branch lengths, no incongruence was 
detected between the minimum evolution tree (Figure 5.4) and the maximum 
likelihood (ML) tree generated from the DENV-4 complete genome sequences 
(Figure 5.5). The same observation was seen for the trees of the other three 
dengue serotypes. This suggests that the computationally less intensive ME 
method is a viable alternative for the ML method for phylogenetic inference 
when using the complete genome sequences of DENV. 
 
Figure 5.5.  Maximum likelihood (ML) phylogenetic tree built from 34 full-
length DENV-4 genome sequences. The DENV-4 subtypes are indicated on 
the main branches and the 8 Malaysian clinical isolates sequenced in this 
study are shown in red. The tree is mid-point root for clarity only, all horizontal 
branch lengths are drawn to a scale of nucleotide substitutions per site, and 
bootstrap values are shown for key nodes. 
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5.4.3 Alignment of sub-genomic length sequences 
From a total of 5165 DENV sequences of sub-genomic length obtained 
from GenBank, 88 were identified as originating from samples collected in 
Malaysia from either the accompanying meta data or from literature search: 
10 DENV-1, 34 DENV-2, 34 DENV-3 and 10 DENV-4 sequences. In addition, 
from the available annotation 12 of the DENV-2 sequences were found to 
originate from the same set of 3 isolates (X15434, X17338, X51708 and 
X51711 from isolate M1; X15433, X17339, X51709 and X51712 from isolate 
M2; X15214, X17340, X51710 and X51713 from isolate M3) and were 
therefore combined into 3 contiguous sequences. DENV-1 sequences with 
accession numbers AF425622 and AF426121 were also from the same 
isolate (P72-1244) but these were not merged because they are not 
contiguous. 
An additional 24 DENV-2 E/NS1 junction sequences (Fong et al., 1998) 
and 5 DENV-1 complete E sequences (A-Nuegoonpipat et al., 2004) from 
Malaysian isolates were found described in the literature but these sequences 
were not submitted to GenBank and thus have no Accession number. These 
short sequences were obtained from the respective labs and included in this 
analysis. 
From the alignment of the resulting 108 sequences to a complete 
dengue genome scaffold it was evident the great majority of the sub-genomic 
length sequences were from either the three structural genes or the E/NS1 
junction (Figure 5.6). The complete E gene and the E/NS1 junction were 
found to be the two most sequenced regions of the DENV genome. The rare 
exceptions were four DENV-3 NS3 sequences and one DENV-1 NS2A-NS2B 
sequence. As often the case, DENV-2 is the most studied dengue serotype 
with the most number of partial sequences available. 
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Figure 5.6.  Alignment of 108 dengue virus sub-genomic length sequences 
originating from samples collected in Malaysia. 
 
5.4.4 Phylogeny inference of sub-genomic length sequences 
The 108 non-redundant DENV sub-genomic length sequences from 
Malaysian isolates were apportioned into 14 discrete sets (Table 5.2) 
according to the protocol described in 5.3.6. After combining the sub-genomic 
length sequences with the respective analogous sub-sequences from the 
complete genomes, 14 phylogenetic trees were constructed from the resulting 
sequence data sets. 
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Table 5.2. Apportionment of sub-genomic length DENV sequences from 
identified Malaysian isolates into discrete sets, sorted by serotype and 
genomic region. Analogous sub-sequences from complete genomes were 
then added to these sequences for phylogeny inference. 
 
Serotype Gene Region Length Total Accession Numbers 
DENV-1 Complete E 1485 11 
AB111067, AF425622, 
EY448395, EY448400 & 
EY448410 & set of 61 
DENV-1 E/NS1 junction 240 1 M32898 
DENV-1 C/partial prM 454 1 EU005249 
DENV-1 E/NS1 306 2 DQ016630 & DQ016642
DENV-2 Complete E 1485 8 
AF231715, AF231716, 
AF231717, X51708, 
X51709, X51710, 
Q518635 & DQ518636 
DENV-2 E/NS1 junction 240 37 
AJ556803, AJ556804,  
AJ556805, AJ556806, 
AJ556807, AJ556808, 
AJ556809, AJ556810, 
AJ556811, AJ556812, 
AJ556813, AJ556814, 
AF400004 & set of 242 
DENV-2 Partial E 266 2 AF435487 & AF435488 
DENV-2 E/NS1 junction 225 2 AF436114 & AF436115 
DENV-3 Complete E 1479 11 
L11427, L11429, 
AF147457, AF147458, 
AF147459, AF147460, 
AY338492, AY338493, 
AY338494, EU448438 &
EU448439 
DENV-3 E/NS1 junction 240 10 
AF029794, AF029795, 
AF029796, AF029797, 
AF029798, AF400003, 
AF400021, AF400022, 
AF400023 & AF400024 
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DENV-3 C/prM/partial E 1050 9 
AB010982, AB010983, 
AB010984, AB010985, 
AB010986, AB010987, 
AB010988, AB010989 & 
AB010990 
DENV-3 Partial NS3 396 4 U11669, U11670, U11671 & U11672 
DENV-4 Complete E 1485 9 
AF231722, AF231723, 
AF231724, AF231725, 
AJ428556, AJ428557, 
AJ428558, AJ428559 &  
AJ428560 
DENV-4 Partial NS1 282 1 AF051110 
Reference: 1 A-Nuegoonpipat et al., 2004 and 2 Fong et al., 1998. 
The 14 phylogenetic trees were characterised by low bootstrap values 
at most branches. In general, the number of well-supported branches 
increased proportionately with the length of the sequences used for tree 
building. As an example, among the four DENV-2 trees listed in Table 5.2 the 
tree constructed from the 1485-nucleotide complete E gene sequences had 
the highest number of well-supported branches (Supplementary Figure 1). 
This underscores the importance of using longer sequences when utilising 
distance-based methods in phylogeny inference. 
The relative clustering positions of the five DENV-2 isolates sequenced 
in this study vary greatly in the four DENV-2 sub-genomic length sequence 
trees (Supplementary Figure 1). Using these five as signposts, it is clear that 
there is substantial incongruence between the relatively-popular complete E 
gene tree and the E/NS1 junction tree. This implies that any interpretation 
from these trees, particularly of leaves near terminal branches, must be used 
with caution. However, apart from two DENV-3 sequences (AF400003 and 
AF400022) all other isolates were consistently classified at the subtype level 
in the 14 trees, which means the phylogenetic trees constructed from these 
sub-genomic length sequences can be reliably used to catalogue the 
presence of the various DENV subtypes for a geographical area. 
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5.4.5 Inferring the history of DENV diversity in Malaysia 
The 46 complete DENV genomes sequenced in this study were from 
virus samples circulating in Malaysia during the 11-year period between 1995 
and 2004. This data set contributed a total of 24 data points (boxes coloured 
in blue) to Figure 5.7 and sequences of all four dengue serotypes were 
represented. Only one subtype each of DENV-4 and DENV-2 was detected in 
the period, i.e. subtype II and the Cosmopolitan subtype respectively. Two 
subtypes of DENV-1, subtype I and IV, were also found to be present. DENV-
3 showed the greatest diversity with three subtypes of DENV-3 detected. The 
fourth known DENV-3 subtype, subtype IV, has not been reported since the 
1970s and no complete genome of that subtype is available. 
Evidence of sylvatic DENV-1, DENV-2 and DENV-4 was only available 
from samples collected in the 1960s and 1970s. This is not surprising 
because Malaysia has undergone rapid development and urbanisation since 
the beginning of the 1980s and sylvatic transmission would be expected to 
decline. 
Understandably, very little sequence data were available from earlier 
decades, which is especially true for DENV-1 and DENV-4 (Figure 5.7). 
DENV-1 was the first dengue serotype isolated in Malaysia in 1954 (Smith, 
1956) and DENV-1 has also been reported to be the predominant serotype in 
Malaysia for many years since the 1970s (Lam, 1994). In spite of this, there 
are few historical DENV-1 sequences available. Even so, it can be surmised 
that subtypes I and IV have probably been the endemic DENV-1 subtypes in 
Malaysia for at least the past 20 years. 
The Cosmopolitan subtype is almost certainly the prevalent DENV-2 
subtype as it has been detected persistently since 1968. There appears to be 
several distinct genetic lineages within the Cosmopolitan subtype rather than 
a single lineage that has been in unbroken transmission since the 1960s 
(Supplementary Figure 1). The Asian 1 subtype, which is common in Thailand 
and Vietnam, was detected in Malaysia in the 1980s and 1990s but its 
continued transmission in the new millennium is in doubt due to a lack of 
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molecular evidence. The presence in 1987 of the American/Asian subtype, 
traditionally associated with Thailand, Vietnam and southern China and later 
the Latin Americas, could represent an imported case although the country of 
origin cannot be inferred reliably from the phylogenetic tree (data not shown). 
The snapshot (Figure 5.7) also indicates that subtypes I and II are the 
predominant DENV-3 subtypes in Malaysia. The subtype I clinical isolates 
clustered to the same branch as viruses from neighbouring Indonesia, 
Singapore and Timor Leste, indicating it is a widespread lineage that is found 
in a large geographical area in SEA (Figure 5.3). The sub-genomic length 
sequences point to the presence of subtype I in Malaysia since at least 1974. 
This lineage of viruses has been circulating in Indonesia since the early 1970s 
and has been implicated in causing at least four epidemics in the past two 
decades (Ong et al., 2008). It is highly probable that this subtype accounts for 
most of the DENV-1 incidences reported in Malaysia since the 1950s (Smith, 
1956). 
Based on sequence data from 1993 and 1994 Kobayashi et al. (1999) 
had previously suggested that the epidemic from 1992-1994 in Malaysia was 
caused by subtype II viruses introduced from Thailand. Our phylogenetic trees 
showed a short sequence from 1992 that clustered closely with the data set 
from Kobayashi et al. (data not shown) and so did the 1995 and 1996 DENV-3 
samples sequenced in this study. This shows that the duration of the epidemic 
resulting from the introduced Thai strain lasted from at least 1992 to 1996. A 
recent study has shown that it could take a few years before an introduced 
virus causes an outbreak (Schreiber et al., 2009). However, the lack of 
sequence data from the 1989-1991 period prevented a better estimation of 
the time of the alleged introduction of subtype II DENV-3 from Thailand to 
Malaysia. 
An earlier subtype II DENV-3 sequence from 1989 was found to be 
clustered with another lineage from Thailand and Vietnam. Although it is 
unlikely to be related to the above-mentioned epidemic, this could be 
evidence of another importation event but one which did not lead to an 
epidemic. Subtype II genome sequences from 2000 onwards clustered 
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together with a separate lineage of Thai isolates, indicating a third possible 
DENV-3 importation event from north of the Malaysian border. 
Subtype III of DENV-3, which had never been reported in Malaysia, 
made a brief appearance in 2001. This subtype can be traced to Sri Lanka 
and it has been implicated in causing sustained epidemics in Central and 
South America since its introduction to Nicaragua and Panama in 1994 
(Usuku et al., 2001; Miagostovich et al., 2002; Messer et al., 2003; Usme-Ciro 
et al., 2008). The detection of the subtype III isolate D3MY01-24056 points to 
an importation event from an unknown foreign source. The reason it did not 
develop into a sustained transmission could be due to the prevalence of 
subtype I and II DENV-3 which may have made it more difficult for another 
highly-similar virus strain to get established in the local vector population. 
DENV-4 was reported to be the predominant serotype isolated from DF 
patients in Malaysia during the period from 1967 to 1969 (Rudnick, 1986). Our 
phylogenetic trees indicate the lone 1969 DENV-4 sequence as belonging to 
subtype I, whereas the more recent samples belong to subtype II. AbuBakar 
et al. (2002) had previously reported the presence of subtype II DENV-4 in 
2001 and speculated it was the result of recombination events. All except one 
of our DENV-4 sequences were isolated from 2001 onwards and they all 
clustered near to the AbuBakar data set. The lone 1995 sequence was 
located on another branch of subtype II meaning it is not related to the 2001-
2004 sequences. Again, due to a lack of sequence information from the 
period just prior to 2001 it is currently not possible to refute or corroborate the 
hypothesis put forward by AbuBakar et al. regarding the genesis of DENV-4 in 
Malaysia. A short 282-nucleotide sequence from 1990 (accession number 
AF051110, isolate LN-72992) clustered with sequences from Central America 
and is most likely the result of another importation from foreign sources. 
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Figure 5.7.  History of dengue virus diversity in Malaysia from 1968 to 2007 as inferred through available sequence data. Coloured 
boxes with an “i” indicate likely importation events. 
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5.5 Discussion 
Southeast Asia is generally considered as a source for dengue virus 
diversity (Kyle and Harris, 2008). Some of these virus strains are strongly 
associated with DHF/DSS and may be inherently more virulent than others as 
exemplified by their worldwide spread and their reported displacement of 
endogenous DENV strains in the Americas (Rosen, 1977; Rico-Hesse et al., 
1997; Leitmeyer et al., 1999). 
The 46 complete genome sequences obtained in this study reaffirmed 
the fact that dengue is hyper-endemic in Malaysia, with all four serotypes and 
multiple subtypes of DENV recovered during the sampling period. The effect 
of this hyper-endemicity and great viral genetic diversity on the epidemiology 
of the disease in SEA is unclear. However, a consistent theme encountered 
when analysing the phylogeny of the DENV serotypes is that the SEA 
countries, in particular Malaysia, Singapore and Indonesia, tend to share the 
same circulating subtypes of viruses. This not only hints strongly of frequent 
transmission and free exchange of virus strains across national borders, but 
also predicates that any future dengue control programs (e.g. vector 
eradication, vaccination et cetera) need to be implemented in a concerted 
manner between all regional governments and international bodies to have 
any real chance of success. 
Malaysia consists of two parts: West Malaysia which borders Thailand 
to the north and Singapore to the south, and East Malaysia on the island of 
Borneo which shares borders with Brunei and Indonesia. The clinical isolates 
sequenced in this study were collected in the capital city of Kuala Lumpur 
which occupies a central location in West Malaysia. With a few exceptions, 
the uncovered sub-genomic length sequences were also from West Malaysia. 
Therefore, the results arising from this study may only be considered as 
representative of the circulating viruses in cities in West Malaysia but not of 
those in East Malaysia. 
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From the minimum evolution (ME) and maximum likelihood (ML) trees 
generated from 34 DENV-4 complete genome sequences (Figure 5.4 and 
Figure 5.5) we have shown that there is little to differentiate the two except for 
branch lengths. As the number of publicly available DENV complete genome 
sequences has been increasing at a tremendous pace in recent years, the 
popular but computationally-demanding character-based ML method of 
phylogeny inference could soon prove to be too resource-straining for regular 
application in the not-too-distant future. Provided the whole length of the 
DENV genome sequences are used, the computationally less intensive 
distance-based ME method should be considered as a viable alternative to 
the ML method for practical reasons. We have also shown that isolate 
classification based on sub-genomic length sequences such as the complete 
E gene and E-NS1 junction is consistent down to the subtype level. We could 
therefore take advantage of this fact to infer the history of DENV subtype 
prevalence in Malaysia using all the available sequence data. 
The comprehensiveness of the Malaysian sub-genomic length 
sequences included in this study can only be described as a best effort. Due 
to the less-than-perfect way metadata of sequences are recorded in public 
sequence depositories such as GenBank, it is highly possible there are other 
usable sequences from Malaysian samples that have been missed. There is 
also the possibility that there exist more sequences which were only described 
in literature but were not submitted to public sequence depositories – as 
exemplified by the 24 E/NS1 DENV-2 sequences from Fong et al. (1998) and 
6 complete E DENV-1 sequences from A-Nuegoonpipat et al. (2004) that 
added considerable amount of valuable information to this study. All in all, it is 
not unreasonable to conclude that the total amount of DENV sequence from 
Malaysia is also a very small sample of the total diversity that might be (or 
have been) circulating in the country. 
Although the snapshot of dengue virus diversity was constructed from 
all available sequence data, great care should be taken when interpreting it 
due to the relative scarcity of sequences from the earlier decades. For 
example it has been reported that DENV-1 was the serotype most commonly 
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encountered between 1973 and 1982 (Lam, 1994), yet a dearth of DENV-1 
sequence data from that period may give the wrong impression that DENV-1 
was not found in the country until subtype V was detected in 1982. In fact, 
DENV-1 was detected in Malaysia in as early as 1954 (Smith, 1956). A more 
accurate picture can only emerge if historical virus samples were subjected to 
sequencing and the newly-derived sequence information used to enhance the 
completeness of the snapshot. Looking forward to the future, it is strongly 
recommended that sampling and complete genome sequencing of DENV be 
conducted on a regular basis, not just during epidemic years but also during 
inter-epidemic periods. 
Since the two criteria for inclusion in this study are the availability of 
sequence data and isolation year, the constructed snapshot (Figure 5.7) gives 
no information about the predominant serotype or subtype. Information about 
the former can only be gleaned from extensive serological testing of clinical 
samples, whereas the predominant subtype currently can only be achieved 
through large-scale sequencing which is unlikely to be carried out in an 
outbreak situation. Consequently, it should be remembered that the raison 
d’setre of such snapshots is to provide qualitative and not quantitative 
information. This gap in quantitative information underlies the difficulty in 
linking dengue outbreaks to the introduction of new strains of viruses that led 
to a change in the predominant DENV subtype in circulation. Decades of 
dengue epidemiological research has so far unearthed only a few examples of 
introduced virus lineages with strong correlation to epidemics of increased 
severity (Rico-Hesse et al, 1997; Messer et al., 2003). 
This study has demonstrated that data from complete genome and 
sub-genomic length sequences can be used synergistically to construct a 
picture of the history of the dengue virus for a particular geographical area. 
The value of having complete genomes has been heightened by using them 
as signposts that allowed sub-genomic length sequences to be reliably 
incorporated into phylogenetic analyses. This simple approach could open 
doors for new molecular epidemiological studies of the dengue virus – 
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especially for localities where currently only fragmentary sequence data are 
available and where there is little possibility of sequencing historical isolates. 
In conclusion, the sequencing of the 46 complete genomes of DENV 
isolated between 1995 and 2005 has contributed to a better understanding of 
the molecular epidemiology of dengue in Malaysia. If more historical isolates 
from the country could be obtained for sequencing, we are certain a more 
complete picture could be constructed. We look forward to concurrently using 
complete genome and fragmentary sequence data originating from 
neighbouring countries such as Thailand, Singapore and Indonesia to draw a 
clearer picture of dengue virus molecular epidemiology in Southeast Asia. 
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6. Discussion and Conclusions 
In the last two decades of the twentieth century the world has 
witnessed the emergence or re-emergence of a number of viral pathogens 
such as human immunodeficiency virus (HIV), West Nile virus, severe acute 
respiratory syndrome coronavirus (SARS-CoV) and a number of influenza A 
subtypes. The majority of these pathogens crossed the species barrier from 
their natural reservoirs to human populations due to human encroachments to 
the natural habitat of the reservoir and vector species. In a relatively short 
period of time, these pathogens were disseminated globally by jet travels or 
migratory birds. 
Another commonality of the viruses cited above is that they are all RNA 
viruses. RNA viruses tend to have high mutation rates and consequently they 
can evolve rapidly to resist treatments and to evade host immune responses. 
Disease emergence can be influenced by several complex interacting factors 
such as environmental, ecological, socio-economic and behavioral influences 
(Morens et al., 2004). Because of this complexity, studying the genetic 
blueprint of the viral pathogen is a relatively simple approach to unraveling 
their virulence or pathogenesis. 
6.1 Argument for viral genome sequencing 
RNA viruses lack proof-reading mechanisms in their RNA polymerases 
and undergo constant mutations. Most of these mutations tend to be either 
neutral or deleterious - in which case the deleterious mutations are purged 
from the viral population via natural selection. However, on rare occasions a 
mutation can endow the virus with the ability to infect a different species, to 
trigger diseases that are more serious, or to develop resistance to treatment. 
The only way to study such molecular events is through the 
comparative analysis of the complete genetic blueprint of the viruses. 
Fortunately, in most cases viral genome sequences are miniscule in size 
compared to microbial and eukaryote genomes. Due to their small size, viral 
genomes are amenable to large-scale sequencing efforts involving sufficient 
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number of isolates with sufficient sampling frequency. This is something that 
is currently challenging for the genomes of protozoan or metazoan organisms. 
Another strong reason to advocate the sequencing of viral genomes is 
due to the fact that viruses are ephemeral (the exception being retroviruses). 
They leave little trace of their genetic makeup once an outbreak is over and 
they are cleared from the affected host population. The value of the genetic 
blueprint in helping to understand the pathogenesis of a viral infectious agent 
was underscored by the well-documented effort to sequence the 1918 
Spanish influenza virus strains from archival autopsy tissues (Taubenberger 
et al. 1997; Reid et al., 2003). 
The main body of work described in this thesis covers: (1) the 
development of a reliable laboratory protocol to sequence and assemble the 
complete (+)ssRNA genome of the dengue viruses, (2) the efforts to 
sequence the complete genomes of dengue virus clinical samples which were 
collected in three dengue-endemic Southeast Asian countries, Indonesia, 
Malaysia and Singapore, (3) the development of an informatics infrastructure 
to store, organize, manipulate and analyse the sequence data, and (4) the 
derivation of knowledge from the annotated sequence data to answer 
pertinent molecular epidemiological questions. 
Before analyses and knowledge discovery can be performed efficient 
informatics architectures for the storage and easy retrieval of carefully 
annotated viral genome sequence data are required. The knowledge 
discovery step relies mainly on using comparative genomics and molecular 
evolutionary approaches to predict the origin and spread of dengue viruses, 
and to understand the causes of epidemics and the genetic basis of virulence. 
The dividends to be gained from such comparative sequence analysis are 
tremendous: it may make prediction of future dengue epidemics a possibility 
and may also point to new routes for the development of antiviral drugs or 
vaccines. 
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6.2 Complete genome versus partial sequencing 
In the early 1990s partial sequencing of the dengue genome was first 
used to uncover the origin of viral strains during outbreak situations (Rico-
Hesse, 1990). Since that time many applications including the discovery of 
virulence factors, tracking the spread of dengue virus strains, study of 
evolutionary selection pressure and vaccine development have relied on 
partial genome sequencing. This preference for limited sequencing of course 
has in it elements of the technological limitations of the time, affordability and 
expediency. Nevertheless, recent advances in sequencing technology and the 
availability of established protocols for complete genome sequencing have 
made sequencing the relatively small genomes of dengue viruses within reach 
of most workers. 
Frequently investigations to link phenotypic traits or epidemic potential 
to viral genetics were inconclusive because only small fragments of the viral 
genome, in particular the E gene, were sequenced and studied (Fong et al., 
2004; A-Nuegoonpipat et al., 2004). Mutations in genes other than E (Twiddy 
et al., 2002) or in the untranslated regions of the DENV genome (Leitmeyer et 
al. 1999; Durbin et al., 2001; Lodeiro et al., 2008) have previously been 
identified as the genetic determinants for traits such as neurovirulence and 
attenuation. 
Similarly, due to the availability of only partial sequences molecular 
epidemiology studies often reported inconclusive results when attempting to 
undercover the genetic basis of disease severity. This has been the case from 
the earliest studies (Chungue et al, 1993) to the more recent ones (Figueiredo 
et al., 2008). In addition, analyzing only partial sequences could potentially 
lead to erroneous conclusions. Only a thorough analysis of the complete 
genetic blueprint of the DENV – obtained through sequencing of the complete 
genome – could lead to unambiguous conclusions. 
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All sequencing in this study was done with the aim of obtaining the 
complete genome sequences of the dengue virus samples. This allowed 
unambiguous interpretation of the sequence analysis results. Additionally, 
regions extracted from the complete genome sequences obtained could also 
be used, in a concurrent manner, with existing partial sequences to construct 
a probable history of dengue virus diversity. These same regions could also 
be extracted and included in previous analyses using only existing partial 
sequences to enhance the breadth if not the accuracy of those studies. 
6.3 Sampling strategies and findings 
Each of the three DENV genome sequencing projects described in 
Chapters 3, 4 and 5 adopted a different approach in terms of the sampling 
strategy. As a result, the DENV genome sequences thus obtained allowed 
different kinds of questions to be asked. Likewise, there are dissimilar 
shortcomings in each of the studies due to the differences in the sampling 
strategy. 
6.3.1 The 2004 epidemic in Jakarta, Indonesia 
For this study, a medium quantity of virus samples (n=69) were 
obtained from hospitals within the city of Jakarta during a dengue epidemic in 
2004. Only 15 virus samples were successfully amplified and sequenced. As 
DENV-3 was found to be the predominant serotype, historical DENV-3 
samples from the city were obtained for sequencing (Figure 6.1). The 
collected genome data allowed two main questions to be answered. The first 
was whether the same genotype of DENV-3 had been circulating locally since 
at least 1988 (the oldest available historical sample from Jakarta), or whether 
the 2004 genotype was a strain imported from a foreign source. Secondly, 
assuming the former hypothesis was true, the sequence data would allow the 
examination of amino acid changes over the 16-year period to look for 
possible signs of virus adaptive evolution that contributed to the epidemic in 
2004. 
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Figure 6.1.  The strategy employed for virus sampling in the Jakarta 2004 
DENV genome sequencing study. Sample size by year and serotype is 
indicated as boxed figures and coloured pie chart respectively, and the total 
serotype breakdown is indicated in the inset table. 
The two historical DENV-3 samples, from 1998 and 1988 respectively, 
were found to be from the same genotype as the 2004 viruses. Phylogenetic 
inference indicates they are from the same lineage (known as subtype I) that 
could be traced to viruses isolated in the same country as far back as 1973. 
This effectively ruled out recent importation and/or introduction of a new 
virulent DENV-3 strain as the cause of the 2004 epidemic in Jakarta. 
An additional four subtype I DENV-3 complete genome sequences 
dating from 1998 were found to be available publicly. These samples were 
collected in the city of Palembang on the island of Sumatra, some 200 km to 
the north of Jakarta during an epidemic in that year. The sixteen subtype I 
DENV-3 complete genomes (12 from this study) were therefore grouped 
together for a comparative analysis of their deduced amino acid sequences in 
order to answer the second question. 
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A total of 98 positions out of the 3390 amino acid residues in the 
subtype I DENV-3 polyprotein were found to have non-synonymous mutations 
(Figure 6.2). Viruses from 1998 and 2004 were almost indistinguishable at the 
amino acid level and none of the observed amino acid changes could be 
suggested as the trigger for the epidemic in 2004. However, there are a 
number of notable differences between the older 1988 sequence and the 
other fifteen samples, in particular at E-301, NS1-93, NS1-98, NS1-127, 
NS2B-60 and NS3-60. E-301 is just next to the putative receptor-binding site 
on domain III of the dengue envelope protein. Sadly, no follow-up experiments 
could be pursued to examine the effects of the aforementioned mutations on 
virus replication efficiency and infectivity due to restrictions in the material 
transfer agreement governing their use. 
One major deficiency of this study is the total lack of serological 
information of the affected population in Jakarta. If the inhabitants were 
exposed to the same virus genotype barely 6 years ago, there ought to be a 
certain percentage that has acquired immunity against it. And, assuming 
further that the subtype I viruses were absent in the intervening years 
between 1998 and 2004, the age of the affected patients would reflect this. 
There were, however, no relevant data to verify or refute this hypothesis. 
The second limitation of this study is the fact that only one sample from 
1988 was available. There is no compelling reason to believe this sample is 
representative of the DENV-3 viruses circulating in Jakarta in 1988. The third 
shortcoming is that there were no virus samples from the intervening years 
between the three epidemics in 1988, 1998 and 2004. Indonesia experiences 
dengue perennially and there should be no lack of samples if active collection 
of virus sample were in practice. Regular sample collection would have given 
investigators the means to understand better the role of virus adaptive 
evolution in the outbreak of epidemics. 
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Figure 6.2.  Amino acid differences among the Indonesian subtype I DENV-3 
strains isolated in 1988, 1998 and 2004. The sequences are sorted in 
chronological order followed by accession number, starting from the left. Only 
98 positions out of 3390 of the DENV-3 polyprotein showed any mutations, 
and none could be suggested as the trigger for the epidemic in 2004. Amino 
acids are color-coded by their chemical properties as shown in the key 
beneath the main diagram. 
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Although DENV-1, DENV-2 and DENV-4 were also detected in the 
2004 epidemic, the presence of all four serotypes during an outbreak is not 
unusual and the number of sequences obtained from these serotypes was too 
small to allow any in-depth analysis. Phylogenetic analysis from the genome 
sequences did reveal that, as in the case for DENV-3, they all belong to 
lineages that have been endemic in the Indonesian archipelago for several 
decades. 
In conclusion, virus sample collection during non-epidemic years on a 
regular basis is recommended for countries experiencing perennial dengue 
infections. For a country as large as Indonesia it would be impractical to get a 
large enough sample size that can reveal the entire diversity of DENV in the 
whole country. Sample archiving efforts should therefore be concentrated in 
densely populated urban centers like Jakarta and Palembang where the 
probability of dengue epidemics occurring is highest. Being important political, 
commercial and cultural centers on the islands of Java and Sumatra 
respectively, it is also highly likely that these cities could serve as the starting 
points of dengue epidemics that then propagate to the surrounding regions. 
Spatial-temporal patterns of DHF incidences in Thailand have pointed to the 
city of Bangkok as playing such a role (Cummings et al., 2004). 
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6.3.2 The 2005 epidemic in Singapore 
The strategy adopted during the epidemic in Singapore in 2005 was to 
acquire very high-resolution sequence data by doing high-frequency sampling 
throughout the duration of the epidemic (Low et al., 2006). This approach 
allowed the study of DENV molecular epidemiology at an unprecedented 
temporal and spatial resolution. The 105 complete genome sequences 
generated from this study was the first high-resolution DENV genome data set 
ever reported (Schreiber et al., 2009). Four other pre-epidemic samples were 
subsequently obtained and sequenced in order to examine the role of 
adaptive evolution in the triggering of the 2005 epidemic (Figure 6.3). 
 
Figure 6.3. The strategy employed for virus sampling in the Singapore 2005 
DENV genome sequencing study. Sample size by year and serotype is 
indicated as boxed figures and coloured pie chart respectively, and the total 
serotype breakdown is indicated in the inset table. 
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Serological tests of the collected samples revealed the presence of 
DENV-1, DENV-2 and DENV-3 during the epidemic. DENV-1 and DENV-3 
accounted for the majority of the cases while DENV-2 registered only a 
nominal presence. The number of genome sequences obtained also reflected 
this pattern. Phylogenetic analyses revealed the presence of more than one 
virus subtype for DENV-1 and DENV-3. In both cases, there was one 
dominant subtype while the second subtype caused only isolated cases. 
Although multiple subtypes of DENV-2 have previously been found circulating 
in a single epidemic in Thailand (Pandey and Igarashi, 2000), the complexity 
of virus subtypes observed in this study was much higher. 
The four DENV-2 isolates were found to belong to the Cosmopolitan 
subtype, a virus lineage that has long been known to be at large in the 
Southeast Asian region. Unsurprisingly subtype I, which is another virus 
lineage long associated with the region, was the predominant DENV-1 in the 
epidemic. The solitary outlier belongs to subtype V which is predominantly 
found in Latin America and West Africa, although its close clustering with a 
2004 sequence from Réunion suggests it could be an imported case by 
travellers from the Indian Ocean island. 
The oddity observed in the DENV-3 cases is that the endemic subtype I 
was not the predominant subtype. Instead, subtype III DENV-3, which was 
originally associated with the Indian subcontinent, was responsible for the 
majority of the DENV-3 cases. The subtype III viruses have been implicated in 
causing epidemics in Latin America and are considered as possessing high 
epidemic potential. Phylogenetic analysis of the nucleotide sequences and 
comparative studies of the deduced amino acid sequences of two DENV-3 
samples from 2003 and 2004 both point to the occurrence of in situ evolution 
of this lineage since its introduction to Singapore. Although the actual time of 
the alleged introduction cannot be ascertained, it is likely to have occurred in 
2003 or even earlier. This indicates that the introduced lineage, despite the 
strong correlation between its introduction and epidemics in Latin America, did 
not cause an immediate epidemic in Singapore. 
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This high-resolution data set allowed the population dynamics of the 
DENV-1 and DENV-3 to be measured and compared in an epidemic situation, 
which is something that was never before possible. The Bayesian coalescent 
analysis used in the study revealed that the two group of viruses exhibited 
similar epidemic profiles, despite the difference in their probable origin as an 
endemic lineage (DENV-1) and a recently introduced lineage (DENV-3). The 
conclusion that can be drawn is that the evolution of the virus is unlikely to be 
the central factor in shaping the dynamics of this dengue outbreak. 
Despite the huge amount of data collected in this study, the relative 
difficulty in getting pre-epidemic samples for comparative analysis 
underscores the fact that regular sequencing of clinical isolates during non-
epidemic years is essential in order to have a better understanding of the role 
of viral genetics in causing epidemics. One final observation is that epidemic 
surveillance of viral genome sequences alone would not have been sufficient 
to predict the 2005 outbreak. Concurrent surveillance of virus diversity, 
mosquito vectors (including the proportion of mosquitoes infected with DENV), 
and periodic survey of population sero-prevalence rates may provide the 
additional required predictive information. 
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6.3.3 The 1995-2005 collection from Kuala Lumpur, Malaysia 
The clinical samples sequenced in this study differed radically from the 
previous two in that they did not originate from a single epidemic but were 
collected longitudinally over a period of 11 years from a single locality (Figure 
6.4). As such, the kind of questions that could be asked also differs from the 
two previous studies to a great extent. 
Malaysia is subjected to perennial dengue outbreaks and the data 
collected may be considered as coming from an 11-year-long epidemic. The 
number of sequences obtained (46) can be considered as large when 
compared to other sequencing efforts. However, except probably for DENV-3, 
the number of sequences available per serotype per year is still insufficient for 
any meaningful analysis apart from allowing the identification of virus 
subtypes for the years in which samples were available (Figure 6.4). This 
reveals that the number of samples collected per year in this study was not 
high enough to adequately investigate the diversity of circulating dengue 
viruses during the study period. 
 
Figure 6.4. The distribution by year of the dengue clinical isolates collected 
between 1995 and 2005 in Kuala Lumpur, Malaysia. Sample size by year and 
serotype is indicated as boxed figures and coloured pie chart respectively, 
and the total serotype breakdown is indicated in the inset table. 
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To extend the usefulness of the obtained sequence data, a simple but 
laborious method was devised that allowed all existing partial sequences from 
Malaysian DENV samples to be used concurrently to construct a qualitative 
snapshot of the diversity of dengue viruses in the country. Short sequences 
are known to be unreliable for interpreting detailed phylogenetic relationships 
but this study showed that such sequences produced consistent classification 
of DENV at the subtype level. As a result, the subtype classification 
information was used to build the first (and admittedly incomplete) picture of 
the history of dengue virus diversity in Malaysia. 
The results showed that Malaysia has experienced several episodes of 
importation in addition to maintaining several lineages of viruses that have 
been in sustained transmission for several decades. Evidently, only one of 
these importation events (of subtype II DENV-3 from Thailand circa 1992) led 
to a change in the predominant circulating virus subtype and a pronounced 
epidemic that lasted several years (Kobayashi et al., 1999). Eight years later 
this lineage of virus was inexplicably no longer found in the sample. The 
subtype II viruses from 2000 and beyond probably shared a common ancestor 
with the 1992 strains but clearly belonged to a different lineage - perhaps the 
result of another importation event. 
There is no straightforward explanation for the observed clade 
extinction event of the subtype II DENV-3. Because of Malaysia’s fairly 
constant tropical climate there are no identifiable climatic factors that could 
account for the disappearance of dengue virus clades as has been reported 
elsewhere (Zhang et al., 2005). With a population size of 25.7 million (July 
2009 estimate), herd immunity, another possible explanation for viral clade 
extinction, is also unlikely to be the factor. Although the actual causes of the 
clade replacement is unclear, the generalisation that can be made is that 
imported viruses do, occasionally, possess the ability to cause widespread 
epidemics for several years. Monitoring changes in the prevalent DENV 
subtypes (not just serotypes) may assist in predicting future dengue outbreaks. 
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The various phylogenetic analyses showed that the three Southeast 
Asian countries of Indonesia, Malaysia and Singapore to a large extent share 
the same subtypes of dengue viruses. That the distribution and transmission 
of DENV strains transcends national borders should come as no surprise. 
One important implication arising from this observation is that dengue control 
programs such as vector eradication (and vaccination, when a vaccine is 
available) must be implemented in a concerted manner between all regional 
governments and international bodies to increase the likelihood of success. 
6.4 Importance of sustained sequence monitoring 
Molecular epidemiology approaches provide a viable way to 
understand the role of viral genetics in disease transmission and clinical 
severity. Of the three components involved in the transmission cycle of 
dengue (virus, vector and host), the viral component is the most amenable to 
genetic investigations. Most of the groundwork required for investigating the 
role of dengue virus genetics has been demonstrated in the course of this 
project. What is needed next is continued sampling and sequencing of clinical 
isolates and sustained monitoring of the accumulated sequence data. 
Among the most pertinent questions that need answering is how the 
dengue virus would react to the introduced selective pressure when vaccines 
and antivirals for dengue eventually become available. Being an RNA virus, it 
is a good bet that it is just a matter of time before mutations that allow it to 
escape the effect of the interventions would appear. In general, detection of 
virus adaptive evolution tends to become increasingly difficult as time goes on. 
Advantageous mutations are likely to be selected and quickly become one of 
the numerous “conserved” residues when sequence analysis is done on 
samples collected long after the mutations have achieved fixation. Two recent 
examples of viral adaptation that were successfully detected, the WNV NS3-
T249P (Brault et al., 2007) and CHIKV E1-A226V (Schuffenecker et al., 2006) 
mutations, were found relatively soon after the mutational events were 
believed to have taken place. Data from currently available dengue genome 
sequences shows there are 1315 residues in the DENV polyprotein (nearly 
149 
39%) that are 100% conserved across all four dengue serotypes. This 
suggests that many advantageous mutations have already reached fixation 
before the start of the global spread of dengue disease in the 1950s. Regular 
monitoring of DENV sequence evolution would enable the detection of such 
adaptive events as they occur. 
It is a certainty that the dengue virus will continue to evolve, and 
probably at an accelerated rate after a drug or vaccine becomes available. 
This means it will be important to keep monitoring the changes in the virus 
genome so that any future adaptive events can be detected quickly and its 
impact on the virulence and drug/vaccine efficacy be assessed. 
6.5 Recommendations for future studies 
It is evident from the experience gained from the three separate 
sequencing projects that both the number and resolution of sequence data are 
of paramount importance in determining the kind of research questions that 
can be adequately addressed. Before the start of sample collection and 
sequencing the desired scientific question(s) should be clearly defined and 
followed by careful experimental design. Putting the cart before the horse 
would be a poor way of conducting DENV genome sequencing projects. 
The second lesson learned is that every little thing matters. During the 
data acquisition phase, curation skills and standard nomenclature are required 
to maintain the accuracy of sample information starting from the stage of 
sample collection, storage and subsequent lab manipulation. The assembly of 
sequencing chromatograms was probably the most mundane and yet most 
crucial task in the entire study. A great deal of effort was invested in manual 
editing to remove artifacts from primer sequences and to deal with less-than-
perfect sequence quality. For data management and interpretation, 
manipulation of sequence data of such massive scale could not be 
accomplished reliably without the help of customised informatics solutions, 
which again require vigorous verification and validation in their development 
process. To avoid the classic problem of garbage in, garbage out, all these 
steps were routinely monitored for quality. 
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The third point to highlight is the importance of doing experimentation 
to verify the insights gained from sequence-based analyses. Although the lack 
of suitable experimentation models for the dengue disease is a serious 
deficiency that impedes the identification of viral genetic virulence factors, 
there are still a number of things that can be investigated. An example would 
be to examine the effect of amino acid changes on virus infectivity. The effect 
of amino acid mutations found in the studies of the 2004 epidemic in Jakarta, 
Indonesia and the 2005 epidemic in Singapore could not be performed for a 
number of reasons, primarily due to a lack of resources, expertise and 
material transfer agreements. 
Frustratingly, unlike most branches of scientific research, many of the 
hypotheses generated in the field of molecular epidemiology are not easily 
amenable to controlled experimentation. Frequently, a conclusion can not be 
reached years or decades after an initial observation was made. The fourth 
lesson is that workers in the field have to be patient and be on constant 
lookout for natural experiments. A good example of a natural experiment, 
though unrelated to the topic under discussion, occurred in 2008. By imposing 
strict pollution control over the city of Beijing during the 2008 Olympics, the 
Chinese government inadvertently created a huge natural laboratory for 
understanding how pollution affects climate. The direct downside of such 
convenience sampling is that the hypothesis often has to be built around the 
nature of data collected. 
The fifth and final point is that it is important to consider the big picture 
at all times. Being a vector-borne disease, dengue transmission is a complex 
phenomenon that involves the human host, the mosquito vector and the 
dengue viruses. The high degree of heterogeneity in the molecular data and 
the distribution of virus subtypes observed in the three studies underscores 
the plurality of the last component. Although not within the scope of this 
project, a multitude of factors affect the human host and mosquito vector and 
contribute to the transmission and maintenance of the dengue disease. In 
future studies it would be prudent to consider molecular data concurrently with 
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clinical, demographic and epidemiological data, both at the planning and data 
interpretation phase. 
In spite of the limitations highlighted, a lot about the history and 
evolutionary dynamics of DENV in the three Southeast Asian countries has 
been learned from this study. The three sequencing studies all differed in 
important aspects which allowed different kinds of questions to be asked, and 
many pertinent lessons have been learned that would enable future studies to 
be better designed for understanding the molecular epidemiology of the 
dengue virus. 
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Appendix A 
The SQL file for the structure of the dengue genome database (without the 
data) generated by the mysqldump tool. 
-- MySQL dump 10.11 
-- 
-- Host: localhost    Database: dbflavivirus 
-- ------------------------------------------------------ 
-- Server version 5.0.67-community-nt 
 
/*!40101 SET @OLD_CHARACTER_SET_CLIENT=@@CHARACTER_SET_CLIENT */; 
/*!40101 SET @OLD_CHARACTER_SET_RESULTS=@@CHARACTER_SET_RESULTS */; 
/*!40101 SET @OLD_COLLATION_CONNECTION=@@COLLATION_CONNECTION */; 
/*!40101 SET NAMES utf8 */; 
/*!40103 SET @OLD_TIME_ZONE=@@TIME_ZONE */; 
/*!40103 SET TIME_ZONE='+00:00' */; 
/*!40014 SET @OLD_UNIQUE_CHECKS=@@UNIQUE_CHECKS, UNIQUE_CHECKS=0 */; 
/*!40014 SET @OLD_FOREIGN_KEY_CHECKS=@@FOREIGN_KEY_CHECKS, 
FOREIGN_KEY_CHECKS=0 */; 
/*!40101 SET @OLD_SQL_MODE=@@SQL_MODE, 
SQL_MODE='NO_AUTO_VALUE_ON_ZERO' */; 
/*!40111 SET @OLD_SQL_NOTES=@@SQL_NOTES, SQL_NOTES=0 */; 
 
-- 
-- Table structure for table `tblannotation` 
-- 
DROP TABLE IF EXISTS `tblannotation`; 
SET @saved_cs_client     = @@character_set_client; 
SET character_set_client = utf8; 
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CREATE TABLE `tblannotation` ( 
  `annotation_accession` varchar(12) NOT NULL default '', 
  `annotation_species` tinyint(2) NOT NULL default '0', 
  `annotation_strain` varchar(40) NOT NULL default 'n/a', 
  `annotation_nature` varchar(20) NOT NULL default 'n/a', 
  `annotation_severity` varchar(10) default 'n/a', 
  `annotation_country` varchar(45) NOT NULL default 'n/a', 
  `annotation_year` year(4) default NULL, 
  `annotation_collection` varchar(25) default 'n/a', 
  `annotation_subtype` varchar(20) default 'n/a', 
  `annotation_date` date default NULL, 
  `annotation_remarks` mediumtext, 
  PRIMARY KEY  (`annotation_accession`) 
) ENGINE=InnoDB DEFAULT CHARSET=latin1; 
SET character_set_client = @saved_cs_client; 
 
-- 
-- Table structure for table `tblcountry` 
-- 
DROP TABLE IF EXISTS ` tblcountry`; 
SET @saved_cs_client     = @@character_set_client; 
SET character_set_client = utf8; 
CREATE TABLE `tblcountry` ( 
  `country_iso` char(2) NOT NULL, 
  `country_name` varchar(80) NOT NULL, 
  `country_printable_name` varchar(80) NOT NULL, 
  `country_iso2` char(2) default NULL, 
156 
  `country_iso3` char(3) default NULL, 
  `country_numcode` smallint(6) default NULL, 
  PRIMARY KEY  (`country_iso`) 
) ENGINE=InnoDB DEFAULT CHARSET=latin1; 
SET character_set_client = @saved_cs_client; 
 
-- 
-- Table structure for table `tblnucleotide` 
-- 
DROP TABLE IF EXISTS `tblnucleotide`; 
SET @saved_cs_client     = @@character_set_client; 
SET character_set_client = utf8; 
CREATE TABLE `tblnucleotide` ( 
  `nucleotide_accession` varchar(12) NOT NULL default '', 
  `nucleotide_bases` mediumtext NOT NULL, 
  PRIMARY KEY  (`nucleotide_accession`) 
) ENGINE=InnoDB DEFAULT CHARSET=latin1; 
SET character_set_client = @saved_cs_client; 
 
-- 
-- Table structure for table `tblspecies` 
-- 
DROP TABLE IF EXISTS `tblspecies`; 
SET @saved_cs_client     = @@character_set_client; 
SET character_set_client = utf8; 
CREATE TABLE `tblspecies` ( 
  `species_id` int(11) NOT NULL auto_increment, 
157 
  `species_name` varchar(30) default NULL, 
  `species_abbrev` varchar(8) default NULL, 
  `species_txid` varchar(8) default NULL, 
  PRIMARY KEY  (`species_id`) 
) ENGINE=InnoDB AUTO_INCREMENT=10 DEFAULT CHARSET=latin1; 
SET character_set_client = @saved_cs_client; 
 
/*!40103 SET TIME_ZONE=@OLD_TIME_ZONE */; 
/*!40101 SET SQL_MODE=@OLD_SQL_MODE */; 
/*!40014 SET FOREIGN_KEY_CHECKS=@OLD_FOREIGN_KEY_CHECKS */; 
/*!40014 SET UNIQUE_CHECKS=@OLD_UNIQUE_CHECKS */; 
/*!40101 SET CHARACTER_SET_CLIENT=@OLD_CHARACTER_SET_CLIENT */; 
/*!40101 SET CHARACTER_SET_RESULTS=@OLD_CHARACTER_SET_RESULTS */; 
/*!40101 SET COLLATION_CONNECTION=@OLD_COLLATION_CONNECTION */; 
/*!40111 SET SQL_NOTES=@OLD_SQL_NOTES */; 
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Appendix B 
Binding positions of RT-PCR primers used in Chapter 3: Periodic re-
emergence of endemic strains with strong epidemic potential—A proposed 
explanation for the 2004 Indonesian dengue epidemic. 
 
Primers for DENV-1 Binding Positions (sense strand) 
d1a5 8558-8577 
d1a9 6551-6573 
d1a13 4544-4561 
d1a17 2540-2559 
d1a23 10716-10735 
d1s6 2201-2223 
d1s10 4213-4231 
d1s14 6216-6235 
d1s18 8211-8232 
d1s22 1 to 20 
  
Primers for DENV-2 Binding Positions (sense strand) 
d2a6 8468-8488 
d2a10 6477-6497 
d2a14 4461-4484 
d2a18 2455-2474 
d2a23 10704-10723 
d2s5 2182-2201 
d2s9 4175-4197 
d2s13 6193-6213 
d2s16 7669-7692 
d2s23 1 to 20 
  
Primers for DENV-3 Binding Positions (sense strand) 
d3a6 8342 – 8361 
d3a10 6339-6360 
d3a14 4334-4356 
d3a18 2361-2380 
d3a23 10688-10707 
d3s5 2035-2053 
d3s8 3532-3553 
d3s13 6032-6053 
d3s17 8025-8046 
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d3s23 1 to 20 
  
Primers for DENV-3 Binding Positions (sense strand) 
AF1 109-131 
AF5 1927-1949 
BF1 3629-3652 
CF1 7111-1734 
AR1 2708-2727 
BR1 4133-4153 
CR1 7664-7687 
DR1 10606-10637 
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Appendix C 
Sequencing and amplification primers used in Chapter 3: Periodic re-
emergence of endemic strains with strong epidemic potential—A proposed 
explanation for the 2004 Indonesian dengue epidemic. 
Primer name Sequence Serotype 
d1a1 5'- ACAGCTTCCCCTGGTGTTGG-3’ DENV-1 
d1a2 5'- DTCTTCCCAACTGGAYACATG-3’ DENV-1 
d1a3 5'- YACRCARTCATCTCCRCTGAT-3’ DENV-1 
d1a4 5'- CACTCCACTGAGTGAATTCTCTCT-3’ DENV-1 
d1a5 5'- GGRATRACATCCCATGGTTT-3’ DENV-1 
d1a6 5'- AGRACACGTAACGTTCTWCCTTC-3’ DENV-1 
d1a7 5'- CCTACCTCCTCCTARAGATTTCA-3’ DENV-1 
d1a8 5'- CAAGTCCCATCAATATAGCTGC-3’ DENV-1 
d1a9 5'- CCAGTYARCACAGCTATCAAAGC-3’ DENV-1 
d1a10 5'- TCTCTCYGGCTCAAAGAGGG-3’ DENV-1 
d1a11 5'- CRTAGCCTGARTTCCATGATCT-3’ DENV-1 
d1a12 5'- CCTCGTCCTCAATCTCTGGTAG-3’ DENV-1 
d1a13 5'- TTCCACTTCYGGAGGGCT-3’ DENV-1 
d1a14 5'- CCGGAAGCCATGTTGTTTT-3’ DENV-1 
d1a15 5'- GCATYTTTCTRCTCCATCTGGATC-3’ DENV-1 
d1a16 5'- CARCTTCCARGTYTCGTTCTT-3’ DENV-1 
d1a17 5'- CCAATGGCYGCTGAYAGTCT-3’ DENV-1 
d1a18 5'- AAAGGTGGYTCYGYYTCAAT-3’ DENV-1 
d1a19 5'- GTTTGTGGACRAGCCATGATT-3’ DENV-1 
d1a20 5'- CGTCTTCAAGAGTTCAATGTCC-3’ DENV-1 
d1a21 5'- CATYGCAATRAGRGTGCACAT-3’ DENV-1 
d1a22 5'- AGCTTCCGATTCGAAACTGT-3’ DENV-1 
d1a23 5'- AGAACCTGTTGATTCAACAG-3’ DENV-1 
d1s1 5'- TRGCTCCATCGTGGGGAT-3’ DENV-1 
d1s2 5'- TTGCTYTCAGGCCAAGGACC-3’ DENV-1 
d1s3 5'- AAACGTTCCGTSGCACTGGC-3’ DENV-1 
d1s4 5'- TGTGTGTCGMCGAACGTT-3’ DENV-1 
d1s5 5'- GCAATGCACACYGCGTTG-3’ DENV-1 
d1s6 5'- GGYTCTATAGGAGGRGTGTTCAC-3’ DENV-1 
d1s7 5'- GGCCCAAGGRAARAAAATG-3’ DENV-1 
d1s8 5'- ACAAACAGCAGGGCCRTGGCA-3’ DENV-1 
d1s9 5'- CCTAGCYYTGATGGCYACTTT-3’ DENV-1 
d1s10 5'- RGCYGGSCCACTAATAGCT-3’ DENV-1 
d1s11 5'- AAGAGRCTGGAACCRAGYTGGGC-3’ DENV-1 
d1s12 5'- AAATGGCAGAGGCGCTCAAGGG-3’ DENV-1 
d1s13 5'- ACAAAAAAYAAYGACTGGGACTAT-3’ DENV-1 
d1s14 5'- ATGGRGAAAGGAACAACCAG-3’ DENV-1 
d1s15 5'- GGATAGCGGCCTCYATCATACT-3’ DENV-1 
d1s16 5'- GCAAARGCYACTAGAGAAGCTCAA DENV-1 
d1s17 5'- GAAACRACYAAACAYGCAGTG-3’ DENV-1 
d1s18 5'- CCACYCATGAAATGTAYTGGGT-3’ DENV-1 
d1s19 5'- GCCARGTGGTTATGGGGTTT-3’ DENV-1 
161 
d1s20 5'- GGATGATCTTCAGAATGAGGC-3’ DENV-1 
d1s21 5'- TYATGAAGGATGGGAGGGA-3’ DENV-1 
d1s22 5’- AGTTGTTAGTCTACGTGGAC-3’ DENV-1 
d2a1 5'- AGGAAACGAAGGAACGCC-3’ DENV-2 
d2a2 5'- ACGCCATGCGTACAGCTT-3’ DENV-2 
d2a3 5'- CCGTYGTCATCCATTCATG-3’ DENV-2 
d2a4 5'- TTTCTTCTGTGRCTGTCAGGTG-3’ DENV-2 
d2a5 5'- TCTGCTGCCTTTTGCCTT-3’ DENV-2 
d2a6 5'- CATGGTAWGCCCAYGTTTTGT-3’ DENV-2 
d2a7 5'- TTCTGGCGGRRTGAAGAA-3’ DENV-2 
d2a8 5'- TGACACYGCAATGGTAGTGTT-3’ DENV-2 
d2a9 5'- CAATGCTATGTCTCARCATTGGTGT-3’ DENV-2 
d2a10 5'- TACGCCCTTCCRCCTGCTTCA-3’ DENV-2 
d2a11 5'- CCAGTGTGCACAGTCTTCATCAT-3’ DENV-2 
d2a12 5'- ATGGRTCTCTRCTTCCCGG-3’ DENV-2 
d2a13 5'- CACCATTACCATAAAGACCCAC-3’ DENV-2 
d2a14 5'- GCCGTGATTGGTATTGATACAGGA-3’ DENV-2 
d2a15 5'- GTGCAACTCACTTTCCATGC-3’ DENV-2 
d2a16 5'- CGGCTGTGACCAAGGAGTT-3’ DENV-2 
d2a17 5'- CCGCTGACATGAGTTTTGAGTC-3’ DENV-2 
d2a18 5'- CCACTGCCACATTTCAGTTC-3’ DENV-2 
d2a19 5'- GGCGRCCTAAGACATRTCTTTT-3’ DENV-2 
d2a20 5'- GCCATARCCTGTCARTTCTGC-3’ DENV-2 
d2a21 5'- CTGAAACCCCTTCTACAAAGTCTC-3’ DENV-2 
d2a22 5'- TGTGGTTCTCCGTTACGTGT-3’ DENV-2 
d2a23 5’- AGAACCTGTTGATTCAACAG-3’ DENV-2 
d2s1 5'- GCAACAGCTGACAAAGAGATTCTC-3’ DENV-2 
d2s2 5'- CACCACRGGAGAACAYAGAAGA-3’ DENV-2 
d2s3 5'- CAGCCTAAAWGAAGAGCAGGA-3’ DENV-2 
d2s4 5'- GCGAAGAAACAGGATGTTGTTG-3’ DENV-2 
d2s5 5'- GGTGACACAGCCTGGGATTT-3’ DENV-2 
d2s6 5'- YATGACAGGAGACATCAAAGGA-3’ DENV-2 
d2s7 5'- WCAACACAACTAYAGACCAGGCT-3’ DENV-2 
d2s8 5'- TGGGCGTGACTTATCTTGC-3’ DENV-2 
d2s9 5'- GCATTTTRGCCAGTTCTCTCCTA-3’ DENV-2 
d2s10 5'- GYGCTGTYCTAATGCATAAAGG-3’ DENV-2 
d2s11 5'- YAGAGTCGTGGCAGCTGAA-3’ DENV-2 
d2s12 5'- GGAAGACYTTTGATTCTGAGTATGT-3’ DENV-2 
d2s13 5'- GCAGACAGAAGGTGGTGTTTT-3’ DENV-2 
d2s14 5'- CCACACTGGATAGCAGCTTCAATA-3’ DENV-2 
d2s15 5'- GACTYCAAGCAAAAGCAACC-3’ DENV-2 
d2s16 5'- CAGGAAGTGGATAGAACCTTAGCA-3’ DENV-2 
d2s17 5'- CTCTCACGRAACTCCACACAT-3’ DENV-2 
d2s18 5'- RGCAGAGTGGCTKTGGAAA-3’ DENV-2 
d2s19 5'- GGGACACAAGAATCACACTAGAAG-3’ DENV-2 
d2s20 5'- GCCYTTYTGTTCACACCATTTCCA-3’ DENV-2 
d2s21 5'- AGGAATACACAGATTACATGCCA-3’ DENV-2 
d2s22 5'- GGAATGGTGCTGTTGAATCAAC-3’ DENV-2 
d2s23 5’- AGTWGTTAGTCTACGTGGAC-3’ DENV-2 
d3a1 5'- GGTTTCTCACGCGTTTCAG-3’ DENV-3 
d3a2 5'- TTTTAACGTCCTTGGACGG-3’ DENV-3 
d3a3 5'- GGATGCTAGTCTRAGATCTCTTCTG-3’ DENV-3 
d3a4 5'- CTGCCTCTTTGGTCTTTCCT-3’ DENV-3 
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d3a5 5'- CGTTCTCTGTCCACAAGTTTCC-3’ DENV-3 
d3a6 5'- GCATTRACATGTCGRGTTCC-3’ DENV-3 
d3a7 5'- TCCTCGCACTTCTGTRACTTT-3’ DENV-3 
d3a8 5'- TTGAACTGCACACARAACCAG-3’ DENV-3 
d3a9 5'- CACCTGGYTCYTTAGACATTCCTA-3’ DENV-3 
d3a10 5'- GCYGCAAARTCCTTGAATTCCT-3’ DENV-3 
d3a11 5'- TTGGTCCAGCCAGGATCA-3’ DENV-3 
d3a12 5'- GTGAAATGRGCCTCATCCAT-3’ DENV-3 
d3a13 5'- CCTGGCATGGTTTGAAAGTT-3’ DENV-3 
d3a14 5'- ACTGTGATCATTAARTTGTGGGA-3’ DENV-3 
d3a15 5'- CCCCARAGCRATTCCATT-3’ DENV-3 
d3a16 5'- GGCAACACCATTCGTGTATCA-3’ DENV-3 
d3a17 5'- CACTTGGACACTCCGGTGT-3’ DENV-3 
d3a18 5'- GATTCCTATCGCAATGCATG-3’ DENV-3 
d3a19 5'- GCGTTTCKGAGACTTCTTTCTTC-3’ DENV-3 
d3a20 5'- GACGGTGTATTTGAGGTTCTCA-3’ DENV-3 
d3a21 5'- GGCTAGTATGGTRAACCCTGG-3’ DENV-3 
d3a22 5'- CCTTCTTGAAGCCTTTYARGACCT-3’ DENV-3 
d3a23 5’-  AGAACCTGTTGATTCAACAG-3’ DENV-3 
d3s1 5'- CAGTTTCGACTCGGAAGCTT-3’ DENV-3 
d3s2 5'- CAACATGTGCACACTCATAGCC-3’ DENV-3 
d3s3 5'- GACTACCATGGCTAAGAACAAGC-3’ DENV-3 
d3s4 5'- GAAGAACAAAGCATGGATGGTA-3’ DENV-3 
d3s5 5'- TGAACCTCCTTTTGGGGAA-3’ DENV-3 
d3s6 5'- CCMAAAAGATTGGCAACAGC-3’ DENV-3 
d3s7 5'- CATGGGCTATTGGATAGAAAGC-3’ DENV-3 
d3s8 5'- GGTGATGAGAGGAAAATTTGGG-3’ DENV-3 
d3s9 5'- GAAAACAGATTGGCTCCCAA-3’ DENV-3 
d3s10 5'- CCCCCCAGAGACACAGAAAG-3’ DENV-3 
d3s11 5'- CGACACCAGAGTTGGAAGAAG-3’ DENV-3 
d3s12 5'- GCTCATGGAATTCAGGCAAT-3’ DENV-3 
d3s13 5'- CCAGCTCTCTTTGAACCAGAAA-3’ DENV-3 
d3s14 5'- CTCYTGGGACTGATGATCTTGT-3’ DENV-3 
d3s15 5'- CTGATGGGTTTRGACAAAGGA-3’ DENV-3 
d3s16 5'- TTTTTCTATYATGAAATCAGTTGGA-3’ DENV-3 
d3s17 5'- CAACAGTGGAAGAAAGCAGAAC-3’ DENV-3 
d3s18 5'- ACAAAACCATGGGATGTGG-3’ DENV-3 
d3s19 5'- CTGGTTCTCGCGTGAAAAC-3’ DENV-3 
d3s20 5'- GGGATGATTGCGTAGTGAAA-3’ DENV-3 
d3s21 5'- TCCAGTCACAACGTGGGAA-3’ DENV-3 
d3s22 5'- TGTACCTCCTTGCAAAGGACTA-3’ DENV-3 
d3s23 5’- AGTTGTTAGTCTACGTGGAC-3’ DENV-3 
AR1 5’-CTTGCCTTYGGTCAACACCC-3’ DENV-4 
BR1 5’-CCTCGTTAAGRGGCCARGATC-3’ DENV-4 
CR1 5’-GGCTTCAGTCCTGTCCACTTCTAG-3’ DENV-4 
DR1 5’-ATCCATCTTGCGGCGCTCTGTG-3’ DENV-4 
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Appendix D 
Supplementary Tables described in Chapter 4: Genomic Epidemiology of a 
Dengue Virus Epidemic in Urban Singapore. 
 
Supplementary Table 1: List of reverse transcription primers. 
Fragment Primer Sequence Position 
    
DENV-1    
    
F1 d1a17 CCAATGGCYGCTGAYAGTCT 2540-2559 
F2 d1a13a CCTACTTGGGACCTGCCCA 4611-4629 
 d1a13b GGGACCTGCCCAACAGTCCT 4603-4622 
 d1a13c TGCCCAACAGTCCTCTCTGC 4597-4616 
F3 d1a9 CCAGTYARCACAGCTATCAAAGC 6551-6573 
F4 d1a4 CACTCCACTGAGTGAATTCTCTCT 9068-9091 
F5 d1a23 AGAACCTGTTGATTCAACAG 10716-10735 
    
DENV-3    
    
F1 d3a18 GATTCCTATCGCAATGCATG 2361-2380 
F2 d3a14 ACTGTGATCATTAARTTGTGGGA 4334-4356 
F3 d3a10 GCYGCAAARTCCTTGAATTCCT 6339-6360 
F4 d3a6 GCATTRACATGTCGRGTTCC 8342-8361 
F5 d3a23 AGAACCTGTTGATTCAACAG 10688-10707 
    
 
 
Supplementary Table 2: Reverse Transcription reaction conditions. 
Step Temperature (°C) Time 
   
1 65 5 min 
2 0 (ice) 1 min 
3 25 5 min 
4 42 60 min 
5 70 15 min 
6 4 Hold 
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Supplementary Table 3: List of PCR primers. 
Fragment Primer Sequence Position 
    
DENV-1    
    
F1 d1a17 CCAATGGCYGCTGAYAGTCT 2540-2559 
 d1s22 AGTTGTTAGTCTACGTGGAC 1-20 
F2 d1a13 TTCCACTTCYGGAGGGCT 4544-4561 
 d1s6 GGYTCTATAGGAGGRGTGTTCAC 2201-2223 
F3 d1a9 CCAGTYARCACAGCTATCAAAGC 6551-6573 
 d1s10 RGCYGGSCCACTAATAGCT 4213-4231 
F4 d1a4 CACTCCACTGAGTGAATTCTCTCT 9068-9091 
 d1s14 ATGGRGAAAGGAACAACCAG 6216-6235 
F5 d1a23 AGAACCTGTTGATTCAACAG 10716-10735 
 d1s18c GGTGAGTCCTCTCCAAACCC 8015-8034 
    
DENV-3    
    
F1 d3a18 GATTCCTATCGCAATGCATG 2361-2380 
 d3s23 AGTTGTTAGTCTACGTGGAC 1-20 
F2 d3a14 ACTGTGATCATTAARTTGTGGGA 4334-4356 
 d3s5 TGAACCTCCTTTTGGGGAA 2035-2053 
F3 d3a10 GCYGCAAARTCCTTGAATTCCT 6339-6360 
 d3s9 GAAAACAGATTGGCTCCCAA 4030-4049 
F4 d3a6 GCATTRACATGTCGRGTTCC 8342-8361 
 d3s13 CCAGCTCTCTTTGAACCAGAAA 6032-6053 
F5 d3a23 AGAACCTGTTGATTCAACAG 10688-10707 
 d3s17 CAACAGTGGAAGAAAGCAGAAC 8025-8046 
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Supplementary Table 4: PCR Program 
Serotype Fragment Cycles Initial Cycle Extend Hold 
DENV-1 F1 35 95°C 
2 min 
95°C 
30 sec 
55°C 
1 min 
72°C 
3.5 min 
72°C 
2 min 
4°C 
 F2 35 95°C 
2 min 
95°C 
30 sec 
58°C 
1 min 
72°C 
3.5 min 
72°C 
2 min 
4°C 
 F3 35 95°C 
2 min 
95°C 
30 sec 
63.1°C 
1 min 
72°C 
3.5 min 
72°C 
2 min 
4°C 
 F4 35 95°C 
2 min 
95°C 
30 sec 
58°C 
1 min 
72°C 
3.5 min 
72°C 
2 min 
4°C 
 F5 40 95°C 
2 min 
95°C 
30 sec 
55°C 
1 min 
72°C 
4 min 
72°C 
2 min 
4°C 
DENV-3 F1 45 95°C 
2 min 
95°C 
30 sec 
55°C 
1 min 
72°C 
3.5 min 
72°C 
2 min 
4°C 
 F2 45 95°C 
2 min 
95°C 
30 sec 
55°C 
1 min 
72°C 
3.5 min 
72°C 
2 min 
4°C 
 F3 45 95°C 
2 min 
95°C 
30 sec 
63.1°C 
1 min 
72°C 
3.5 min 
72°C 
2 min 
4°C 
 F4 45 95°C 
2 min 
95°C 
30 sec 
55°C 
1 min 
72°C 
3.5 min 
72°C 
2 min 
4°C 
 F5 45 95°C 
2 min 
95°C 
30 sec 
55°C 
1 min 
72°C 
3.5 min 
72°C 
2 min 
4°C 
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Supplementary Table 5: DENV Isolates Used in this Study 
GenBank Accession Standardized Strain Name 
A75711 DENV-1/SG/S275-90/1990 
AB074760 DENV-1/JP/Mochizuki/1943 
AB074761 DENV-1/ID/A88/1988 
AB178040 DENV-1/JP/20-Feb/XXXX 
AB189120 DENV-1/ID/98901518 DHF DV-1/1998 
AB189121 DENV-1/ID/98901530 DF DV-1/1998 
AB195673 DENV-1/SC/D1-hu-Seychelles-NIID41-2003/2003 
AB204803 DENV-1/JP/D1-hu-Yap-NIID27-2004/2004 
AF180817 DENV-1/TH/16007/1964 
AF180818 DENV-1/XX/PDK-13/XXXX 
AF226685 DENV-1/BR/BR-90/1990 
AF226686 DENV-1/XX/FGA-NA d1d/XXXX 
AF226687 DENV-1/GF/FGA-89/1989 
AF298807 DENV-1/CI/Dl-H-IMTSSA-ABID-99-1056/1998 
AF298808 DENV-1/DJ/Dl-H-IMTSSA-DJIB-98-606/1998 
AF309641 DENV-1/KH/Dl-H-IMTSSA-CAMB-98-658/1998 
AF311956 DENV-1/BR/BR-97-111/1997 
AF311957 DENV-1/BR/BR-97-409/1997 
AF311958 DENV-1/BR/BR-97-233/1997 
AF350498 DENV-1/CN/GZ-80/1980 
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AF513110 DENV-1/BR/BR-01-MR/2001 
AF514876 DENV-1/AR/301arg00/2000 
AF514878 DENV-1/PY/280par00/2000 
AF514883 DENV-1/PY/259par00/2000 
AF514885 DENV-1/AR/295arg00/2000 
AF514889 DENV-1/AR/297arg00/2000 
AY145121 DENV-1/XX/Western Pacific (WP)/XXXX 
AY145122 DENV-1/XX/rDEN1mutF/XXXX 
AY145123 DENV-1/XX/rDEN1 30/XXXX 
AY206457 DENV-1/AR/293arg00/2000 
AY277664 DENV-1/AR/ARG9920/1999 
AY277665 DENV-1/AR/ARG0028/2000 
AY277666 DENV-1/AR/ARG0048/2000 
AY373427 DENV-1/CN/GD23-95/1995 
AY376737 DENV-1/CN/GD14-97/1997 
AY376738 DENV-1/CN/GD05-99/1999 
AY708047 DENV-1/MM/D1.Myanmar.059-01/2001 
AY713473 DENV-1/MM/D1.Myanmar.40553-71/1971 
AY713474 DENV-1/MM/D1.Myanmar.194-01/2001 
AY713475 DENV-1/MM/D1.Myanmar.206-01/2001 
AY713476 DENV-1/MM/D1.Myanmar.305-01/2001 
AY722801 DENV-1/MM/D1.Myanmar.40568-76/1976 
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AY722802 DENV-1/MM/D1.Myanmar.23819-96/1996 
AY722803 DENV-1/MM/D1.Myanmar.32514-98/1998 
AY726549 DENV-1/MM/D1.Myanmar.37726-01/2001 
AY726550 DENV-1/MM/D1.Myanmar.38862-01/2001 
AY726551 DENV-1/MM/D1.Myanmar.44168-01/2001 
AY726552 DENV-1/MM/D1.Myanmar.44988-02/2002 
AY726553 DENV-1/MM/D1.Myanmar.49440-02/2002 
AY726554 DENV-1/MM/D1.Myanmar.31987-98/1998 
AY726555 DENV-1/MM/D1.Myanmar.31459-98/1998 
AY732474 DENV-1/TH/ThD1_0673_80/1980 
AY732475 DENV-1/TH/ThD1_0488_94/1994 
AY732476 DENV-1/TH/ThD1_0442_80/1980 
AY732477 DENV-1/TH/ThD1_0336_91/1991 
AY732478 DENV-1/TH/ThD1_0323_91/1991 
AY732479 DENV-1/TH/ThD1_0102_01/2001 
AY732480 DENV-1/TH/ThD1_0097_94/1994 
AY732481 DENV-1/TH/ThD1_0081_82/1982 
AY732482 DENV-1/TH/ThD1_0049_01/2001 
AY732483 DENV-1/TH/ThD1_0008_81/1981 
AY762084 DENV-1/SG/Singapore 8114-93/1993 
CS477263 DENV-1/XX/WO2006134433-1/XXXX 
CS477264 DENV-1/XX/WO2006134433-2/XXXX 
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CS477265 DENV-1/XX/WO2006134433-3/XXXX 
CS479203 DENV-1/XX/WO2006134443-39/XXXX 
CS479204 DENV-1/XX/WO2006134443-40/XXXX 
M87512 DENV-1/SG/S275-90/1990 
DQ193572 DENV-1/CN/Fj231-04/2004 
DQ285558 DENV-1/RE/Reunion 185-04/2004 
DQ285559 DENV-1/RE/Reunion 191-04/2004 
DQ285560 DENV-1/RE/Reunion 257-04/2004 
DQ285561 DENV-1/SC/Seychelles 1480-04/2004 
DQ285562 DENV-1/KM/Comoros 04.329-93/1993 
DQ672556 DENV-1/FP/FP0203/XXXX 
DQ672557 DENV-1/FP/FP0705/XXXX 
DQ672558 DENV-1/FP/FP0908/XXXX 
DQ672559 DENV-1/FP/FP1104/XXXX 
DQ672560 DENV-1/US/HawM2516/2001 
DQ672561 DENV-1/US/HawM3430/2001 
DQ672562 DENV-1/US/HawM2540/2001 
DQ672563 DENV-1/US/HawO3758/2001 
DQ672564 DENV-1/US/HawO3663/2001 
U88535 DENV-1/NR/WestPac/1974 
U88536 DENV-1/XX/45AZ5 PDK-0/XXXX 
U88537 DENV-1/XX/45AZ5 PDK27/XXXX 
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EF025110 DENV-1/CN/71-02GZ/1971 
EF032590 DENV-1/CN/GZ01-95/1995 
EU081226 DENV-1/SG/05K814DK1/2005 
EU081227 DENV-1/SG/05K847DK1/2005 
EU081228 DENV-1/SG/05K872DK1/2005 
EU081229 DENV-1/SG/05K2398DK1/2005 
EU081230 DENV-1/SG/05K2402DK1/2005 
EU081231 DENV-1/SG/05K2887DK1/2005 
EU081232 DENV-1/SG/05K2895DK1/2005 
EU081233 DENV-1/SG/05K2901DK1/2005 
EU081234 DENV-1/SG/05K2916DK1/2005 
EU081235 DENV-1/SG/05K2928DK1/2005 
EU081236 DENV-1/SG/05K3297DK1/2005 
EU081237 DENV-1/SG/05K3300DK1/2005 
EU081238 DENV-1/SG/05K3301DK1/2005 
EU081239 DENV-1/SG/05K3318DK1/2005 
EU081240 DENV-1/SG/05K3886DK1/2005 
EU081241 DENV-1/SG/05K3894DK1/2005 
EU081242 DENV-1/SG/05K3903DK1/2005 
EU081243 DENV-1/SG/05K3904DK1/2005 
EU081244 DENV-1/SG/05K3905DK1/2005 
EU081245 DENV-1/SG/05K3908DK1/2005 
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EU081246 DENV-1/SG/05K3910DK1/2005 
EU081247 DENV-1/SG/05K3911DK1/2005 
EU081248 DENV-1/SG/05K3915DK1/2005 
EU081249 DENV-1/SG/05K3916DK1/2005 
EU081250 DENV-1/SG/05K3930DK1/2005 
EU081251 DENV-1/SG/05K3933DK1/2005 
EU081252 DENV-1/SG/05K3934DK1/2005 
EU081253 DENV-1/SG/05K3935DK1/2005 
EU081254 DENV-1/SG/05K4138DK1/2005 
EU081255 DENV-1/SG/05K4139DK1/2005 
EU081256 DENV-1/SG/05K4140DK1/2005 
EU081257 DENV-1/SG/05K4142DK1/2005 
EU081258 DENV-1/SG/05K4147DK1/2005 
EU081259 DENV-1/SG/05K4152DK1/2005 
EU081260 DENV-1/SG/05K4154DK1/2005 
EU081261 DENV-1/SG/05K4172DK1/2005 
EU081262 DENV-1/SG/05K4173DK1/2005 
EU081263 DENV-1/SG/05K4174DK1/2005 
EU081264 DENV-1/SG/05K4175DK1/2005 
EU081265 DENV-1/SG/05K4183DK1/2005 
EU081266 DENV-1/SG/05K4441DK1/2005 
EU081267 DENV-1/SG/05K4443DK1/2005 
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EU081268 DENV-1/SG/05K4468DK1/2005 
EU081269 DENV-1/SG/05K4479DK1/2005 
EU081270 DENV-1/SG/05K4480DK1/2005 
EU081271 DENV-1/SG/05K4604DK1/2005 
EU081272 DENV-1/SG/05K4605DK1/2005 
EU081273 DENV-1/SG/05K4606DK1/2005 
EU081274 DENV-1/SG/05K4609DK1/2005 
EU081275 DENV-1/SG/05K4620DK1/2005 
EU081276 DENV-1/SG/05K4621DK1/2005 
EU081277 DENV-1/SG/05K4622DK1/2005 
EU081278 DENV-1/SG/05K4632DK1/2005 
EU081279 DENV-1/SG/05K4820DK1/2005 
EU081280 DENV-1/SG/06K2236DK1/2006 
EU081281 DENV-1/SG/06K2290DK1/2006 
FJ469907 DENV-1/SG/S210Y03/2003 
FJ469908 DENV-1/SG/S210Y03/2003 
FJ469909 DENV-1/SG/S210Y03/2003 
AB122020 DENV-2/DO/DR23-01/2001 
AB122021 DENV-2/DO/DR31-01/2001 
AB122022 DENV-2/DO/DR59-01/2001 
AB189122 DENV-2/ID/98900663 DHF DV-2/1998 
AB189123 DENV-2/ID/98900665 DF DV-2/1998 
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AB189124 DENV-2/ID/98900666 DSS DV-2/1998 
AF022434 DENV-2/TH/ThNH-7-93/1993 
AF022435 DENV-2/TH/ThNH-28-93/1993 
AF022436 DENV-2/TH/ThNH-52-93/1993 
AF022437 DENV-2/TH/ThNH-p11-93/1993 
AF022438 DENV-2/TH/ThNH-p12-93/1993 
AF022439 DENV-2/TH/ThNH-p14-93/1993 
AF022440 DENV-2/TH/ThNH-p16-93/1993 
AF022441 DENV-2/TH/ThNH-p36-93/1993 
AF038402 DENV-2/XX/MON310/XXXX 
AF038403 DENV-2/XX/MON501/XXXX 
AF100459 DENV-2/TH/K0008/1994 
AF100460 DENV-2/TH/K0010/1994 
AF100461 DENV-2/TH/C0371/1995 
AF100462 DENV-2/TH/C0390/1995 
AF100463 DENV-2/TH/C0166/1996 
AF100464 DENV-2/TH/C0167/1996 
AF100465 DENV-2/VE/Ven2/1987 
AF100466 DENV-2/VE/Mara4/1990 
AF100467 DENV-2/PE/IQT1797/1995 
AF100468 DENV-2/PE/IQT2913/1995 
AF100469 DENV-2/MX/O131/1992 
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AF119661 DENV-2/CN/China 04/1985 
AF169678 DENV-2/TH/ThNH29-93/1993 
AF169679 DENV-2/TH/ThNH36-93/1993 
AF169680 DENV-2/TH/ThNH45-93/1993 
AF169681 DENV-2/TH/ThNH55-93/1993 
AF169682 DENV-2/TH/ThNH54-93/1993 
AF169683 DENV-2/TH/ThNH62-93/1993 
AF169684 DENV-2/TH/ThNH63-93/1993 
AF169685 DENV-2/TH/ThNH69-93/1993 
AF169686 DENV-2/TH/ThNH73-93/1993 
AF169687 DENV-2/TH/ThNH76-93/1993 
AF169688 DENV-2/TH/ThNH81-93/1993 
AF204177 DENV-2/CN/44/1989 
AF204178 DENV-2/CN/43/1987 
AF208496 DENV-2/MQ/DEN2-H-IMTSSA-MART-98-703/1998 
AF276619 DENV-2/CN/FJ-10/1999 
AF359579 DENV-2/CN/FJ11-99/1999 
AF489932 DENV-2/BR/BR64022/1998 
AJ968413 DENV-2/TW/PL046/XXXX 
AY037116 DENV-2/AU/TSV01/1993 
AY702034 DENV-2/CU/Cuba13-97/1997 
AY702035 DENV-2/CU/Cuba58-97/1997 
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AY702036 DENV-2/CU/Cuba115-97/1997 
AY702037 DENV-2/CU/Cuba89-97/1997 
AY702038 DENV-2/CU/Cuba165-97/1997 
AY702039 DENV-2/CU/Cuba205-97/1997 
AY702040 DENV-2/CO/I348600/1986 
AY744147 DENV-2/TO/Tonga-74/1974 
AY776328 DENV-2/TW/Taiwan-1008DHF/XXXX 
AY858035 DENV-2/ID/BA05i/2004 
AY858036 DENV-2/ID/TB61i/2004 
CS477302 DENV-2/XX/WO2006134433-40/XXXX 
CS477304 DENV-2/XX/WO2006134433-42/XXXX 
CS479165 DENV-2/XX/WO2006134443-1/XXXX 
CS479167 DENV-2/XX/WO2006134443-3/XXXX 
CS479202 DENV-2/XX/WO2006134443-38/XXXX 
M29095 DENV-2/PG/New Guinea-C/1944 
M20558 DENV-2/JM/Jamaica-N.1409/1983 
M84728 DENV-2/XX/16681-PDK53/XXXX 
M84727 DENV-2/TH/16681/1964 
M19197 DENV-2/PR/S1/1969 
DQ181797 DENV-2/TH/ThD2_0078_01/2001 
DQ181798 DENV-2/TH/ThD2_0055_99/1999 
DQ181799 DENV-2/TH/ThD2_0017_98/1998 
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DQ181800 DENV-2/TH/ThD2_0263_95/1995 
DQ181801 DENV-2/TH/ThD2_0284_90/1990 
DQ181802 DENV-2/TH/ThD2_0026_88/1988 
DQ181803 DENV-2/TH/ThD2_0433_85/1985 
DQ181804 DENV-2/TH/ThD2_0498_84/1984 
DQ181805 DENV-2/TH/ThD2_0168_79/1979 
DQ181806 DENV-2/TH/ThD2_0038_74/1974 
AJ487271 DENV-2/TH/Bank74/1974 
EF051521 DENV-2/CN/ZS01-01/2001 
EU081177 DENV-2/SG/05K3295DK1/2005 
EU081178 DENV-2/SG/05K3330DK1/2005 
EU081179 DENV-2/SG/05K4137DK1/2005 
EU081180 DENV-2/SG/05K4155DK1/2005 
U87411 DENV-2/TH/16681/1964 
U87412 DENV-2/XX/PDK-53/XXXX 
AB189125 DENV-3/ID/98901403 DSS DV-3/1998 
AB189126 DENV-3/ID/98901437 DSS DV-3/1998 
AB189127 DENV-3/ID/98901517 DHF DV-3/1998 
AB189128 DENV-3/ID/98902890 DF DV-3/1998 
AB214879 DENV-3/TL/D3-Hu-TL018NIID-2005/2005 
AB214880 DENV-3/TL/D3-Hu-TL029NIID-2005/2005 
AB214881 DENV-3/TL/D3-Hu-TL109NIID-2005/2005 
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AB214882 DENV-3/TL/D3-Hu-TL129NIID-2005/2005 
AF317645 DENV-3/CN/80-2/XXXX 
AY099336 DENV-3/LK/D3SriLa1266/2000 
AY099337 DENV-3/MQ/D3Mart1243/1999 
AY496871 DENV-3/BD/BDH02-01/2002 
AY496873 DENV-3/BD/BDH02-03/2002 
AY496874 DENV-3/BD/BDH02-04/2002 
AY496877 DENV-3/BD/BDH02-07/2002 
AY496879 DENV-3/PH/PhMH-J1-97/1997 
AY648961 DENV-3/ID/Sleman-78/1978 
AY662691 DENV-3/SG/S221-03/2003 
AY676348 DENV-3/TH/ThD3_1687_98/1998 
AY676349 DENV-3/TH/ThD3_1283_98/1998 
AY676350 DENV-3/TH/ThD3_0104_93/1993 
AY676351 DENV-3/TH/ThD3_0055_93/1993 
AY676352 DENV-3/TH/ThD3_0010_87/1987 
AY676353 DENV-3/TH/ThD3_0007_87/1987 
AY679147 DENV-3/BR/BR74886-02/2002 
AY744677 DENV-3/PF/PF89-27643/1989 
AY744678 DENV-3/PF/PF89-320219/1989 
AY744679 DENV-3/PF/PF90-3050/1990 
AY744680 DENV-3/PF/PF90-3056/1990 
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AY744681 DENV-3/PF/PF90-6056/1990 
AY744682 DENV-3/PF/PF92-2956/1992 
AY744683 DENV-3/PF/PF92-2986/1992 
AY744684 DENV-3/PF/PF92-4190/1992 
AY744685 DENV-3/PF/PF94-136116/1994 
AY766104 DENV-3/SG/Singapore 8120-95/1995 
AY776329 DENV-3/TW/Taiwan-739079A/XXXX 
AY858037 DENV-3/ID/BA51/2004 
AY858038 DENV-3/ID/den3_88/1988 
AY858039 DENV-3/ID/den3_98/1998 
AY858040 DENV-3/ID/FW01/2004 
AY858041 DENV-3/ID/FW06/2004 
AY858042 DENV-3/ID/KJ30i/2004 
AY858043 DENV-3/ID/KJ46/2004 
AY858044 DENV-3/ID/KJ71/2004 
AY858045 DENV-3/ID/PH86/2004 
AY858046 DENV-3/ID/PI64/2004 
AY858047 DENV-3/ID/TB16/2004 
AY858048 DENV-3/ID/TB55i/2004 
AY876494 DENV-3/TH/C0331-94/1994 
AY923865 DENV-3/TH/C0360-94/1994 
CS477305 DENV-3/XX/WO2006134433-43/XXXX 
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CS479205 DENV-3/XX/WO2006134443-41/XXXX 
M93130 DENV-3/PH/H87/1956 
DQ401689 DENV-3/BD/BDH02-01/XXXX 
DQ401690 DENV-3/ID/InJ-16-82/XXXX 
DQ401691 DENV-3/BD/BDH02-03/XXXX 
DQ401692 DENV-3/BD/BDH02-04/XXXX 
DQ401693 DENV-3/BD/BDH02-07/XXXX 
DQ401694 DENV-3/ID/InJ-16-82/XXXX 
DQ401695 DENV-3/PH/PhMH-J1-97/XXXX 
DQ675519 DENV-3/TW/95TW466/1995 
DQ675520 DENV-3/ID/98TW182/1998 
DQ675521 DENV-3/TW/98TW349/1998 
DQ675522 DENV-3/TW/98TW358/1998 
DQ675523 DENV-3/TW/98TW360/1998 
DQ675524 DENV-3/TW/98TW364/1998 
DQ675525 DENV-3/TW/98TW368/1998 
DQ675526 DENV-3/TW/98TW388/1998 
DQ675527 DENV-3/TW/98TW390/1998 
DQ675528 DENV-3/TW/98TW407/1998 
DQ675529 DENV-3/TW/98TW414/1998 
DQ675530 DENV-3/TW/98TW434/1998 
DQ675531 DENV-3/TW/98TW503/1999 
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DQ675532 DENV-3/TW/98TWmosq/1998 
DQ675533 DENV-3/TW/99TW628/1999 
EU081181 DENV-3/SG/SS710/2004 
EU081182 DENV-3/SG/05K791DK1/2005 
EU081183 DENV-3/SG/05K797DK1/2005 
EU081184 DENV-3/SG/05K802DK1/2005 
EU081185 DENV-3/SG/05K805DK1/2005 
EU081186 DENV-3/SG/05K827DK1/2005 
EU081187 DENV-3/SG/05K843DK1/2005 
EU081188 DENV-3/SG/05K845DK1/2005 
EU081189 DENV-3/SG/05K852DK1/2005 
EU081190 DENV-3/SG/05K863DK1/2005 
EU081191 DENV-3/SG/05K868DK1/2005 
EU081192 DENV-3/SG/05K871DK1/2005 
EU081193 DENV-3/SG/05K2400DK1/2005 
EU081194 DENV-3/SG/05K2406DK1/2005 
EU081195 DENV-3/SG/05K2418DK1/2005 
EU081196 DENV-3/SG/05K2899DK1/2005 
EU081197 DENV-3/SG/05K2918DK0/2005 
EU081198 DENV-3/SG/05K2933DK1/2005 
EU081199 DENV-3/SG/05K3305DK1/2005 
EU081200 DENV-3/SG/05K3312DK1/2005 
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EU081201 DENV-3/SG/05K3314DK1/2005 
EU081202 DENV-3/SG/05K3316DK1/2005 
EU081203 DENV-3/SG/05K3324DK1/2005 
EU081204 DENV-3/SG/05K3325DK1/2005 
EU081205 DENV-3/SG/05K3329DK1/2005 
EU081206 DENV-3/SG/05K3887DK1/2005 
EU081207 DENV-3/SG/05K3897DK1/2005 
EU081208 DENV-3/SG/05K3900DK1/2005 
EU081209 DENV-3/SG/05K3912DK1/2005 
EU081210 DENV-3/SG/05K3913DK1/2005 
EU081211 DENV-3/SG/05K3923DK1/2005 
EU081212 DENV-3/SG/05K3927DK1/2005 
EU081213 DENV-3/SG/05K3928DK1/2005 
EU081214 DENV-3/SG/05K4141DK1/2005 
EU081215 DENV-3/SG/05K4144DK1/2005 
EU081216 DENV-3/SG/05K4157DK1/2005 
EU081217 DENV-3/SG/05K4159DK1/2005 
EU081218 DENV-3/SG/05K4168DK1/2005 
EU081219 DENV-3/SG/05K4176DK1/2005 
EU081220 DENV-3/SG/05K4182DK1/2005 
EU081221 DENV-3/SG/05K4440DK1/2005 
EU081222 DENV-3/SG/05K4454DK1/2005 
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EU081223 DENV-3/SG/05K4477DK1/2005 
EU081224 DENV-3/SG/05K4647DK1/2005 
EU081225 DENV-3/SG/05K4648DK1/2005 
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Appendix E 
Supplementary Figure described in Chapter 5: Inferring the History of Dengue 
Virus Diversity in Malaysia from Sequence Data. 
 
Supplementary Figure 1: Montage of four neighbour-joining trees constructed 
from the Cosmopolitan genotype DENV-2 complete genome and partial 
sequences. The trees are mid-point rooted, all horizontal branches are drawn 
to scale, and only nodes with over 80% bootstrap support are highlighted. 
Complete genome sequences are labeled with their GenBank accession 
number, country and year of isolation. Partial sequences from Malaysia (listed 
in Table 5.2) are labeled only with their GenBank accession number and year 
of isolation. The five DENV-2 complete genomes sequenced in this study are 
D2MY00-22563, D2MY04-32618, D2MY04-32883, D2MY04-33054 and 
D2MY97-10340 and are highlighted in different colours. From left, the tree 
constructed from the sequence of the complete E gene (1485 nucleotides), 
the E/NS1 junction (240 nucleotides), partial E gene (266 nucleotides) and a 
shorter E/NS1 junction (225 nucleotides). 
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